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FOREWORD
This thesis addresses the  concep t  and p ractice  o f  qua l i ty  of life in dem entia .  Q u a ­
lity o f  life in dem en tia  is a rap id ly  g row ing  f ie ld  o f  research. W e present an over­
v iew o f  theory , m easurem ent and research. The thesis includes a theo re t ica l and 
an em pir ica l part.  The f irst pa r t  addresses theore t ica l no t ions on qua l i ty  o f  life in 
dem en tia .  The em pir ica l data consecu tive ly  address qua l i ty  o f  life m easurem ent 
in pa t ien ts  and in formal caregivers, and app l ica t ion ,  unde rs tand ing  and d e v e lo p ­
m en t o f  qua l i ty  o f  life m easurem ent instruments. The genera l in t ro du c t ion  wil l help 
to  unders tand the  com p le x  scenery o f  qua l i ty  o f  life research in dem entia ,  and it 
wi ll exp la in the  relevance and the  t y p e  of the  research ques t ions  to  be answered in 
this  thesis. But fo r  readers who are unfamil iar w i th  dem en tia  and qua l i ty  of life re­
search, we s tart  w i th  a g lossary o f  basic de f in i t ions o f  key te rm s used in this  thesis.
GLOSSARY OF KEYWORDS
A A lzh e im e r's  disease
Alzheimer's disease (AD) is a progressive neuro log ica l brain d isorder leading to  ir­
reversible loss of neurons and dementia.  The NINCDS-ADRDA Alzheimer's criteria 
were p roposed  in 1984 and are am ong the most used in the  diagnosis of AD.1 These 
criteria require tha t  the  presence of cogn it ive  im pairm ent and a suspected d e m e n ­
tia syndrom e be con f irm ed by neuropsycho log ica l tes t ing  fo r  a clinical d iagnosis of 
possib le or p robab le  AD, while they need h is topa tho log ic  conf irmation fo r  the  de f i ­
nit ive diagnosis. The criteria specify  e igh t cognit ive domains tha t  may be impaired: 
memory, or ien ta tion, language, perceptual skills, atten tion, construct ive abil i ties and 
functiona l abili ties, and p rob lem  solving. Since this proposal the  advances in fu n c t i ­
onal neuro im ag ing techniques and CSF biomarker profiles have led to  proposals  of 
revision in to research criteria tha t  take into account these techn iques.2 A D  is the  most 
com m on cause o f  dem entia  (60% of all cases) and usually arises in late m idd le  age or 
in e lderly  peop le, bu t the re  is a rare famil ia l sub type  tha t  occurs earlier.
A A no sog no s ia
Unawareness o f  cognit ive, em otiona l,  and func t iona l defic its. C o n d it ion  in which 
persons w ho suffer d isab i l i ty  seem unaware o f  or deny the  ex is tence o f  the ir  d isab i­
lity. There is no s trong consisten t re la t ionship be tw een d e g re e  o f  anosognosia and 
severity  o f  dem entia .  F ron to tem pora l dem en tia  o f ten  starts w ith  anosognosia . The 
word  comes f rom  the  G reek  words nosos (disease) and gnosis (knowledge).
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B Beh avior
A c t ions  or reactions of persons, usually in re lat ion to  the ir  env ironm ent.  Behavioral 
sym ptom s inc lude d is tu rbe d  percep t ion ,  th o u g h t  con tent,  m oo d  or behavior.
C  C a reg ive r (in fo rm al)
Person who prov ides unpa id  care by look ing  a fte r  fam ily  m em bers, f r iends  or p a r t ­
ners w ith  disabil i t ies. A  b ig chunk o f  all costs of dem en tia  (more than 40% globally) 
is a t t r ib u te d  to  in formal care. It is the re fo re  w o rr isom e that, while the  cost o f  form al 
care in h igh - incom e countr ies con t inues to  escalate to  unsustainable levels, the  
ava ilab i l i ty  of in formal su p p o r t  is p re d ic te d  to  dec l ine  in all regions.
C  C a re -re la ted  q u a lity  o f life
Care-re la ted qua l i ty  o f  life ref lects and values the  im pac t  o f  in formal caregiv ing on 
the  caregiver's overall qua l i ty  o f  life.
C  C o g n itio n
Menta l processes character ized by a t ten t ion ,  knowing, th ink ing ,  learning, re m e m ­
ber ing, language, p lanning action, and judg ing .
C  C op ing
Process o f  m anag ing d e m an d in g  circumstances and em p lo y m e n t  o f  behaviora l 
and psycho log ica l e f fo r ts  to  deal w i th  stressful events.
C  C ost u t il ity  analysis
Cost u t i l i ty  analysis (CUA) est imates the  rat io  be tw een  the  cost of an in te rven tion  
and th e  bene fi t  it p roduces. Cost is measured in m one ta ry  units, bene fi t  is ex­
pressed in QALYs (see Q ua li ty -ad jus ted  life years) or the  re lated DALYs (d isabil i ty- 
ad jus ted life years). Both equal 1 fo r  each year of fu l l -hea lth  life, and less than 1 fo r  
various degrees  o f  illness or d isabil i ty . Thus the  cost-e ffec t iveness o f  a t rea tm e n t  
can be assessed by the  cost per QALY or DALY it produces.
D D em entia
Progressive brain synd rom e with s ign if icant loss of or dec l ine  in in te l lec tua l ab i l i ­
t ies such as memory, in te l lec tua l func t ions  like reasoning and planning, and even­
tual loss o f  physical func t ions  and personali ty, severe enough  to  in terfe re w ith  a 
person's  da ily  social o r  occupa t iona l func t ion ing .  The sym ptom s may also inc lude 
changes in m o o d  and behavior. Dementia  mainly a ffec ts  o lde r  peop le ,  a lthough 
the re  is a g row ing  awareness o f  cases tha t  s ta r t  be fore  th e  age o f  65. A f te r  age 65,
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the  l ike lihood of de ve lop ing  dem en tia  rough ly  doub les  every five years. D e m e n ­
tia affects 1 in 20 p e op le  above 65, 1 in 5 over 80 and 1 in 3 over 90 years o f  age. 
A lzhe imer 's  disease (AD) is the  m ost com m o n  cause o f  dem en tia  and accounts fo r  
60% o f  all cases. O th e r  causes are vascular dem en tia  (VD; 15%), m ixed dem entia  
(AD and VD; 13%) and remain ing (12%), such as f ro n to te m p o ra l  dem entia ,  dem en tia  
w ith  Lewy bod ies  and Parkinson dem entia .  D i f fe rent  types  o f  dem en tia  have been 
associa ted w ith  d i f fe re n t  sym ptom  pa tte rns  and d is t ingu ish ing  m ic roscop ic  brain 
abnorm ali t ies . The sym ptom s o f  d i f fe re n t  types  o f  dem en tia  however may overlap 
and can be fu r the r  com p l ica ted  by coex is t ing  medica l cond it ions. Dementia  is still 
an incurable disease, stressing the  necessity o f  pall iat ive care (see Palliative care).
D D em en tia  Personalized Care P lanning
Dementia  Personalized Care Planning (DPCP) is a p ro to co l  we p ropose  to  g u id e  d e ­
mentia care. DPCP will be based on personal needs and goals o f  bo th  pa t ien ts  and 
caregivers. DPCP is der ived  f rom  th e  choices and choos ing (C-C) m ode l,  a process 
tha t  features the  personal m anagem en t  o f  accessing choices and choos ing am ong 
th e m .3 The C-C m ode l in troduces a science base fo r  unde rs tand ing  and gu id ing  
in te rven tions tha t  can assist p e o p le  to  achieve the ir  qua l i ty  of life goals. The C-C 
m ode l is sup p le m e n te d  w ith s t ruc tu red  e l ic it ing  o f  realistic m ost u rgen t prob lem s 
and needs. The result o f  th is  process is conver ted  into concre te  goals fo r  care p lan ­
ning, t rea tm e n t  and evaluation du r ing  fo l low -u p  visits.
D D e scrip tive  q u a lity  o f life  in s tru m en ts
Descr ip t ive qua l i ty  o f  life ins trum ents  (health profiles) com pr ise  m u l t ip le  d im e n ­
sions o f  health status. A  small set o f  re lated items covers the  con ten t  o f  various 
health dom ains and a score fo r  each d im ens ion  is ge ne ra ted  based on classical 
tes t  theo ry .4 The dom ains are regarded  in d e p e n d e n t ly  and the ir  relative separa te 
rat ings are no t in te nd ed  to  be ag g re ga te d  in to one score. Thus, these ins trum ents  
are no t  ap p ro p r ia te  to  measure the  overall level o f  health states. The SF-36 (M e d i­
cal O u tcom es  Study 36- item  Short-Form  Health Survey) ins trum en t is a f requ en t ly  
used descr ip t ive  gene r ic  qua l i ty  o f  life measure w o r ld w id e .5
D D is a b ility  pa rad ox
It is o f ten  assumed tha t  living w ith  a chronic disease means a reduced qua l i ty  of life. 
D isabi l i ty  pa radox  is the  ph en om en on  tha t  persons w ith  serious d isab il i t ies against 
all odds  rep o r t  a relat ively  h igh hea lth -re la ted qua l i ty  o f  life, while observers ju d g e  
the ir  life to  be undesirab le . The d i f fe rence  may be exp la ined because pat ien ts  f irst 
o f ten  f igh t,  neg lec t  or avoid losses, while adap t ing  to  the ir  disease later in life.
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D D isease -spec ific  index  in s tru m en ts  fo r  q u a lity  o f life
This ty p e  o f  ins trum en t com b ines  d isease-spec if ic ity  and quant i f ica t ion  o f  per­
ceived qua l i ty  in several health dom ains into one single f igure. These ins trum ents  
have been de ve lope d  fo r  som e diseases, bu t  not fo r  dem entia .  W e des igned  the  
p ro to ty p e  o f  a d isease-specif ic  index  ins trum en t fo r  dem en tia ,  the  Dementia  Q u a ­
lity o f  life Ins trum ent (DQI). The DQI is a c lassif ication system w ith  five se lec ted 
dem en tia  dom ains to  descr ibe  dem en tia  status.
D D isease -spec ific  q u a lity  o f life  in s tru m en ts
Disease-specif ic measures ta rge t  indiv idual diseases (or domains). They aim at e m ­
phasizing prob lem s specif ic  to  patients with a specif ic  disease such as dementia .  
C om pared with generic  measures, disease-specif ic measures normally are more sen­
sitive and responsive to  the  changes in the  assessment of qual ity  of life of specific 
pat ient groups. Disease-specific scales only include items relevant fo r  the  disease in 
quest ion and thus contain less 'noise' than generic  instruments which also contain less 
appropr ia te  items. However, the  cost of g reater specif ic ity is less generalizabili ty.
G G eneric  q u a lity  o f life  in s tru m en ts
Generic  qual ity of life instruments are universal and cover general health aspects, 
which makes them relevant for multip le  patient groups and allows comparison across 
dif fe rent diseases. They rate qual ity of life in terms that are relevant for everybody, 
regardless of the presence or absence of a specific disease. Generic  measures may 
include domains not relevant for patients with a specific disease and underestimate 
more relevant areas. This may result in a lower responsiveness. Typically a generic mea­
sure in clinical research is com b ined with one or more disease-specific measures.
H H e a lth -re la te d  q u a lity  o f life  (HRQoL)
Health-re la ted qual ity  of life is a more narrow concep t than qual ity  of life and reflects 
the  indiv idual's percep tion  o f  the  im pact  o f a health status, e.g. dementia, on the  a b i­
li ty to  pe r fo rm  usual tasks and effects on everyday life, and physical, social and e m o ­
t ional we ll-be ing. HRQoL primari ly  looks at qua l i ty  of life th rough  the  perspective of 
a person's health status and /o r  im pact of a person's health cond it ion  or disabili ty.
H H ealth  s ta tus
Health (status) accord ing  to  the  W or ld  Health O rgan iza t ion  de f in i t ion: a state of 
c om p le te  physical, menta l and social w e l l-be ing ,  and no t m ere ly  the  absence of 
disease or infirmity. Self-ra ted health status has been shown to  be m ost ly  re lated to  
physical health and func t ion .
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I Index  q u a lity  o f life  in s tru m en ts
Index (pre ference or value-based) qua l i ty  of life ins trum ents  evaluate the  value tha t  
persons place on a part icu lar  health s tate and no t  d irec t ly  the  im pac t  of a disease 
or t re a tm e n t  on the ir  ab i l i ty  to  fun c t ion  in life. Index measures quan t i fy  m u l t ip le  
health dom ains  into one single f igure. In the  case o f  HRQoL, index  measures q u an ­
t i fy  the  des irab i l i ty  o f  a certa in  health state.6 The ge ne ra ted  values (variously called 
util it ies, preferences, s treng th  o f  preference, or weights) are o f ten  unam biguous; 
e.g., a value of 1.0 stands fo r  'pe r fe c t  health ' and 0.0 fo r  'de a th '  (see Utilities). HR­
Q oL  values w ith  m etr ic  character is tics are especia lly useful because they  prov ide  
vital in fo rm at ion  fo r  health ou tc o m e  research and econom ic  evaluations. The Euro- 
Q o l-5  D (EQ-5D) is the  m ost w ide ly  used HRQoL index  ins trum en t.7;S A p p l ic a b le  to  
a w ide  range of health cond it ions  and trea tm ents ,  it p rov ides a s im p le  descr ip t ive  
profi le  and a s ingle index  value (utility) fo r  health status.
M M easurem en t o f HRQoL
There are tw o  fundam enta l ly  d i f fe rent  approaches to  HRQoL measurement. The first 
is the  standard 'quest ionna ire ' approach, using descrip tive or profi le instruments 
(see Descrip t ive qua l i ty  of life instruments). 'The second is the  ' index '  approach, using 
pre fe rence-based  ins trum ents  (see Index qua l i ty  of life instruments).111111 Based on 
the  ex ten t  to  which illnesses are covered, bo th  types  o f  HRQoL measures can be 
ca tegor ized  in to d isease-specif ic  ins trum ents  (see D isease-specif ic qua l i ty  o f  life 
instruments) and gene r ic  ins trum ents  (see Gener ic  qua l i ty  o f  life instruments). The 
f irst ta rg e t  ind iv idual diseases o r  specif ic  health p rob lem s, while gener ic  ins tru ­
ments  are m ore  universal and cover genera l health aspects. In sum, the re  are 4 t y ­
pes of qua l i ty  of life m easurem ent instruments: d isease-specif ic  index  ins trum ents  
(i.e. the  Dementia  Q ua li ty  o f  life Ins trum ent (DQI), d isease-specif ic  descr ip t ive  in ­
s trum en ts  (i.e. Q ua l i ty  o f  L ife-A lzheimer's  Disease Scale (QOL-AD), gener ic  index 
ins trum ents  (i.e. EQ-5D), and gener ic  descr ip t ive  ins trum ents  (i.e. SF-36).
M M ild  c o g n itiv e  im p a irm e n t
Forgetfu lness tha t  is worse than normal fo r  one's age bu t  is not (yet) associa ted 
w ith  certa in  cogn it ive  p rob lem s c om m o n  in dem entia ,  such as d iso r ien ta t ion  or 
confus ion. Persons w ith  M ild C ogn it ive  Im pa irm en t (MCI) are ab le to  func t ion  in 
everyday activ i t ies w i th o u t  m ore  assistance f rom  others than previously  needed, 
bu t  have d i f f icu l ty  w i th  m e m o ry  or o th e r  cogn it ive  functions.  A  variab le part  o f  the  
sub jects  w ith MCI convert  to  dem en tia  patients.
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M M in i-M e n ta l S tate E xam ina tion
The M in i-M en ta l State Examination (MMSE) is a screening tes t  o f cogn it ive  func t ion  
involv ing o r ien ta t ion ,  reg is tra t ion, a t ten t ion  and calcula t ion, recall, language and 
praxis. The MMSE is w ide ly  used as a research too l,  and has been extensive ly  val i­
da ted,  t rans la ted, and m od if ied .
O O u tco m e  m easures
Assessing m eaningfu l t re a tm e n t  benefi ts  is com p lex .  Many researchers state tha t 
cogn it ive  response no longer suffices in an t i-dem ent ia  tr ials.12 There is l i t t le  c o n ­
sensus on which dom ains are best su ited to  evaluate c l in ically m ean ingfu l results 
o f  t rea tm en t .  Neverthe less European consensus to  im prove com p a ra b i l i ty  of psy­
chosocia l in te rven t ion  stud ies in dem en tia  was reached. R ecom m ended ou tcom e  
measures were fo r  patients: qua l i ty  o f  life, m ood ,  g loba l func t ion ,  behav ior and 
daily living skills. For in formal caregivers the  p re fe rred ou tcom es  were m ood, bu r­
den, cop ing  w ith behav ior and qua l i ty  of life.l3There is increasing recogn it ion  tha t 
a d d ing  p a t ie n t- re po r te d  ou tcom es  such as HRQoL is warranted.14
P Pallia tive care
Defin it ion o f  the  W or ld  Health O rgan isa t ion  (WHO): an approach tha t  improves 
the  qua l i ty  of life o f  pa t ien ts  and the ir  famil ies fac ing the  p rob lem s associa ted w ith 
life th rea ten ing  illness, th ro u g h  the  preven tion  and rel ief o f  su ffe r ing  by means of 
early iden t i f ica t ion  and im peccab le  assessment and t rea tm e n t  of pain and physical, 
psychosocia l and spir i tua l p rob lem s. Palliative care provides rel ie f f rom  distressing 
sym ptom s, offers a s u p p o r t  system to  he lp pa t ien ts  live as active ly  as possib le  until  
death, offers a su p p o r t  system to  he lp the  fam ily  cope  du r ing  the  pa t ien ts  illness 
and in the ir  own bereavem ent,  uses a team approach to  address the  needs o f  pa ­
t ien ts  and the ir  famil ies, wil l enhance qua l i ty  of life and is app l icab le  early in the  
course o f  illness.
Q Q u a lity -a d ju s te d  life  years
Q ua li ty -ad jus ted  life years (QALYs) assess the  ex ten t  of benefi ts  ga ined  f rom  in ­
te rven t ions.  It com b ines  ga ined  life t im e  and qua l i ty  o f  the  ga ined t im e  and it is 
de f ined  tha t  the re  exists the  poss ib i l i ty  o f  t r a d e -o f f  be tw een  these tw o  aspects. 
W hen QALYs are used in d i f fe ren t  in terventions, c ross-comparisons can be made 
to  descr ibe  the  relative benefi t .  W hen com b in e d  w ith  the  costs of p rov id ing  these 
in terventions, decis ion makers can unders tand  the ir  relative cost-e ffect iveness. In 
case of scarce resources in te rven tions should be re im bursed which p rov ide  the  
best increm enta l cost-e ffec t iveness ratio.
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Q Q u a lity  o f life
Defin it ion according to  the  W H O : the  percep tion  of indiv iduals of the ir  posit ion in life 
in the  con text of the  culture and value systems in which they live, and in relation to 
the ir  goals, expectat ions, s tandards and concerns (W H O Q O L 1995). Q ua l i ty  of life is 
a m ult id imensiona l construct of physical, material, social and em otiona l we ll-be ing, 
deve lopm en t  and activity, and the  ab il i ty  to  func t ion  in daily life. It is a broad ranging 
concep t a f fec ted by the  person's physical health, psychological state, level o f  in de ­
pendence, personal beliefs, social relationships, relat ionship to  salient features of 
the  environment, such as financial resources, accessib il i ty  and qual ity  of professional 
care, op po r tun i t ie s  fo r  acquir ing new in formation, skills and recreation. But, facets 
like t ransport ,  sp ir i tua lity  and rel ig ion are also involved. In this thesis the  te rm  'quali ty 
o f  life' can refer to  bo th  qual ity  of life and health-re la ted qua l i ty  of life.
R Response s h ift
Response sh ift  is the  change in self-eva luat ion o f  qua l i ty  o f  life as a result  of reca­
l ibrat ion (changes in in ternal m easurem ent s tandards in assessing qua l i ty  o f  life), 
rep r io r i t iza t ion  (changes in values or im p o r tan ce  o f  dom ains cons t i tu t ing  qua l i ty  of 
life), or reconceptua l iza tion  ( redef in it ion o f  qua l i ty  o f  life). A cco rd in g  to  response 
sh ift  th e o ry  p e op le  rate the ir  health in reference to  a relative instead o f  an absolute 
s tandard , namely  the ir  current health. However, health state, and thus standards, 
change o v e r t im e  in case o f  progressive diseases. Response sh i ft  is o f ten  seen in 
pa t ien ts  w ith  chronic disease who adap t to  disease progress ion (see also Disabi l i ty  
paradox).
S Sense o f com p e ten ce
Sense o f  com p e ten ce  is the  concep t tha t  deno tes  in formal caregivers ' fee l ing  of 
be ing  capab le  to  care fo r  the ir  care recip ients. It inc ludes sa t is faction w ith  the  care 
rec ip ient,  sa t is faction w ith  the  person's  own perfo rm ance, and (adverse) conse­
quences of caregiv ing fo r  the  personal life of the  caregiver.
U U til ity
Util it ies are values fo r  health states: numeric  m easurem ents  (0=death , 1 = best po s ­
sib le health state) tha t  ref lect a person 's  be liefs ab o u t  the  qua l i ty  of life w e igh t  
o f  a health state. Util it ies are de r ived  by e i ther  d i rec t  or ind irec t  index  (utility) in­
strum ents . D irec t measures inc lude visual ana logue scales (VAS), s tandard  ga m b le  
(SG), and t im e  t ra d e -o f f  (TTO) techn iques.  Health s tate uti l i t ies are used to  ca lcu­
late QALYs (see also Q ua li ty -ad jus ted  life years) which are ap p l ied  in cos t-u t i l i ty  or 
cost-e ffec t iveness analysis.
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W W e ll-b e in g
State o f  be ing healthy, happy. Expression o f ten  used in te rchangeab le  w ith  qua l i ty  
o f  life, bu t as qua l i ty  of life is de f ined  broader, w e l l-be ing  is best cons idered as as­
soc ia ted w ith  qua l i ty  o f  life. A t  the  ind iv idual level, w e l l -be ing  is in fluenced by fa c ­
tors such as fam ily  and social relat ionships, health and work. A t  the  societa l level, 
w e l l -be ing  consists o f  the  co l lec t ive  w e l l-be ing  o f  indiv iduals , social insti tu t ions, 
and the  qua l i ty  o f the ir  in te ract ions. Choices and s ign if icant life events can alter the  
course o f  a person 's  life, and thus, his or her we l l-be ing.
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INTRODUCTION
Q u a lity  o f life
Q ua l i ty  o f  life is the  pe rcep t ion  of p e o p le  of the ir  pos it ion  in life in the  con tex t  of 
the  cu ltu re and value systems in which they  live and in re lat ion to  the ir  goals, ex­
pecta t ions, s tandards and concerns, ir respect ive of health status (W H O Q O L  1995). 
Q ua l i ty  o f  life inc ludes pe rcep t ions  o f  overall qua l i ty  o f  life, health, physical and m a­
ter ia l w e l l-be ing ,  work, family, social relat ionships, com m u n ity -  and social activ it ies, 
personal deve lopm e n t ,  personal ach ievements, happiness, life satisfaction, p e rso ­
nal exper iences and values, active recreation, learning, educa t ion ,  and leisure.15'16 
Consequently ,  qua l i ty  of life is a m u l t id im ens iona l concep t  tha t  can be de f ined  in 
te rm s o f  ob jec t ive ly  measurable life cond it ions  and the  sub jec t ive ly  measurable 
sa t is faction w ith these cond it ions .  W hen qua l i ty  o f  life is desc r ibed  th ree  quest ions 
need to  be answered. How well measure ob jec t ive  ind ica tors the  variance in qua l i ty  
o f  life of an indiv idual? How im p o r ta n t  is a g iven qua l i ty  o f  life dom ain  fo r  som eone, 
and how satis fied is the  person w ith  this  domain?
Q ua l i ty  o f  life has a m u lt i fa ce ted  perspective . This requires a sh ift  away f rom  
approaches tha t  focus on ly on single areas of life (e.g. health, func t ion ing ,  social 
s up po r t ,  life satisfaction, and we ll-be ing) tow ards  an approach  tha t  also reveals 
the  views o f  the  persons w ith  dem entia .  How qua l i ty  o f  life is u n de rs to od  depe nd s  
on which pe rspec t ive  one uses.17;1a Q ua l i ty  of life is a dynam ic cons truc t  w i th  in te r­
active dom ains and chang ing  values result ing f rom  processes such as ag ing, life 
exper iences and diseases.
Thus, qua l i ty  o f  life is on the  one hand ob jective , external and quan ti ta t ive , bu t  on 
the  o th e r  hand sub jective, in ternal and qual itat ive. O b je c t ive  in fo rm at ion  can be 
desc r ibed  w ith  descr ip t ive  indicators, sub jec t ive  in fo rm at ion  is desc r ibed  w ith  eva­
luative ind ica tors  (e.g. sa t is faction w ith  a descr ip t ive  indicator).  Both approaches 
are com p le m e n ta ry  and shou ld  not be t rea ted  as oppos ites .
W e ll-b e in g
The expression 'w e l l -be in g '  is o f ten  used in te rchangeab le  w ith  qua l i ty  of life, bu t 
the  la tte r has a b roader de f in i t ion . W e l l -be ing  is a state o f  be ing healthy, happy. 
W e l l -be ing  is best cons idered  as associa ted w ith qua l i ty  o f  life. A t  the  ind iv idual le­
vel, w e l l -be ing  is in fluenced by fac tors  such as fam ily  and social relat ionships, health 
and work. A t  the  societa l level, w e l l -be ing  consists o f  the  co l lec t ive  w e l l -be ing  of 
indiv iduals , social insti tu t ions, and the  qua l i ty  o f  the ir  in teract ions. Choices and 
s ign if icant life events can a l te r th e  course o f  an ind iv idual's  life, and thus, his or her 
we ll-be ing.
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W hen cons ider ing  qua l i ty  o f  life as a g loba l overarch ing concep t  it is also im p o r ta n t  
to  discern be tw een what is a face t o f  qua l i ty  o f  life and what de te rm ines  qua l i ty  of 
life. De te rm inants  are fac tors  tha t  can in fluence qua l i ty  o f  life bu t  are no t part  o f  it. 
Treating or in fluencing m ajor d e te rm inan ts  has consequences fo r  qua l i ty  o f  life and 
thus th e ra pe u t ic  consequences.
H e a lth -re la te d  q u a lity  o f life  (HRQoL)
HRQoL is qua l i ty  o f  life f rom  the  medica l and health perspective . HRQoL primari ly  
looks at qua l i ty  o f  life th ro u g h  the  pe rspec t ive  o f  a person's  health status and /o r  
im pac t  o f  a person's  health cond i t ion  or d isabil i ty . By de f in i t ion  HRQoL is a nar­
rower con cep t  than qua l i ty  o f  life. The te rm  HRQoL o r ig ina ted  to  d is t inguish o u t ­
comes relevant to  health research f rom  earlier soc io log ica l research on sub jective 
w e l l -be ing  and life sat is faction in healthy popu la t ions .  HRQoL can be de f ined  as 
the  value assigned to  leng th  o f  life as m od if ied  by the  im pa irm ents ,  func t iona l 
states, pe rcep tions, and social o p p o r tu n i t ie s  tha t  are in f luenced by disease, injury, 
t rea tm en t ,  or policy.1' HRQoL reflects the  ind iv idual's  pe rcep t ion  o f  th e  im pac t  o f  a 
health cond i t ion  on the  ab i l i ty  to  pe r fo rm  usual tasks and the  effec ts  on everyday 
life, physical, social and em otiona l w e l l -b e in g .21-1 HRQoL can be d is t ingu ished  f rom  
qua l i ty  o f  life in tha t  it concerns itself  pr im ar i ly  w ith  those  fac tors  tha t  fall under 
the  pu rv iew  of health care prov iders  and systems. However, because health is not 
just the  absence o f  disease, HRQoL measures o f ten  also incorpora te  percep tions, 
role func t ions ,  social health, and genera l w e l l-be ing .  Carr et al. assumed HRQoL to  
be those  aspects o f  an indiv idual's  sub jec t ive  exper ience tha t  relate bo th  d irec t ly  
and ind irec t ly  to  health, disease, d isabil i ty , and im p a irm e n t .21 However, the re  is no 
consensus on the  de f in i t ion  of HRQoL.
H ealth  s ta tus
Q ua l i ty  o f  life and health status are separa te constructs.  Health status is c o m p a ­
rable to  HRQoL. However, in contrast to t  HRQoL, health status is more clinically 
o r ien ted  and the re fo re  does not inc lude dom ains such as social activ it ies. W hen 
rating qua l i ty  o f  life, pa t ien ts  give grea te r  emphasis to  menta l health than to  physi­
cal func t ion ing .  This pa t te rn  is reversed f o r t h e  appra isal o f  health status, fo r  which 
physical fun c t io n in g  is a m ore  im p o r ta n t  de te rm in an t  than menta l health. Thus, 
eva luations o f  e f fect iveness of in te rven tions may d i f fe r  d e p e n d in g  on w he the r  
qua l i ty  o f  life, HRQoL or health status is the  s tudy  o u tcom e .22 Instruments to  m ea­
sure health status, inc lud ing u t i l i ty -based quest ionnaires, may not be su i tab le  for  
measuring overall (HR)QoL, because m ost responden ts  will refer pr im ari ly  to  the ir  
physical c o n d i t io n .22
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In sum, qua l i ty  o f  life, w e l l-be ing ,  HRQoL and health status are ove r lapp ing ,  bu t 
d is t inc t  concepts. The in te rre la t ionsh ip  be tw een  these concep ts  is p resen ted in 
Figure 1. In this  thesis the  te rm  'qua l i ty  o f  life' is used as the  overarch ing concep t 
cover ing qua l i ty  o f  life, w e l l-be ing ,  hea l th -re la ted qua l i ty  o f life (HRQoL) and health 
status. 'Q ua l i ty  o f  life' can refer to  any of these concepts.
Figure 1. O verarch ing c on cep t  o f  qua l i ty  o f  life in dem en tia
Dementia  is a com p lex  neurodegenera t ive  synd rom e characterized by dec l ine  in 
cognit ive, social and physical func t ion ing .  The burden o f  dem entia  is not on ly  or 
pr imari ly  ref lected by decrease in cogn it ion ,  bu t also by a variety  o f  non-cogn it ive  
sym ptom s such as behavioral p rob lem s and physical handicaps. As the  popu la t ion  
ages more p e op le  will be faced with dem entia .  The num ber of dem entia  patients 
in the  Nether lands is ab ou t  250,000, inc lud ing 175,000 pat ien ts w ith A lzheimer's 
disease. Prevalence is 1-2% in peop le  aged  65-70 years (www.RIVM.nl) and rises 
s teeply with aging, up to  30-55% in peop le  aged 90-94 years. The num ber of newly 
d iagnosed dem entia  patients is abou t 30,000 per year. Dementia places a subs tan­
tial medical,  social and psycholog ica l burden on patients and the ir  famil ies and 
caregivers. The de tr im en ta l im pact  upon qua l i ty  of life of all persons involved is well 
established. Most p e op le  regard dem entia  as a devastat ing end of life. Avai lable 
m ed ica tions fo r  A lzheimer's  disease tem po ra r i ly  reduce sym ptom s fo r  some, bu t 
cannot change the  under ly ing course o f  the  disease. Given the  com p le x i ty  o f  d e ­
mentia, the re  is em erg ing  consensus tha t  besides d iscrete areas o f  func t ion ,  broad 
pa t ien t- re po r te d  ou tcom e  measures such as qua l i ty  o f  life are warranted fo r  c o m ­
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prehensive ou tcom e  m easurem ent in clinical t rea tm ent,  research and economical 
decis ion making. As such, qua l i ty  o f  life can be regarded as one of the  health o u tc o ­
mes of dem entia ,  which in tu rn  is related to  and in fluenced by o ther  ou tcomes. 
M easurem ent o f  qua l i ty  o f  life prov ides a sub jec t ive  evaluation th a t  captures the  
benefi ts  and harms o f  in te rven tions and e lem ents  o f  health not de te c te d  by 
s tandard  clinical ou tcom es .23 Next to  survival and clinical ou tc o m e  parameters 
(such as cogn it ion ,  behavior, ins trum enta l and basic activ i t ies o f  da ily living) qua l i ty  
o f  life has becom e an estab l ished ou tcom e  measure in evaluating clinical in te rven ­
t ions, and fo r  dem en tia  pat ien ts  and caregivers.13;24;25
The im pac t  of dem entia ,  bo th  in te rm s o f  cost o f  care and of lives af fec ted ,  is s ta g ­
ger ing .  Dementia  places a massive strain on an a lready ove rbu rdened  health care 
bu dg e t .  In th e  absence o f  d isease -m od ify ing  t rea tm en ts  dem en tia  is a chronic and 
st ill incurable disease, im p ly ing  the  need o f  pall iat ive t rea tm en t .  The pr im ary  aim 
o f  pall iat ive t re a tm e n t  shou ld  be to  mainta in o r  im prove qua l i ty  o f  life. M ed ica l m o ­
dels o f  qua l i ty  o f  life t rad i t iona l ly  assume tha t  the  more sym ptom s present, and the  
m ore advanced the  disease, the  po o re r  the  qua l i ty  o f  life. Neverthe less, many p e o ­
ple w ith  serious and pers is ten t d isab il i t ies rep o r t  a high qua l i ty  o f  life against all 
o d d s .26 This ph en om en on  is called d isab i l i ty  paradox. Disabi l i ty  pa radox  expla ins 
why many p e o p le  w ith  serious d isab il i t ies rep o r t  tha t  they  exper ience  a g o o d  or 
even exce llent qua l i ty  o f  life when to  most external observers they  seem to  live 
an undes irab le  da ily existence. People o f ten  overest im ate  the  em otiona l im pact 
tha t  chronic illnesses and d isab i l i ty  will have on the ir  lives. There is a d iscrepancy 
be tw een  th e  happ iness repor ts  o f  pa t ien ts  w ith  chronic il lness or d isab i l i ty  versus 
the  happiness p red ic t ions  o f  healthy p e op le  asked to  im ag ine the  same il lnesses 
and disabil i t ies. The available ev idence suggests  that, whereas pa t ien ts  m is report  
the ir  w e l l-be ing ,  healthy p e op le  also m isp red ic t  the  em o tiona l im pac t  tha t  chronic 
illness and d isab i l i ty  wil l have on the ir  lives.27 The d i f fe rence  may be exp la ined 
because pa t ien ts  f irst o f ten  f igh t,  neg lec t  or avoid losses, while adap t ing  to  the ir  
disease later in life. If we assume tha t  in te l lec tua l capacities, ju d g m e n t  and insight 
are intact, d isab il i ty  paradox may be expla ined by the  dynamics of cop ing and ad ap ­
tat ions to  disease states. First patients may f ight, neg lect or avoid losses, and la­
te r  they may adap t themselves.2“ Thus, qual ity  o f  life does not necessarily decrease 
du r ing  the  course of de m en t ia ,2v;3uand is preserved in some p e op le  w ith  advanced 
dem en tia  desp i te  disease progress ion .31 A p p a re n t ly  the  re la t ionship be tw een  se­
ver i ty  of dem en tia  and qua l i ty  of life is ne ither s im p le  nor d irec t.  Q ua l i ty  o f  life is 
dependen t upon finding a balance between body, mind and spir it  and on establishing 
and main ta in ing harm on ious re lat ionships w ith in  the  person 's  social con tex t  and 
external env ironm ent.
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Changes in ind iv idual qua l i ty  o f  life m easurem ents  o f ten  do  not on ly  ref lect chan­
ges in health status, bu t also changes in the  psychological adap ta tion  o f  percep tion 
o f  qual ity  o f  life fo l low ing  a change in health status, e.g. by adap ta tion to  progress 
o f  the  disease. This phenom enon is called response shift. Response shift  needs to  be 
considered when in terpre ting serially measured pat ient reported  ou tcom es.32 Res­
ponse shift  is inextricably  bound up with the  qual ity  o f  life concep t and should be 
taken in to account in the  design and in terpre ta tion o f  clinical research. However, in 
the  absence o f  go ld  standards fo r  bo th  qual ity  of life and response shift, it is not yet 
clear which m ethods best quanti fy  response shift.
Dementia is a hope-h inder ing  life experience fo r  patients as well as the ir  informal 
caregivers and hope is im portan t  to  maintain qual ity  o f  life. But there are also many 
factors outs ide the  dem entia  tha t  influence qual ity  o f  life. Qua lity  o f  life is primarily 
de f ined by the  person and his or her circumstances and not just by the  dementia. 
It is there fore im portan t  to  deve lop  m ethodo log ies  tha t  include bo th  gener ic  and 
dementia-specif ic  qual ity  o f  life indicators, because domains tha t feature generic 
qual ity  o f  life measures may be o f  just as much relevance to  peop le  with dementia  as 
the  more dementia-specif ic  domains in disease-related qual ity  of life measures. 
Q ua lity  o f  life measurement can dem onstra te  whether benefi ts  o f  t reatm ents  are 
perceived as meaningful by patients and caregivers.33 If tw o  diffe rent t rea tm ent o p ­
tions equally affect cognit ive or functional domains, but one im proved qual ity  o f  life 
and the  o ther d id not, the  therapy tha t  w ou ld  improve qual ity  o f  life should probab ly  
be the  therapy o f  choice (also de pe nd ing  on side effects, safety issues and costs). 
The International W ork ing  G roup  fo r  the  Harmonization o f  Dementia Guidelines has 
recom m ended tha t qual ity  o f  life should be inc luded as ou tcom e parameter in d e ­
mentia trials.34 Empir ical results o f  qual ity  o f  life research will lead to  identi f ication of 
the  relevant t rea tm ent goals fo r  bo th  patients and caregivers.
Figure 2 provides an overview of the  relevant ou tcom es associated with qual ity  o f  life 
in dementia . The ob jective dom ain includes dem entia -re la ted personal factors tha t 
are strong ly influenced by the  disease (e.g. physical health, function, cognition), g e ­
neral personal factors (e.g. age, sex, income) and ob jective external environmenta l 
influences (e.g. social support,  living situation). The subjective dom ain  consists o f  the 
indiv iduals ' personal values, de f in ing the im portance o f  certain ob jective life con­
ditions, the ir  subjective fee ling of we l l-be ing (i.e. degree  o f  satisfaction o f  persons 
with the ir  ob jective life conditions) and finally the  subjective evaluation of a person's 
life in general.  All these domains and factors are intr icately linked with each other. 
Indiv idual qual ity  o f  life is p robab ly  d e te rm ined  by m ult ip le  ob jective and subjective 
factors. This thesis will t ry  to  clarify some of these com p lex  relationships.
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W hat are th e  p itfa lls  o f m easuring qu a lity  o f life  in dem entia?
Dementia may in terfere with understanding, the  abil i ty  to  rem em ber relevant events, 
making comparisons across com p lex  domains, and com m unica t ing . This raises d o u b t  
on valid ity and rel iabil ity o f  pa t ien t reported  outcomes, especially on reflective m ea­
sures such as qual ity  of life. The im pact o f  dec lin ing inte llectual capacities, semantic  
know ledge and ep isod ic  memory, as well as varying defic its o f  ju d g m e n t  and insight, 
may com prom ise ju d g m e n t  and add to  inter- and in tra-indiv idual variation in qual ity 
o f  life rating. Anosognosia (unawareness o f  deficits) is f requently  reported as a cau­
se fo r  less rel iable repeated self-reports and discrepancies between self-rating and 
proxy-rating. Also, judgm ents  abou t what is im portan t  to  qual ity  o f  life may change 
as the  dementia  progresses: what seems im portan t  in early stages (e.g., preservation 
o f  inte llectual capacity) may seem un im portan t  in late stages, when safety and c o m ­
fo r t  may take on primary importance. In the  first section o f  this thesis we will discuss 
theoret ica l concepts tha t  posit ion qual ity  o f  life in the  broader perspective of patient 
related outcom es and needs, and discuss which criteria may gu ide  in selecting spe­
cific types o f  qual ity  o f  life measures fo r  specif ic goals.
W ho should rate qu a lity  o f life  in dem entia?
The quest ion who should rate qual ity  of life is especially crucial in dementia .  Discre­
pancy between ob jective and subjective assessments is com m on. Patients with the
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same condition respond differently and even the same patient can respond d iffe­
rently at d ifferent tim e points, as a result o f unawareness and variance or decrease in 
self-report accuracy. The objective approach o f quality of life measurement reflects 
the trad itional biomedical approach with the emphasis on objective measurement 
by e.g. professionals. However, there is no linear correlation between poor health 
and poor quality o f life. The subjective approach values quality of life by defin ition as 
a subjective phenomenon tha t therefore can only be meaningful evaluated through 
self-report by the person concerned. Dementia patients are the persons w ith the ac­
tual experience of living w ith dementia, but the reliability of the ir quality o f life rating 
may be(come) influenced by cognitive lim itations. Reliable self-report is probably 
feasible until late dementia stages, also depending on the type of dementia, if scales 
are well chosen. Probably, the best approach is to  combine self-report, observations 
and other evidence.35 However, there is no consensus whether patients suffering from 
the impact o f a certain disease, or persons naïve to  this disease, provide more appro­
priate and representative valuation of health states from  a societal perspective.
The subjective nature of quality o f life limits the value of proxy-reports. The major 
advantage of proxy-rating, by someone closely related to  the patient, is tha t it resol­
ves the problem of missing data in longitudinal investigations in dementia research 
when patients in late disease stages are no longer possible to  rate the ir own quality 
o f life. A  crucial question is whether proxy-rating offers a reliable alternative fo r self- 
report. Informal caregivers generally rate patients' quality of life low erthan dementia 
patients themselves.363“ However, they are neither experiencing dementia, nor have 
prior knowledge o f dementia, and often underestimate or neglect the capacity of 
patients to  adapt to  the ir illness. Confronted with a particular health state, people 
who are not in that state will report lower quality of life scores than patients who are 
actually experiencing tha t state. Furthermore, caregivers have the ir own health and 
mood problems, burden, changed relationship with the care recipient and altered 
perspectives. Also, they usually have not received professional training and are often 
isolated. Their quality o f life depends on the balance between caregiving-related 
stressors and caregiving uplifts. Imbalance can lead to  caregiver burn-out. Caring 
fo r people with dementia is associated with increases in distress and decreases in 
mental health, well-being and quality o f life. A ll these issues influence proxy-rating. 
Also, the impact o f dementia remains hypothetical and theoretical fo r formal and 
informal caregivers. It is hard to  imagine how valuable life can be fo r people in later 
stages o f dementia. Discrepancies may arise if patients adapt to  illness and proxies 
(as well as the patients themselves beforehand) do not predict or appreciate this 
adaptation. Conventional quality o f life measures will always be influenced by factors 
above and beyond the disease process. That is the ir strength, and at the same tim e
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the ir weakness.
In sum, the patient's own opinion should remain the reference standard as long as 
possible when it comes to  the subjective evaluation o f quality o f life. Use o f paral­
lel proxy-measures from the start o f a longitudinal study prevents the necessity for 
substituting patient-rating by proxy-rating when patients are no longer able to  judge 
the ir own quality o f life. This reduces bias ove rtim e  and prevents missing data. In the 
second section o f this thesis we will address several questions concerning patient 
and proxy measurements of quality of life.
W hich measures are available and should be used?
First we present an overview of how often quality of life is used as endpoint in phar­
macological and non-pharmacological intervention randomized controlled trials in 
patients w ith MCI and dementia and the ir caregivers. Better understanding of the 
key determ inants of quality of life of dementia patients and informal caregivers can 
help to  improve dementia care. W e therefore assessed how quality o f life o f pa­
tients and caregivers were associated. W e have also attem pted to  identify the de­
term inants of the ir individual quality of life. And finally we report on the valid ity and 
feasib ility o f the Dementia Q uality o f life Instrument (DQI) prototype. The DQI will 
become the first dementia-specific index measure allowing overall quantification of 
relevant health domains into one single metric figure. This figure will enable unequi­
vocal interpretation of subjective dementia HRQoL states and provide the field with 
an outcome measure of added value fo r evaluation research in dementia.
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OUTLINE OF THE THESIS
Q ua lity  o f life  in dem en tia . Theo re tica l pa rt
Chapter 2 is a narrative review o f the concept of quality  o f life and o f the available 
measurement scales. Chapter 3 presents an overview  of available measurement 
instrum ents and guidance fo r selection of the appropriate scale. Chapter 4 ex­
plores the interaction between quality  of life in dementia in relationship to  unm et 
needs. Chapter 5 describes the challenges and problems of accurate measurement 
o f quality  o f life in dementia.
Q ua lity  o f life  in dem en tia . Em pirica l pa rt
Chapter 6 presents the  results of measurement of quality of life o f A lzheim er's pa­
tien ts  and the ir caregivers w ith the Schedule fo r the Evaluation o f Individual Q uality  
o f Life (SEIQoL). In Chapter 7 associations between quality  o f life and burden of 
spouses of dementia patients are investigated. Chapter 8 provides a systematic 
review of how often quality o f life is used as outcom e in clinical trials. Chapter 9 in ­
vestigates associations and determ inants o f quality o f life in dementia patients and 
inform al caregivers, and the im plications fo r treatm ent. Chapter 10 presents the 
results o f a cross-sectional study of dementia patient-caregiver pairs and a survey 
of dementia professionals about the construct va lid ity  o f the p ro totype of the DQI 
(Dementia Q uality  o f life Instrument), a novel disease-specific index instrum ent. 
Chapter 11 summarizes the main findings o f this thesis and provides conclusions 
and fu tu re  perspectives.
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ABSTRACT
Dementia profoundly affects quality  o f life of patients as well as fam ily and care­
givers. Q ua lity  o f life (QoL) refers to  people's em otional, social and physical w e ll­
being, and the ir ab ility  to  function in daily life. QoL measures a ttem p t to  evaluate 
d irectly the impact of dementia or interventions on people's ab ility  to  function 
in life. Besides this global conceptualisation of QoL there is a growing field of re­
search on QoL measures focused on the measurement of health-re lated quality of 
life (HRQoL), i.e. a person's satisfaction or happiness w ith domains of life insofar as 
they affect or are affected by the dementia. HRQoL can be distinguished from  QoL 
in tha t it concerns itse lf prim arily w ith those factors tha t fall under the  purview of 
health care providers and health care systems. QoL measurement provides a sub­
jective evaluation tha t captures benefits and harms of interventions not detected 
by standard clinical outcomes. Three methods of QoL assessment are available: 
se lf-report, p roxy-report and rating by direct observation of behavior assumed to  
be related to  QoL. Acknow ledging the problem of potential bias of proxy-reports, 
se lf-report methods are preferable if possible. If not, observational methods by an 
uninvolved professional are an acceptable alternative.
By content, QoL m easurement scales also can be categorized into three groups: 
generic, domain-specific or disease-specific. Generic scales can be divided in 
health profiles and u tility  measurements. Health profiles classify subjects w ith res­
pect to  a broad spectrum of QoL domains, thus producing a descriptive profile 
from  several health domains. Generic u tility  measures enable cost-u tility  analysis. 
Cost is measured in m onetary units. Benefit is usually expressed in quality-adjusted 
life years (QALYs) or d isability-adjusted life years (DALYs). Domain-specific ques­
tionnaires rate QoL on circumscript areas, such as m obility, physical restrictions, 
autonom y or mastery. Dementia-specific measures probably have a higher grade 
of responsiveness, i.e. a higher ab ility  to  iden tify  changes tha t relate to  the natural 
course o f dementia or trea tm ent interventions.
QoL measurement m ethods in dementia are still facing im portant challenges. Mea­
surement properties encompass reliability, valid ity and responsiveness. Responsi­
veness, the ab ility  to  detect relevant change o ve rtim e  in health status, is an essen­
tia l p roperty  of outcom e measures fo r intervention studies and still largely unclear 
in dementia research. A no the r im portant item  is response shift, referring to  the 
psychological adaptation o f perception o f QoL fo llow ing  a change in health status 
(e.g. progress o f the dementia), which should also be addressed adequately.
Next to  the d iffe rentia l effects o f dementia on the patients themselves, caring fo r 
people w ith dementia is often associated w ith increase in distress and decrease
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in mental health and well-being, thus affecting QoL o f proxies as well. Therefore, 
despite the remaining scientific challenges in the field, it is highly recommendable 
to  include QoL assessment of patients and proxies as endpoints in all dementia 
and MCI intervention trials.
In tro du c tio n
Dementia is placing a substantial medical, social and psychological burden on pa­
tien ts  and the ir fam ilies and profoundly affects quality  o f life (QoL) o f all persons 
involved. QoL refers to  people's em otional, social and physical well-being, and 
the ir ab ility  to  function in daily life. QoL measures a ttem p t to  evaluate d irectly the 
impact o f dementia or interventions on people's ab ility  to  function in life. Besides 
this global conceptualisation o f QoL there is a growing field o f research on QoL 
measures focused on the m easurement o f health-re lated quality o f life (HRQoL),
i.e. a person's satisfaction or happiness w ith domains of life insofar as they affect 
or are affected by the dementia. HRQoL can be distinguished from  QoL in tha t it 
concerns itse lf prim arily w ith those factors tha t fall under the purview o f health 
care providers and health care systems. HRQoL is a m ultid im ensional concept tha t 
reflects the individual's perception of the impact o f a health condition, such as de­
mentia, on everyday life.1 Instrum ents aimed at measuring subjects' health status 
ou tlook  enable us to  quantify  the loss of QoL caused by disease and the im pro­
vem ent tha t can be achieved by interventions. HRQoL m easurement provides a 
subjective evaluation tha t captures the  benefits and harms of an intervention and 
elem ents o f health not detected by standard clinical outcom es.2 HRQoL measures 
are part of the  class of patient reported outcom e (PRO) measures. Improvement 
o f QoL should have high p rio rity  in care and treatm ent, and become a focus of 
research of a chronic and as yet incurable disease like dementia. The international 
W orking Group fo r the Harm onization of Dementia Guidelines has recommended 
tha t HRQoL should be included as outcom e param eter in dementia tria ls .3 Syste­
matic reviews however proof tha t QoL has been used only in a very lim ited way in 
pharmacological and non-pharmacological randomized controlled trials (RCTs) in 
dementia and Mild Cognitive Im pairm ent (MCI),46 and tha t HRQoL measures are 
not used on a regular basis in drug clinical tria ls in general.7
Both dementia and dementia caregiving are processes tha t by face value pro­
found ly  affect QoL. Q ua lity  o f life o f caregivers depends on the  balance between 
caregiving-related stressors and caregiving up lifts. Therefore, it is generally ac­
cepted tha t QoL assessment may provide a fo rm at fo r patients and (in)formal care­
givers to  express w hether an intervention has made an im portant d ifference to  
the patient's and caregiver's life. Severity o f dementia, care type, setting, and the
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specific QoL domains an intervention focuses on, probably are im portant d e te rm i­
nants in defining which QoL instrum ent is m ost appropriate in a specific s itua tion .“ 
The d ifferent approaches to  QoL assessment in dementia are summarized in Table 1. 
In this chapter we review the  concept o f QoL in dementia and the  optional modes 
to  assess HRQoL, present an overview  o f available m easurement scales, including 
an overview o f the ir psychometric characteristics, and high light issues fo r fu rthe r 
study.
Q ua lity  o f life  as ou tcom e measure in dem en tia  research
Current sym ptom atic treatm ents fo r dementia have only m odest efficacy and d e­
mentia is still an incurable disease. Assessing meaningful benefits in this variably 
progressive syndrome is complex and d ifficult. Many authors state tha t cognitive 
sym ptom response no longer suffices in anti-dem entia trials.7 QoL is m entioned 
as one of the primary outcomes of interest in dementia drug trials in a Cochrane 
update on cholinesterase inh ib itors fo r A lzheimer's disease (AD).IU However, in a 
recent systematic review we showed tha t the use of QoL as outcom e measure is 
lim ited to  4,4% of all dementia and MCI related RCTs. In case QoL measures were 
applied, most papers included insuffic ient details to  quantify  responsiveness, i.e. 
sensitivity  to  clinically relevant changes, and to  define clinical relevance. In non- 
pharmacological trials QoL was measured more often and resulted more o ften in 
positive outcom e than in pharmacological in tervention studies (5 out of 7 vs 0 out 
o f 3 trials reporting  QoL, respectively).6 These results confirm the literature descri­
bed in a systematic review published in 2004 of RCTs of pharmacologic treatm ent, 
which also showed tha t QoL was rarely included as an outcom e measure.5
Q ua lity  o f life  m easurem ents: by pa tie n t, p ro xy  o r obse rva tion
Subjective evaluation of QoL by dementia patients may be influenced by the ir cog­
nitive lim ita tions and may reflect reduced insight. Yet, they represent the best way 
of understanding the experience o f life w ith dementia.11 However, dementia may 
interfere w ith understanding, ab ility  to  rem em ber relevant events, making com ­
parisons across complex domains and com m unicating.12 This features potentia lly  
jeopardize both re liab ility  and va lid ity  o f self-rating of QoL. The way out seems to 
be to  have proxies rate the  QoL of the patients w ith dementia they care for. Unfor­
tunately, proxy QoL ratings generally do not accurately reflect patients' ratings.2 
Fo rth is  reason o ften both modes of assessment are used, depending on the aim of 
QoL measurements, recognizing the ir advantages and lim ita tions. In longitudinal 
studies in dementia it may have advantages to  s im ultaneously use proxy-rating, be­
cause of the progressive global de te rio ra tion  of dementia patients. Furtherm ore,
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the use of proxy reports th roughout the course of a longitud inal study, rather than 
substitu ting  them  only when the person w ith dementia becomes unable to  report 
his or her own HRQoL, reduces bias over tim e.13 In case of (very) severe dementia 
independent professionals can use qualitative observation o f behavior assumed to  
be related to  QoL to  assess QoL and to  investigate the effects of an intervention. 
A lso qualitative observations however are subjective.
In sum, three methods of QoL assessment are available: se lf-report by patient, 
p roxy-report and direct observation. Two types o f proxies can be distinguished: 
informal and form al, the latter referring to  professional proxies. Logsdon et al. 
showed tha t patients can rate the ir own QoL until late stages of dementia, and tha t 
caregiver ratings do not substitu te fo r patient ratings.14 Sands et al. found tha t care­
givers rated patients' QoL lower than patients, associated w ith increased caregiver 
burden and depressive symptoms of the patient.15 Boyer et al. found poor p a tien t/ 
fam ily  proxy concordance fo r the dim ension em otional reaction of the N ottingham  
Health Profile.16 The disadvantage o f proxy-ratings is tha t they filte r a subjective 
measure through the op in ion o f another person. Moreover, this rating can be bi­
ased because of perceived caregiver burden or depression. Acknow ledging the 
problem  of potentia l bias of proxy-reports, self-rating m ethods are preferable if 
possible. If not, observational methods by an uninvolved professional are an ac­
ceptable alternative. W e agree w ith Brod et al. tha t the patient's subjective ratings 
should be the gold standard, but tha t independent observational ratings are of 
benefit fo r patients w ith (very) severe dementia.17
Q ua lity  o f life  o f p rox ies o f dem en tia  pa tien ts
Outcomes should also appropriately encompass effects on caregivers. Caring fo r 
people w ith dementia is associated w ith well-docum ented increases in distress 
and decrease in mental health and w ell-being.1“ Caregivers o f dementia patients 
experience higher levels o f stress and psychological m orb id ity  compared to  care­
givers of non-dem ented elderly persons. Especially behavioral symptoms and im ­
pairments in instrum ental activities of daily living activities cause caregiver strain.1' 
Q ua lity  o f life assessment so far largely focuses on QoL o f dementia patients. How­
ever, assessment of QoL of the proxy is equally im portant, especially if the patient 
still lives in the  com munity. To our knowledge, three disease-specific m ethods are 
available tha t can valid ly assess QoL in patients as well as the ir carers: the SEIQoL, 
QOL-AD and the QoL scale developed in the PIXEL studies.“;14;2U Also, generic in­
strum ents can be applied. More o ften QoL o f caregivers is measured ind irectly 
w ith m ood/depression scales or caregiver burden scales. Theoretically, a direct 
and detailed measurement o f subjective proxy QoL, however, is a be tter too l, be­
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cause positive factors and stressors affecting the personal QoL are probably highly 
variable among caregivers.21 It is highly recommendable to  include QoL assessment 
o f proxies as effectiveness endpoint in all dementia and MCI intervention trials.
Q ua lity  o f life  m easurem ents: dem en tia -spec ific , dom a in -spec ific  o r generic
Based on the ir content, QoL measures can be categorized into three groups: 
disease-specific, domain-specific and generic measures.22 Disease-specific instru­
ments measure the consequences of a specific disease such as dementia. Domain- 
specific questionnaires rate QoL on circumscript areas of life, such as m obility, phy­
sical restrictions, autonom y or mastery. Generic measures can be divided in health 
profiles and u tility  measures. Generic measures rate QoL in term s tha t are relevant 
fo r everybody, regardless of the presence or absence of a specific disease. U tility  
measures enable cost-u tility  analysis (CUA), a form  of economic analysis used to  
guide procurem ent decisions, applied in pharmacoeconomics, especially health 
technology assessment (HTA). The purpose of CUA is to  estim ate the ratio between 
the cost o f a health-re lated in tervention and the benefit it produces in term s o f the 
num ber o f years lived in fu ll health. Hence it can be considered a special case of 
cost-effectiveness analysis (CEA), and the tw o  terms are often used interchange­
ably. Cost is measured in m onetary units. Benefit is expressed in quality-adjusted 
life years (QALYs) or the related d isability-adjusted life years (DALYs). Both equal
1 fo r each year o f fu ll-hea lth  life, and less than 1 fo r various degrees of illness or 
disability. Thus the cost-effectiveness of a trea tm ent can be assessed by the cost 
per QALY or DALY it produces. W e will subsequently discuss the most im portant 
disease-specific and generic measurement scales we are aware of.
D isease-specific  q u a lity  o f life  m easurem ent
Disease-specific measurements are devised to  assess the impact o f a specific 
disease across a spectrum of im portant domains o f life. They evaluate the domains 
relevant fo r a specific disease. Thus, dementia-specific HRQoL measurements in­
tend to  focus on dimensions relevant to  dementia. This enables a higher grade 
of responsiveness, i.e. a higher ab ility  to  iden tify  changes tha t relate to  the natu­
ral course of dementia or to  trea tm en t in terventions.22 An advantage of disease- 
specific scales is tha t they contain less inappropriate and irrelevant items and thus 
contain less 'noise'. However, the cost o f greater specific ity is less generalizability. 
A  large num ber of disease-specific scale fo r dementia are available. In Table 2 an 
overview  of the dementia-specific rating scales and the ir references is presented. 
In summary: ADR-QL: A lzheim er's Disease health-Related Q uality  o f Life scale, 
CBS: C ornell-Brown Scale fo r QoL in dementia, QOLAS: Q uality  o f Life Assessment
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Schedule, DCM: Dementia Care Mapping, DEMQOL, DQoL: Dementia Q ua lity  of 
Life scale, DSDAT: D iscom fort Scale-Dementia of A lzheim er Type, QOL-D: Q uality  
o f Life fo r Dementia, QOL-AD: Q uality  of Life-Alzheim er's Disease scale, PDS: Pro­
gressive D eteriora tion Scale, AAI: A c tiv ity  and A ffec t Indicators o f QoL, PWB-CIP: 
Psychological W ell-Being in Cognitively Impaired Persons, QUALID: Q uality  o f Life 
in Late-Stage Dementia scale, Qualidem, Vienna List and BASQID: Bath Assess­
ment o f Subjective Q uality  o f Life in Dementia. Because o f this large number of 
measurement scales it is very relevant to  define selection criteria, and consequent­
ly select the appropriate QoL rating scale. On the one hand, recom m endation of 
specific measures depends on the type of research question, severity of dementia, 
care type, setting and the specific QoL domains an in tervention focuses on. On the 
o ther hand, the psychometric qualities of QoL measurement scales also guide the 
selection process. No instrum ent can be used in all stages of dementia, or in all 
types of care and settings. The QOL-AD probably is the m ost promising and most 
w idely used dementia-specific questionnaire, consisting o f a 13-item self-report 
scale, which remains applicable up to  very low M ini-M enta l State Exam ination sco­
res. This measurement scale has separate versions both fo r patients (Participant 
self-reported QoL) and informal caregivers (Caregiver report o f the Participant's 
QoL). Besides this, caregivers can report on the ir own QoL w ith the COOL (Care­
giver QoL). Recently a new self-reporting  measure, the BASQID, proved to  pro­
vide valid, reliable and useful in form ation at a group level in people w ith mild to  
m oderate dementia.11 The Qualidem is a 40-item  behavior observation-scale fo r 
patients up to  severe dementia in institu tions. The DSDAT is an ob jective scale 
fo r tra ined observers to  measure d iscom fort in non-com m unicative patients w ith 
severe dem entia .“ Pros and cons of the various measures have been discussed in 
detail earlier.“123
G eneric  q ua lity  o f life  measures
Generic measures generally are the measures of choice in case of economic health 
care research and in case external va lid ity  is of primary im portance. These instru­
ments enable comparisons across d iffe rent (severity of) diseases or interventions, 
measurement o f the burden of illness o f groups of patients w ith chronic diseases as 
compared w ith normals and can also be of use in health policy decision making.4:22 
They encompass a broad scope of QoL domains, are applicable fo r every disease, 
and thus produce results tha t are externally valid and can be compared to  o ther 
studies. Because generic scales are usually more frequently  used, there are more 
data available regarding va lid ity  and reliability. However, generic measures also 
include domains not relevant fo r patients w ith a specific disease and underesti­
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mate more relevant areas. This may result in a lower responsiveness. In general, 
patient's im pairm ents are b e tte r reflected in d isability measures, than in HRQoL 
instrum ents.24
For the m easurement o f HRQoL tw o  d iffe rent approaches exist: health profile and 
u tility  measurements. For extensive details on the ir theore tic  background, va lid i­
ty, re liab ility  and applicability, we refer to  numerous excellent reviews comparing 
these instrum ents (see o ther chapters in this book). Here we will lim it ourselves to  
some general findings and to  results o f validation studies using these generic QoL 
measures in populations of patients suffering from  dementia, and we only give a 
few  examples o f this type of measurements.
G eneric  q ua lity  o f life  measures, sub ca tego ry  hea lth  p ro files
Health profiles classify subjects w ith respect to  a broad spectrum  of QoL domains, 
thus producing a descriptive profile from  several health domains. These health d o ­
mains are considered independently and are not intended to  be commensurable 
or aggregated. The scores on these domains are relative and fo r tha t reason such 
figures are not appropriate to  measure the overall level o f health states. Examples 
are the SF-36: Medical Outcom es Study 36-item  Short Form Health Survey, SF-12: 
Medical Outcomes Study 12-Item Short Form Health Survey, SIP: Sickness Impact 
Profile, NHP: N ottingham  Health Profile, DHP: Duke Health Profile, QOLAS: Q uality  
o f Life Assessment Schedule, W H O Q O L 100: W orld  Health Organization Q uality 
o f Life 100, HSQ: Health Status Questionnaire and SEIQoL: Schedule fo r the Eva­
luation of Individual Q uality  o f Life. The health profiles and the ir references are 
summarized in Table 3.
The SEIQoL m easurement scale is a good example of a generic QoL instrum ent co­
vering m ultip le  domains. It measures the level of function ing  in five self-nom inated 
facets o f life (qualitative inform ation) and the  relative weight or im portance a tta ­
ched to  these areas. Thus, the SEIQoL allows quantita tive m easurement of ind iv i­
dualized QoL and probably can be used to  m on itor changes in Q oL.25 It is a generic 
instrum ent validated in dementia, and is applicable until mild dementia stages.26- 7 
For later stages the more simple SEIQoL-DW  (Direct W eighting ; replacing w eigh­
ting  procedure w ith a pie chart form at) version offers an alternative. The SEIQoL 
provides an overall score of QoL of both patient and proxy.
G eneric  q ua lity  o f life  measures, sub ca tego ry  u t il ity  measures
Unlike QoL measures, u tility  measures a ttem pt to  evaluate the value tha t persons 
place on a particular health state and not d irectly the impact o f a disease or tre a t­
ment on the ir ab ility  to  function in life. C os t-u tility  analysis (CUA) quantifies the re­
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lationships between in tervention and outcom es in term s o f money. CUA is enabled 
by u tility  measures: economical evaluations express health effects in quality-adjus- 
ted life years (QALYs) or d isability-adjusted life years (DALYs). Typically, health-state 
values based on the HRQoL concept are combined w ith duration spent in these 
states, thus generating QALYs. QALYs are global summary measures o f health and 
are very attractive because they enable medical specialists to  express d iffe rent 
diseases into one single comparable measure. A no the r benefit o f QALYs is tha t 
these measures not only inform  physicians, but are also easily understood by policy 
makers and patients.
Thus, u tility  measures produce a descriptive profile on m ultip le  health domains, 
but in addition are specifically designed to  aggregate the scores into one overall 
score expressing the quality o f health states. U tility-based QoL measures often 
place levels o f wellness on a continuum  anchored by death (0.00) and optim um  
function or perfect health (1.00). Preference measurement studies are used to  de­
fine the meaning of points along tha t continuum. This approach is also referred to  
as a preference-based or value-based m ethodo logy and produces overall scores 
from  0.00-1.00 w ith a fixed meaning and in terp re tation . Such scores have metric 
properties, allowing comparison of the severity o f various diseases and to  perform  
basic com putational procedures. The many methods to  quantify health states and 
continuous scales are described in Table 4a and b. Health states are valued using 
techniques such as standard gamble (SG), tim e tra d e -o ff (TTO),2“ or person tra d e ­
o ff (PTO). PTO differs from  TTO in tha t subjects are required to  tra d e -o ff person 
years lived healthy against person years lived w ith some defined disability, thus 
making choices in the  context of a decision involving other people rather than 
themselves. W he ther PTO reflects actual preferences is still unclear.27 These valu­
ations are used to  generate a scoring algorithm , by which a single u tility  score fo r 
each health state can be deduced.
An overview  of u tility  measures is presented in Table 5. The European Q uality 
o f life-5 Dimensions (EQ-5D) questionnaire describes health status according to  
the dimensions m obility, self-care, usual activities, pain /d iscom fort and anxiety/ 
depression. Each dim ension has three levels, which were valued using the TTO 
method. Based on these valuations, u tility  scores can be deduced by means of an 
additive function. These are now w idely used in cost-u tility  analyses.3U Besides the 
five dimensions, the EQ-5D consists of a visual analogue scale (VAS) ranging from
0 (worst imaginable health state) to  100 (best imaginable health state). The EQ- 
5D+C or EQ-6D is an extended version of the EQ-5D tha t also includes the domain 
cognitive func tion ing .31 A t this m om ent u tilities are only available fo r the EQ-5D. 
It is still unclear w hether addition of a cognitive dim ension to  the EQ-5D has a
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separate and significant e ffec t on u tility  values.32 The EQ-5D is com m only used to  
measure HRQoL and has been shown to  be responsive, internally consistent and 
reliable in the  normal population and o ther patient groups,33 as well as in patients 
w ith dem entia .34
O ther preference based measures are the SF-6D,35 Health U tilities Index Mark
2 (HUI2),36 Health U tilities Index Mark 3 (HUI3),37 and Q uality  of W ell-Being scale 
(QWB),3“ all standardized m ulti-d im ensional health state classifications. The SF-6D 
was derived from  the SF-36 by revision into a six-dimensional health state classifica­
tion , fo r use in economic evaluations. The health states were valued using Standard 
Gamble.37 Am ong studies tha t compared preference-based systems, the EQ-5D 
tended to  provide larger change scores and more favourable cost-effectiveness 
ratios than the HUI2 and -3, while the SF-6D provided smaller change scores and 
less favourable ratios than the other systems.411 In a systematic litera ture review 
the EQ-5D proved to  be the m ost frequently  used u tility  measure (47,5%). O ther 
instrum ents used were HUI, QWB, SF-6D, Rosser-Kind Index, and 15D. The rest 
(23.8%) used a direct valuation m ethod: TTO, SG, VAS or rating scale.41 Using d iffe ­
rent preference-based HRQoL instrum ents may yield d iffe rent u tility  scores, which 
could have a great impact on QALY estimates. This highlights the im portance of se­
lecting appropriate instrum ents fo r economic evaluations.42 O thers however state 
tha t although clinically im portant differences in u tility  measurements were present 
fo r d iffe rent preference-based instrum ents, the impact o f these differences on 
CUA appeared relatively m inor.43 Here we conclude tha t the various u tility  measu­
rem ent too ls  measure a sim ilar underlying construct, but are not interchangeable 
because they are scaled d iffe rently  and produce varying results. A part from  this, 
u tility  measurements in dementia have m ethodological problems sim ilar to  the 
o ther QoL measurements in dementia (described earlier). These findings all have 
potentia l implications fo r the in te rp re ta tion  and com parability o f health outcom e 
studies and economic analyses.44
G eneric  q ua lity  o f life  measures and th e ir  use and re levance in dem en tia
The EQ-5D, QWB and HUI were all administered to  dementia patients and the ir 
proxies. The EQ-5D is a valid but easy to  adm inister measure w ith a short com ple­
tion  tim e. One of the criticisms of the QWB is tha t it is in general more d ifficu lt to  
adm inister than competing measures, such as the SF-36. This can be a disadvan­
tage in dementia. The Q uality  o f W ell-Being scale, Self-Adm inistered (QWB-SA) 
addresses this criticism. The QW B-SA was acceptable to  older respondents and 
correlated w ith o ther measures of HRQoL (SIP and SF-36).45 For the SF-6D there 
are concerns w ith inconsistent estimates and over prediction of the value of the
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poorest health states, which is especially of in terest in a discussion on applicability 
in dem entia .3vCouncill et al. expressed concerns regarding the valid ity o f patient 
self-rated HRQoL data obtained w ith the EQ-5D.46 O thers however concluded that 
dementia patients are capable of expressing the ir HRQoL through a brief instru­
ment as the  EQ-5D.32:34 Nag lie et a I. compared the EQ-5D, QWB and HUI in patients 
w ith mild dementia and the ir proxies. They found tha t fo r patient and proxy ratings, 
the EQ-5D had the  best com bination o f measurement properties, although it had a 
substantial ceiling effect fo r patient ratings. In this study proxy QoL ratings did not 
accurately reflect patients' ratings.2 O thers however found tha t proxies can reliably 
assess the  QoL o f dementia patients w ith the EQ-5D,2;32 HUI,4“ and QW B.3“ Until 
now, health u tility  measures are not validated satisfactorily in dementia, th e re ­
by questioning the results o f previous health economic analyses in dem entia .4' In 
mental health patients w ith mood and/or anxiety disorders both EQ-5D and SF-6D 
discrim inated between severity subgroups and captured im provem ents in health 
over tim e. However, the use o f EQ-5D resulted in larger health gains and conse­
quent lower cost-u tility  ratios, especially fo r the  subgroup w ith the highest severity 
o f problem s.511 These findings may also have consequences fo r outcom e studies in 
dementia.
C lin ica l re levance o f Q oL m easurem ents: responsiveness and m in imal im po rta n t  
d iffe ren ce
To fu lfil it's promise o f high(er) clinical relevance, QoL measurements should not 
only be valid and reliable (over tim e and between raters), but also sensitive to  
change (responsive) and it should be possible to  reach agreem ent on scale d if­
ferences reflecting clinically relevant changes. Inform ation on valid ity and re liab i­
lity of the dementia specific measures is summarized in Table 6. Patients, proxies, 
clinicians, investigators and drug companies all have d iffe rent interests, resulting 
in d iffe rent defin itions of a positive response to  treatm ents. Furtherm ore, small 
changes on responsive psychometric cognitive tests, even if sta tistica lly significant 
by including large numbers of patients, may not be clinically relevant. Registration 
authorities already require tha t outcom e measures' response criteria are defined 
unam biguously in registered tria l designs, which requires to  define the changes in 
the outcom e variables considered to  be clinically relevant. Here we w ill shortly  des­
cribe the concepts o f responsiveness and m inimal im portant difference as relevant 
in comparing and selecting QoL measurements scales in dementia.
Responsiveness
Measurement properties encompass reliability, va lid ity  and responsiveness. Res­
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ponsiveness represents an instrum ent's ab ility  to  detect relevant change over tim e 
in health status and is a critical p roperty  o f outcom e measures in clinical tria l set­
tings. Responsiveness has three im portant aspects: 1. type o f change (within per­
sons, between persons, or both; investigated w ith anchor- and d istribution-based 
procedures), 2. type of setting  (group or individual) and 3. m agnitude of change: 
m inimal or substantial. Responsiveness of QoL measures used in dementia drug 
trials has had little  form al analysis,14 and still lacks a firm  empirical base. Dem entia- 
specific measures may be hypothesized to  have a higher responsiveness, because 
they focus only on dimensions relevant to  dementia. Generic QoL measures often 
dem onstrate low responsiveness, but a firm  comparison has not been made fo r 
QoL ratings in dem entia .22
Responsiveness is determ ined by evaluating the relationship between changes in 
clinical and patient-based endpoints and changes in scores ove rtim e , or based on 
the application of a trea tm ent o f known and dem onstrated efficacy (anchor-based 
responsiveness). Longitudinal studies are needed to  determ ine w hether a PRO in­
strum ent is responsive.51 Responsiveness can be assessed using measures of in ter­
nal responsiveness (standardized effec t size, standardized response mean) and ex­
ternal responsiveness (receiver op era tor curve analysis, mixed model regression).
M in im a l im p o rta n t d iffe ren ce
The m inimal im portant difference (MID) is a related concept to  responsiveness 
and denotes the smallest difference in scores of a PRO measure tha t signifies a 
clinically significant change, rather than a triv ia l change in sym ptom s.52 In valida­
tion  studies MID can serve as the anchor fo r validation. Anchor-based methods 
applying relevant patient- or clinician-rated and disease-specific variables provide 
meaningful estimates of an instrum ent's MID. D istribution-based methods can sup­
port estimates from  anchor-based approaches and can be used in situations where 
anchor-based estimates are unavailable. MID is best be based prim arily on relevant 
patient-based and clinical anchors, w ith clinical tria l experience used to  fu rthe r 
inform  understanding of MID. W hen MID is connected to  clinical anchors, it is refer­
red to  as the m inimal clinically im portant difference (MCID).51 The responsiveness 
index (Rl) as developed by G uyatt is one way of quantifying sensitiv ity  to  change 
in clin im etrics.53 The Rl reflects the ratio between the m agnitude of the m inimally 
or o ther standardized im portant difference tha t can be detected and the noise 
level (the differences measured in a population in which QoL may be assumed not 
to  have changed, according to  anchor-based comparisons). In o ther words, the 
Rl is based on the  m agnitude o f m eaningful change related to  the d is tribution of 
change by chance in a stable population, which is im portant in defining the sample
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size needed fo r clinical trials to  detect a m eaningful d ifference.52 Because respon­
siveness and MID depend on population and contextual characteristics, there is 
not necessarily a single MID value fo r a PRO instrum ent across all applications and 
patient samples.51
Q ua lity  o f life  m easurem ent and response sh ift
W hen applying QoL measures in patients and proxies the phenom enon of response 
sh ift should always be taken into account. Medical models of QoL trad itiona lly  as­
sume tha t QoL decreases when more symptoms are present, and disease progres­
ses.11 However, persons w ith chronically invalidating diseases o ften keep reporting 
a high Q oL,54 while caregivers in itia lly  rate patients' QoL lower than dementia pa­
tien ts  them selves and caregivers also rate QoL lower than patients during disease 
progression.151'6 In these ratings, the phenom enon tha t patients or caregivers may 
rate the ir QoL d iffe rently  during the course o f a disease is referred to  as response 
shift. In general term s, response sh ift is a change in valuation of QoL over tim e 
and over disease severity, which may result from  a change in internal standards of 
Q oL.55 Response sh ift is the psychological change in perception of QoL fo llow ing  a 
change in health status and thus can affect results of QoL outcom e measurements. 
If significant response shift is likely to  occur, one should take this into account in 
designing fu ture  clinical research. Response sh ift may also have biased the results 
o f previous studies, in which this problem was not considered beforehand. A dap­
ta tion  to  illness provides a reasonable explanation fo r the occurrence of response 
shift.
Response sh ift can be determ ined and estim ated w ith several approaches, fo r in ­
stance the Then-test, Ideal scale approach, anchor-recalibration, structural equa­
tion  m odelling (SEM) and Rating of v ignettes. The Then-test is a retrospective 
judgm ent o f p re-in tervention QoL and is used in com bination w ith the pretest- 
posttest design. Results o f interventions are usually measured by comparing pre- 
and post-treatm ent scores, assuming tha t the observed change represents a tre a t­
ment effect. However, in case of response shift the person's rating is changed and 
this may confound in te rp re ta tion  of the  results. The Then-test is one o f the least 
complicated methods to  measure response sh ift.55 An im portant drawback o f the 
Then-test is tha t it's va lid ity  depends on the correct recall o f the pre-in tervention 
health state. In the Ideal scale approach current and ideal QoL are rated on the 
same scale. Persons rate the ir current and the ir ideal QoL on the same scale on d if­
fe ren t points o f tim e. The assumption is tha t response sh ift influences the current 
score to  the  same extent as the ideal score. W ith  this m ethod shifts in the ideal 
scores, indicative o f response shift, can be de tected .56 In the  Anchor-recalibration
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approach shifts in patients' individual defin itions o f the scale-anchors (worst and 
best imaginable QoL) over tim e are assessed.57 In the SEM approach response 
sh ift is deduced from  m athem atically defined changes in confirm atory fac tor ana­
lysis' results and variance-covariance matrices over tim e. The claim is tha t SEM can 
detect reconceptualization, reprio ritiza tion, and recalibration.55 Finally, rating of 
vignettes, a novel m ethod, is a promising additional technique to  assess response 
sh ift.5“ It has not been established so far if a dementia diagnosis induces response 
shift, but longitud inal QoL measurements of dementia patients not resulting in 
significant QoL changes o v e rtim e  make response sh ift in dementia highly likely.57 
For studies this is a problem, fo r patients it is p rofitab le to  be able to  adapt to  newly 
occurring disease stages and not perceiving a gradual decrease in QoL. In proxies, 
response sh ift probably is d iffe rent from  response sh ift in patients, which may have 
im plications when using proxy-rating.
Ava ilab le  scales fo r  q u a lity  o f life m easurem ent in dem en tia : wh ich one and why?
The selection o f appropriate outcom e measures in dementia research firs t de­
pends on the type of in tervention and the  study aim. O ften  it is im portant to  relate 
outcomes directly to  healthcare utilization, QoL, caregiver burden and to  be able 
to  allow pharmacoeconomic analyses.611 Providing meaningful outcomes will im pro­
ve acceptance of therapeutic  strategies. Thus, selection of appropriate outcom e 
measures is very im portant. In Table 7 the selection criteria fo r QoL measurements 
in dementia research are presented. No instrum ent can be used in all stages of 
dementia, types of care, settings and research questions. In our view, four measu­
rem ent scales best represent the  domains of QoL tha t are im portant fo r patients 
and tha t professionals focus on: QOL-AD, SEIQoL, Qualidem  and DSDAT. The first 
tw o  are self-rating quantitative instrum ents tha t can assess QoL of patients as well 
as proxies. If se lf-report is no longer possible observational instrum ents like Q ua­
lidem (for mild to  severe dementia) and D iscom fort scale-Dem entia o f A lzheim er 
Type (DSDAT; fo r severe dementia) by uninvolved professionals can be used. U tility  
measures are a central com ponent of economic evaluations in health care. To cal­
culate u tility  values the EQ-5D perform s well fo r evaluating HRQoL in patients aged 
55 and older w ith cognitive im pairm ents, also by using proxy-ratings.32 However, 
until now, health u tility  measures are not validated satisfactorily in dementia, thus 
calling into question previous health economic analyses.47
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Table 1. D iffe ren t approaches to  quality o f life assessment in dementia
Type o f measure Dementia specific Generic-health profile G eneric-utility
Adm inistration Self report Proxy report Observational report
Target M ild dementia M oderate dementia Advanced dementia
Longitudinal valid ity Responsive Nonresponsive
Respondent Patient Proxy Both
Domains Broad scope Narrow scope
Change over tim e Stable Response shift
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Table 2. Examples o f disease-specific quality o f  life measurements in dementia
Acronym M easurem ent scale References
ADR-QL Alzheimer's Disease health-Rela- 
ted Q uality  o f Life scale
Rabins e t al. J M ent Health Aging 
199;5:33
CBS Cornell-Brown Scale fo r 
quality o f life in dementia
Ready e t al. Alzh Dis Assoc Disord 
2002;16:109
QOLAS Q uality  o f Life Assessment 
Schedule
Selai e t al. Neuropsych 
Rehabilitation 2001; 11:219
DCM Dementia Care Mapping Kitwood e t al. J Adv Health Nurs Care 
1992;1:41
DEM QOL Smith et al. Int J Geriatr Psych 2005)20:889. 
Smith Health Technol Assess 2005)9:1
DQoL Dementia Q uality  o f Life scale Brod e t al. G eronto log is t 1999)39:25
DSDAT Discom fort Scale-Dementia o f 
A lzheim er Type
Hurley e t al. Res Nurs Health 1992)369 
Volicer. J Mental Health Aging 1999)5:83
QOL-D Q uality  o f Life fo r Dementia Terada e t al. Int J G eriatr Psychiatry 
2002)17:851
QOL-AD Q uality  o f Life-Alzheimer's 
Disease scale
Logsdon e t al. Psychosom Med 2002; 
64:510
PDS Progressive D eterioration Scale De Jong e t al. Clin Ther 1989)11:545
AAI Activ ity  and A ffect Indicators o f 
quality o f life
A lbe rt e t al. J Am  G eriatr Soc 1996; 
44:1342
PWB-CIP Psychological W ell-Being in Cog­
n itively Impaired Persons
Burgener e t al. Alzh Dis Assoc Disord 
2002)16:88
QUALID Q uality  o f Life in Late-Stage 
Dem entia scale
W einer et al. J Am  Med Dir Assoc 
2000)1:114
Q ualidem Ettem a e t al. Int J G eriatr Psych 2007; 
22:424&549
Vienna List Porzsolt e t al. Health Qual Life Outcome 
2004)2:10
BASQID Bath Assessment o f Subjective 
Q uality  o f Life in Dementia
Trigg e t al. Age Ageing 2007)36:663 
Trigg e t al. G erontolog ist, 47:789-97
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Table 3. Examples o f  generic health p rofile  measurements applicable in dementia
Acronym Measurem ent scale References
SEIQoL Schedule fo r the Evaluation o f 
Individual Q uality o f Life
McGee. Psychol Med 1991; 21:749. 
Scholzel. T Ger G eriatr 2000;31:23
SF-36 Medical Outcom es Study 36-item 
Short Form Health Survey
Ware e t al. Med Care 1992;30:473
SF-12 Medical Outcom es Study 12-Item 
Short Form Health Survey
Ware e t al. Med Care 1995; 
33:AS264
SIP Sickness Impact Profile Bergner e t al. Med Care 1981; 
19:787
NHP Nottingham  Health Profile Bureau-Chalot e t al. G erontology 
2002;48:220
DHP Duke Health Profile Novella e t al. Dem ent Geriatr 
Cogn Disord 2001; 12:158
QOLAS Q uality  o f Life Assessment 
Schedule
Selai e ta l. Neuropsychol Rehab 
2001; 11:219
W H O Q O L 100 W orld  Health Organization 
Q uality  o f Life 100
W H O Q O L Group. Psychol Med 
1998;28:551
HSQ Health Status Questionnaire P e ttit e t al. Int J G eriatr Psychiatry 
2001; 16:1061
Table 4a. Methods to  quantify health states
Valuation technique Based on
Utility  m easurement SG (Standard Gamble) 
TTO  (Time Trade-Off)
Ordinal judgm ent Ranking
Category rating 
Paired comparisons
Cardinal judgm ent M agnitude estim ation 
PTO (Person Trade-Off) 
VAS (visual analogue scale)
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Table 4b. Methods o f quantification o f  various continuous scales
One dimensional One dimensional One dimensional Separate dimensions
Direct estim ation Comparative methods Econom etric methods Sim ilarities o f objects
VAS Thurstone's method SG
Adjectival scales Guttm an scaling TTO MDS (M ulti­
dimensional scaling)
Likert scale Paired-comparisons
Table 5. Examples o f generic u tility  measurements applicable in dementia
Acronym M easurem ent scale References
EQ-5D European Q uality o f life - 5 
Dimensions
EuroQol Group. Health Policy 
1990;16:199. Brooks. Health Policy 
1996;37:53
EQ-6D European Q uality o f life - 6 
Dimensions
Krabbe e t al. J Clin Epidem iol 
1999)52:293
QWB Q uality o f W ell-Being scale Kerner e t al. J Aging Health 1998; 
10:44
QW B-SA Q uality o f W ell-Being scale, 
Self-Adm inistered
Andresen e t al. Med Care 1998; 
36:1349
HUI2 Health U tilities Index Mark 2 Feeny e t al. Pharmacoecon 1995; 
7:490
HUI3 Health U tilities Index Mark 3 Furlong e t al. Ann Med 2001; 
33:375
SF-6D SF-36 revised into  a six-dimen- 
sional health state classification
Brazier e t al. J Health Econ 2002; 
21:271
O ther Activ ities L im itations Index. 
Rosser-Kind Index. 15D
Rasanen e t al. Int J Technol Assess 
Health Care 2006;22:235
Direct valuation Tim e Trade-Off, Person Trade- 
Off, Standard Gamble, Visual 
Analogue Scale, Rating Scale
Pinto Prades. Health Econ 1997; 
6:71. Green. Health Econ 2001; 
10:233. Rasanen e t al. Int J Techn 
Assess Health Care 2006; 22:235
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Table 6. Valid ity and re liab ility o f  qua lity  o f  life  measures in dementia
Measure SEIQoL
McGee
1991
DQoL
Brod
1999
ADRQL
Rabins
1999
QOL-AD
Logsdon
1999
DSDAT
Volicer
1999
CBS
Ready
2002
QOLAS
Selai
2001
PDS
De Jong 
1989
Reliability
Internal consistency 0,60-0,75 0,67-0,89 0,80 0,81 -0,90 0,86-0,89 0,81 0,78 +
Inter-rater reliability + n.a. n.a. >0,70 0,74-0,98 0,90 +
Test-retest reliability 0,88 0,64-0,90 n.a. 0,76 /  0,92 0,97 n.a. +
Validity
Criterion related - - - - - - +
Construct validity + + + + + + + +
Responsiveness
Sensit. to interventions + n.a. + n.a. + n.a.
Longitudinal change + + + + + n.a. +
Sample size n=22
Measure AAI
Albert
1996
PWB-CIP
Burgener
2002
QUALID
Weiner
2000
DEMQOL
Smith
2005
Qualidem
Ettema
2006
Basqid 24
Trigg
2007
Vienna List
Porzsolt
2004
Reliability
Internal consistency 0,66-0,79 0,77 0,87 0,60-0,90 0,91 0,81-0,94
Inter-rater reliability 0,83 n.a. 0,66-0,88 0,35-0,81
Test-retest reliability 0,81 0,76-0,84 0,74-0,88 0,82 n.a.
Validity
Criterion related - - n.a. -
Construct validity + + + +
Responsiveness
Sensit. to interventions n.a. + n.a. n.a. n.a. n.a.
Longitudinal change n.a. ± ± n.a. n.a. + n.a.
Sample size n=130 3 il o o n=42 n=60/150
n.a.= not available
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Table 7. Selection criteria fo r qua lity  o f life measurements in dementia research
Type o f measure Generic Domain specific Disease specific
Type o f rating By patient By proxy By observation
Type o f rating Q uantitative Q ualitative
Valid ity Criterion related Construct valid ity
Reliability Internal consistency Inter-rater reliability Test-retest reliability
Responsiveness Sensitive to  intervention Longitudinal change
Feasibility T im e to  com pletion Difficulty o f scale
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ABSTRACT
Background: A  literature study was conducted to  contribute to  an adequate use 
of quality  of life (QoL) instrum ents fo r the evaluation of interventions in dementia 
care by providing an overview  of properties o f QoL measures tha t acknowledge 
domains im portant to  dementia patients.
Methods: Domains im portant to  patients, and domains tha t professional caregi­
vers in d iffe rent settings focus on, are compared to  domains represented in nine 
QoL instruments. Data on psychometrics and app licab ility are generated.
Results: Four instrum ents best represent domains of QoL im portant to  patients and 
domains professional caregivers in 24-hour care and daytime activities focus on. 
Two are self-rating instruments: Schedule fo r the Evaluation of Individual Q uality 
o f Life, applicable in mild dementia, measuring individual QoL of patient and infor­
mal caregiver, and Q uality  o f Life-Alzheimer's Disease scale, which can be applied 
up to  m oderately severe dementia. For patients w ith advanced dementia receiving 
residential care, the observational instrum ents Qualidem and Discom fort scale-De- 
mentia o f A lzheim er Type are recommended. The first is easily administered by nur­
se assistants or occupational therapists and covers several QoL domains on which 
they focus in daily practice. The second can be used by various professionals. 
Conclusions: QoL assessment provides a fo rm at fo r patients and (in)formal caregi­
vers to  express w hether an in tervention has made an im portant difference to  the 
patient's life. Im provement of QoL in dementia should have high p rio rity  in care, 
trea tm en t and research. This study shows tha t severity o f dementia, care type, set­
ting , and the specific QoL domains an in tervention focuses on, determ ine which 
QoL instrum ent is most appropriate in a specific situation.
In tro du c tio n
Q uality of life (QoL) is a multi-dimensional concept that includes well-being and has 
objective and subjective aspects (Logsdon et al., 2004; Sprangers, 2005). Domains 
in QoL measures vary considerably (A lbert et al., 2001). Examples are: affect, self­
esteem/awareness of self, social contact and physical/mental health. The QoL in 
dementia working group of the Leo Cahn Foundation investigated which domains 
patients and professional caregivers in nursing homes and meeting centres consi­
der im portant. Most domains mentioned by patients were acknowledged by care­
givers and represented in QoL scales, although each instrument contains only a se­
lection of the domains. Some were not mentioned by caregivers (being useful/giving 
meaning to  life) and not represented in the scales (security/privacy, selfdeterm ina­
tion /freedom , being useful). Apparantly there are differences in views on QoL between
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patients, caregivers and theoretical models (Droes et al., 2006). The working group 
also investigated on which domains professional caregivers actually focus in daily 
practice (Gerritsen et al., submitted). Caregivers focus on most o f the domains that 
patients consider im portant. However, financial situation, self-determ ination/free- 
dom, and being useful/giving meaning to  life are focused on least, the latter domain 
being particularly im portant to  patients w ith dementia (Rabins, 2000).
QoL scales must encompass the domains considered im portant by patients and the 
domains an intervention focuses on. Because cognitive decline may interfere w ith 
the ability to  understand a complex top ic such as QoL, the selection o f the instru­
ment is also influenced by the severity o f dementia (Rabins, 2000). To contribute to  an 
optimal use of QoL instruments in intervention studies, we reviewed the ir properties 
and the domains indicated as relevant by patients and focused on by professional 
caregivers. W e propose which scales are best used to  evaluate the outcome of care 
at d ifferent stages of dementia and fo r a specific research question/setting.
M ethods
Nine QoL instruments were selected: Dementia QoL scale (DQoL) (Brod et al., 1999b); 
A lzheim er's Disease Health-Related QoL (ADRQL) (Rabins et al., 1999); Q uality  
o f Life-Alzheimer's Disease scale (QOL-AD) (Logsdon et al., 2002); D iscomfort sca- 
le- Dementia o f A lzheim er Type (DSDAT) (Hurley et al., 1992; Volicer et al., 1999); 
Cornell-Brown Scale fo r QoL in Dementia (CBS) (Ready et al., 2002); Vienna List 
(Porzsolt et al., 2004); DEMQOL (Smith et al., 2005a,b); Qualidem  (Ettema et al., 
2006) and Schedule fo r the Evaluation o f Individual QoL (SEIQoL), a non-dem entia 
specific instrum ent validated in dementia (McGee et al., 1991).
W e investigated to  what extent domains patients consider im portant are represen­
ted, if the scales measure the domains on which professional caregivers focus in 
daily practice and fo r which patients they are intended. For each scale we reviewed 
psychometric properties, setting, expertise necessary fo r application, m ethod of 
data collection, sensitivity  to  change, and validated languages.
Because QoL of the caregiver/proxy is o f major influence on coping w ith the pa­
tien t (Logsdon et al., 2004), we investigated w hether the instrum ent also provides 
fo r measurement o f the ir QoL. Finally, based on the earlier studies of the  working 
group, we selected the scales best used to  evaluate daytim e ac tiv ities /institu tiona l 
24-hour care at d iffe rent stages o f dementia.
Results
Dom ains o f  QoL
Table 1 summarizes domains considered im portant by patients, domains tha t profes­
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sional caregivers focus on and representation of these domains in the nine scales. 
Caregivers providing daytim e activ ities/24-hour care focus especially on affect, 
social contact, attachm ent, general health, security/privacy; to  some degree on 
se lf-de te rm ination /freedom  and sp iritua lity ; and to  a lim ited degree on financial 
situation. Differences between daytim e activ ities/24-hour care exist mainly in the 
degree o f focusing on enjoym ent o f activities, sense of aesthetics and being use­
fu l/g iv ing  meaning to  life (Gerritsen et a I., subm itted).
The domain affect is represented in all scales, except fo r the DEMQOL. Self-es- 
teem /social contact are often included. Only four instrum ents include attachm ent 
and physical/mental health (SEIQoL, DQOL, DSDAT, Qualidem), and tw o  include 
enjoym ent o f activities/sense of aesthetics (ADR-QL, SEIQoL). Security/privacy, 
se lf-de te rm ination /freedom , being useful/g iving meaning to  life and sp iritua lity  
can only be assessed w ith the SEIQoL. Yet all these domains are explic itly m en ti­
oned by patients as im portant aspects of the ir QoL.
D escrip tion  and p ro pe rtie s  o f QoL scales
Characteristics and practical applicability o f the scales are presented in Table 2. 
SEIQoL
The SEIQoL uses a technique derived from  judgm ent analysis tha t enables respon­
dents to  nom inate five areas most im portant to  the ir QoL (McGee et a I., 1991; 
Scholzel-Dorenbos and Jellesma-Eggenkamp, 2001). The technique is applicable 
in mild dementia (Coen et a I., 1993; Scholzel-Dorenbos, 2000). For later stages the 
SEIQoL-DW  (Direct W eighting ; replacing weighting procedure w ith a pie chart fo r­
mat) offers an a lternative (Hickey et a I., 1996). The SEIQoL provides an overall score 
of QoL of both patient and proxy.
DQ oL
29-item interview  o f patients w ith m ild -m oderate dementia (M in i-M ental State 
Exam ination (MMSE; 0 -30)>12) (Brod et a I., 1999b). Ten domains on five subscales 
(self-esteem /positive-negative a ffec t/fee lings of belonging/sense of aesthetics) 
are assessed w ith a 5-poin t Likert-scale, providing a profile o f scores. Subjects w ith 
a MMSE>13 understood the questions (Suzuki et a I., 2005). 60% of people w ith a 
MMSE of 10 could com plete the DQoL (Selwood et a I., 2005).
ADRQ L
Dementia-specific scale applicable regardless of disease severity (Rabins et a I., 
1999). The proxy-rated measure focuses on observable behavior during the past
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2-4 weeks. An overall QoL score is obtained by a tra ined interview er summarizing 
the scores of 47 items in five domains: social interaction/awareness of se lf/en joy­
ment of ac tiv ities /fee ling -m ood/response to  surroundings. The ADRQL-score is as­
sociated w ith disease severity. It measures efficacy of in terventions/se ttings and is 
sensitive to  change (Lyketsos et a I 2003).
QOL-AD
Dementia-specific 13-item se lf-report scale covering physical hea lth /energy/m ood / 
living s itua tion /m em ory/fam ily /m arriage /friends/chores/fun /m oney/se lf and life as 
a whole, scored on a 4-po in t Likert-scale (Logsdon et a I., 2002). The QOL-AD can 
be used by patients (Participant self-reported QoL) and inform al caregivers (Care­
giver report o f the Participant's QoL), yielding a single score, weighing the patient's 
score tw ice as heavily as the caregiver's. Caregivers can report on the ir own QoL 
w ith the CQOL (Caregiver QoL). Interrater-reIiabiIity, content and criterion-con- 
current va lid ity  (DQoL, EQ-5D) are good (Thorgrim sen et a I., 2003). Subjects w ith 
m ild -m oderate dementia (MMSE>11) could com plete the QOL-AD, including 3% of 
people w ith a MMSE of 11 (Selwood et a I., 2005). There is evidence fo r re liab ility  
in severe dementia (MMSE 3; Hoe et a I., 2005; Thorgrim sen et a I., 2003). QoL did 
not decrease as cognition deteriorated. The level of agreem ent between p a tien t/ 
caregiver ratings was modest, caregivers consistently rate the patient's QoL lower 
(Thorgrimsen et a I., 2003). This was not explained by cognitive ab ility  o f the patient 
and probably reflects a real difference in the way they perceive the patient's QoL. 
Caregiver reports correlated strongly w ith both caregiver depression and burden.
DSDAT
O bjective sca le fo rtra in ed  observers to  measure d iscom fort in non-com m unicative 
patients w ith severe dementia (MMSE 0-2), by observing the ir behavior during five 
m inutes (Hurley et a I., 1992; Volicer et a I., 1999). It encompasses nine behavioral 
indicators, 7 negative (noisy breath ing/negative vocalization/sad/frightened facial 
expression/frow ning/tense bodylanguage/fidgeting) and 2 positive (content facial 
expression/relaxed bodylanguage). The Dutch version o f the DSDAT showed good 
inter-observer re liab ility  (Hoogendoorn et a I., 2001).
CBS
M odification of Cornell Scale fo r Depression in Dementia, based on the conceptu­
alization tha t high QoL is indicated by presence of positive affect, satisfactions and 
self-esteem , and relative absence of negative affect (Ready et a I., 2002); completed 
by a clinician after brie f in terview  w ith patient and caregiver. The CBS is composed
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of 19 b ipolar items, rated on a 5-poin t scale, yield ing a single QoL score. Domains 
are m ood, ideational/behavioral disturbances, physical signs and cyclic fu n c ti­
ons. The scale dem onstrated adequate in te rra ter/in te rnal consistency re liab ility  
and crite rion-va lid ity  (visual analogue positive mood ratings) in 50 patients (mean 
MMSE 22) (Ready et a l„ 2002).
Vienna List
Description o f w ell-being in severe dementia, based on observations of profes­
sionals. Containing five factors encompassing most o f the behavioral reperto ire in 
severe dementia: com m unication/negative a ffec t/b od ily  contact/aggression/m o­
bility. The psychometric properties have to  be proved in fu rth e r studies (Porzsolt 
et a l„ 2004).
DEM Q O L
Se lf-report questionnaire administered by interview er (Smith et a I., 2005a,b). It has 
a patient (DEMQOL; 28 items) and carer (DEMQOL-Proxy; 31 items) version and 
assesses dementia-specific QoL from  the patient's perspective. The tw o versions 
give d iffe rent but com plem entary perspectives on QoL and it is recommended 
tha t both are used together. Five domains are covered: daily ac tiv ities /look ing  after 
yourse lf/hea lth /w e ll-be ing /cognitive  function ing/socia l re lationships/self-concept. 
In severe dementia (MMSE<10), only DEM QOL-Proxy should be used.
Qua lidem
40-item  behavior observation-scale fo r patients up to  severe dementia in insti­
tu tions (Ettema et al, 2006; Ettema et al, subm itted). Nine subscales (care re la ti­
onship / positive and negative affect/restless/tense behavior/positive self im age/ 
social relations/social iso la tion/fee ling  at hom e/having som ething to  do) provide a 
QoL profile. It can be used fo r longitud inal investigation, and to  evaluate effects of 
in terventions and changes in daily care.
Se lec tion  o f QoL ins trum en ts  fo r  app lica tio n  in p rac tice
Selection o f the appropriate instrum ent should take into account, apart from  its 
psychometric properties, the fo llow ing . Firstly, instrum ents tha t allow patients to 
rate the ir own QoL are preferred, if the ir judgm ent perm its. Secondly, fo r what 
stage of dementia and setting is the instrum ent to  be used? Thirdly, does the in ­
strum ent measure the QoL domains tha t the professional or intervention focuses 
on? Finally, in case of com m unity-dwelling patients, it is preferable if the scale 
provides fo r QoL measurement o f the caregiver as well.
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Based on these criteria four scales (Table 3) are recommended. For those offering 
daytim e activities to  people w ith mild dementia the SEIQoL seems the best choice, 
fo r 24-hour care the QOL-AD is advised. The SEIQoL offers both patient and care­
giver QoL measurement. In m oderately severe dementia, the  SEIQoL-DW  can be 
used. The QOL-AD contains most of the domains nurse assistants focus on in 24- 
hour care, and remains applicable during disease progression, an advantage in 
longitud inal studies. W ith  the CQOL-AD the QoL o f the  caregiver can be assessed. 
ADRQL (all stages of dementia) and DQoL (m ild-m oderate ly severe dementia) are 
appropriate choices fo r professionals offering  daytim e activities focusing specifi­
cally on affect, self esteem, sense of aesthetics, social contact (DQoL) and en joy­
ment o f activities (ADRQL). For general evaluation of daytim e activities these mea­
sures are less appropriate, because both instrum ents only represent a selection 
o f the domains tha t professionals offering daytim e activities focus on. A  relative 
disadvantage o f the ADRQL is tha t the (in)formal caregiver reports on the patient, 
as it is known tha t inform ant and self-perception of QoL d iffe r substantially. To 
date, ne ither source o f inform ation is superior (Ready et a I., 2004). Professional 
caregivers could assess the well-being o f patients more positively if they are also 
the care-provider (Porsolt et a I., 2004). To measure QoL in m ild -m oderate dementia 
in 24-hour institu tiona l care the  observational instrum ent Qualidem  seems most 
appropriate, supplem ented w ith the  se lf-report QOL-AD instrum ent, which is also 
applicable in day-care. In severe dementia the Qualidem tog e th e r w ith the DSDAT 
seem adequate to  evaluate the influence of daytim e activities and 24-hour care on 
QoL. The selected instrum ents obviously do not cover all stages o f dementia. Two 
instrum ents can assess QoL of both patient and caregiver: SEIQoL and QOL-AD 
(CQOL version).
Discussion
Measuring cognitive and functional response in dementia is no longer enough 
(Bannerjee et a I., 2006). QoL measures should be applied more o ften as currently 
no disease m odifying therapy is available. O ur aim was to  operationalize QoL cri­
teria tha t are m ost im portant fo r patients and help professionals select the best 
scale, taking into account the relevant domains they focus on in daily practice.
Our overview shows three methods of QoL assessment: se lf-report by patient, 
p roxy-report by proxy or professional, and direct observation o f behavior assumed 
to  be related to  QoL. Dementia may interfere w ith understanding, ab ility  to  re­
mem ber relevant events, making comparisons across complex domains and com ­
municating (Rabins, 2000). Logsdon et al. (2002), however, showed tha t patients 
can rate the ir own QoL until late stages of dementia and tha t caregiver-ratings do
61
not substitu te fo r patient-ratings. Sands et al. (2004) found tha t caregivers rated 
patients' QoL lower than patients, associated w ith increased caregiver burden and 
depressive symptoms of the patient. Boyer et al. (2004) found poor pa tien t/fam ily  
proxy concordance fo r the dimension em otional reaction of the N ottingham  Health 
Profile. The disadvantage of proxy-ratings is tha t they filte r a subjective measure 
through the op inion of another person.
Acknow ledging the problem of potentia l bias o f proxy-reports, self-rating methods 
are preferable if possible. If not, observational m ethods by an uninvolved profes­
sional are an acceptable alternative. W e agree w ith Brod et al. (1999a) tha t the 
patient's subjective ratings should be the gold standard, but tha t independent 
observational ratings are of benefit fo r patients w ith (very) severe dementia.
In this paper we specifically focused on QoL scales appropriate fo r professional 
caregivers providing daytim e activ ities/24-hour care. W e found no instrum ents 
tha t can be used in all stages o f dementia, types of care/settings. Four measures 
best represent the domains of QoL tha t are im portant fo r patients and tha t p ro­
fessionals focus on in the m entioned care settings. The firs t tw o  are self-rating 
instrum ents. For people living in the com m unity who are offered daytim e activities, 
and the ir proxies, we advise assessment o f QoL w ith the SEIQoL (mild dementia) 
or SEIQoL-DW  (m ild-m oderate dementia). The QOL-AD remains applicable up to  
MMSE scores of 3. Though the QOL-AD encompasses only 4/13 domains m en ti­
oned as relevant fo r QoL by dem entia-patients, this is suffic ient if the intervention 
deals prim arily w ith these domains, as is often the case in 24-hour care. The CQOL- 
AD  version assesses caregiver's QoL. If se lf-report is not possible we recommend 
the observational instrum ents Qualidem  (for mild to  severe dementia) and DSDAT 
(for severe dementia) by uninvolved professionals, both fo r evaluation of daytime 
activities and 24-hour care. The o ther QoL instrum ents are less appropriate, but 
could be useful in the evaluation of in terventions tha t focus specifically on domains 
included in those instrum ents.
In conclusion, QoL instrum ents must, if possible, acknowledge the op in ion of pa­
tien ts  w ith dementia. Interventions must take into account the domains they consi­
der m ost im portant and the  applied instrum ent should encompass the relevant d o ­
mains fo r the care typ e /se tting  in question. If necessary more instrum ents could be 
used to g e th e rto  compensate fo r omissions in the application of one isolated scale. 
Investigators must select the  scale(s) appropriate fo r the user, research question 
and care-type/setting . Rating of QoL of the caregiver is equally im portant, espe­
cially in com m unity-dwelling patients. Improvem ent o f QoL o f dem entia-patients 
and the ir caregivers should have a high p rio rity  in dementia care. QoL assessment 
provides a form at to  express w hether an intervention has made an im portant d if­
ference to  the patient's life (Selwood et al., 2005). The measures we recommend are
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tools to  contribute to  this goal. One should not assume that any instrum ent fo r QoL is 
automatically suitable to  evaluate the effect o f every intervention in all care-settings 
and stages of dementia. If the main focus in daily practice is on aspects that are not 
measured w ith the applied instrument, the effectiveness o f the intervention cannot 
be assessed adequately. This study shows that severity o f dementia, care-type/set- 
ting, and the specific QoL domains an intervention focuses on, are im portant factors 
to  decide which QoL instrum ent would be best to  use in a specific situation.
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Table 1. Domains important fo r quality o f  life according to  patients with dementia, focused on by professional caregivers and the ir representation
in measuring instruments fo r quality o f life in dementia
Domain of quality 
of life
Affect Self­
esteem
/self-image
Social
contact
Attach­
ment
Physical 
and mental 
health
Enjoyment 
of activities
Sense of aes­
thetics in living 
environment
Finan­
cial
situation
Security 
and pri­
vacy
Self-deter- 
mi nation 
and freedom
Being useful/ 
giving mea­
ning to life
Spirituality
Important to patients 
in NH/MC*
+/++ +/+ +/+ +/+ +/+ +/+ +/- +/+ +/+ +/+ +/+ -/+
Focused on by NA in 
24-hour care in NH*
4* 4 3,5 4 4 3 3 2 4 3 2 3
Focused on by NA/ 
OTin NH and MC*
4* 4 3,5 4 4 4 4 2 4 3 3 3
SEIQoL
McGee et al. 1991
+ + + + + + + + + + + +
DQoL
Brod et al. 1999a
+ + + +
ADR-QL
Rabins et al. 1999
+ + + + +
QoL-AD
Logsdon et al. 1999
+ + + +
DSDAT
Volicer etal. 1999
+ + +
CBS
Ready et al. 2002
+ + +
Vienna List 
Porzsolt et al. 2004
+ + ±
DEMQOL 
Smith et al. 2005
+ + +
Qualidem 
Ettema et al. 2006
+ + + + +
* NH = nursing home; MC = meeting and day-care centre; NA = nurse assistant; OT = occupational th e ra p is t+ + = present; - = absent. * 5 = daily practice focused on the domain to a very high 
degree; 4 = a high degree; 3 = some degree; 2 = a limited degree; 1 = a very limited degree.
Table 2. Psychometric and practical properties o f  quality o f  life measures in dementia
SEIQoL 
McGee et al.
DQoL 
Brod et al.
ADRQL 
Rabins et al.
QOL-AD 
Logsdon et al.
DS-DAT 
Volicer et al.
CBS
Ready et al.
Vienna List 
Porzsolt et al.
DEMQOL 
Smith et al.
Qualidem 
Ettema et al.
Reliability
Internal consistency 0,60-0,75 0,67-0,89 0,80 0,81 -0,90 0,86-0,89 0,81 0,81-0,94 0,87 0,60-0,90
Inter-rater reliability + n.a.* n.a. >0,70 0,74-0,98 0,90 0,35-0,81 n.a. 0,66-0,88
Test-retest reliability 0,88 0,64-0,90 n.a. P0,76, CO,92 0,97 n.a. n.a. 0,76-0,84 0,74-0,88+
Criterion related* - - - - - - - - -
Construct validity + + + + + + + + +
Responsiveness
Sensitive to intervention + n.a. + n.a. + n.a. n.a. n.a. n.a.
Longitudinal change + + + + n.a. n.a. n.a. n.a. n.a.
Applicability
Stage of dementia Mild Mild-moderate All stages Mild-moderate Severe Mild-moderate Severe Mild-moderate§ Mild-severe
Data collection Interview Interview Observation Interview Observation Interview Observation Interview Observation
Rating by Patient Patient Proxy Professional Professional Professional Professional Patient; Proxy Professional
Assessment QoL proxy + - - + (CQOL) - - - - -
Setting Community,
institution
Community,
institution
Institution Community,
institution
Institution Community,
institution
Institution Community,
institution
Institution
Inclusion environmental 
factors
+ - + + - - - - +
Rating by# O O O O O, N O NA, O Ph, N 2 NA
Difficulty of application Trained
interviewer
Easily
administered
Trained
interviewer
Easily
administered
Trained
interviewer
Easily
administered
Easily
administe­
red
Easily
administered
Easily
administered
Validated in E/D" E E E E/D E E E D
*n.a.: not available.+ By 2 nurse assistants. 1 nurse assistant: 0,49-0,79. * There is no gold standard, because Quality of Life is by definition subject to individual interpretations. 
§ Severe dementia: only DEMQOL-Proxy. # 0=o the r investigators/researchers. N=nurse. NA=nurse assistant. Ph=physician.N E = English D = Dutch.
Table 3. Four measures to evaluate the outcome o f daytime activities and 24-hour care on quality o f life (QoL) in dementia
SEIQoL(-DW) QOL-AD/CQOL-AD Qualidem DSDAT
Stage of dementia Mild dementia (DW: moderate) Mild-moderate severe dementia Mild-moderate severe dementia Severe dementia
Setting Community and institution Community and institution Institution Institution
Type of care Daytime activities 24-hour care Daytime activities/24-hour care 24-hour care
Domains of QoL All relevant domains Sufficient Attuned to institutional care Attuned to institutional care
Rating QoL proxy + + - -
Difficulty of application Trained interviewer, difficult Easy after simple training Easy after simple training Easy after simple training
Rating by Investigator Investigator Two nurse assistants Nurse assistant/investigator
Dutch validation + - + +
English validation + + - +
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ABSTRACT
Objectives: To make an inventory o f needs assessment instrum ents in dementia, 
explore the interaction between unm et needs and health-re lated quality o f life 
(HRQoL), and relate these to  the conceptual model o f Maslow's Hierarchy of needs 
in order to  design a dementia-specific model.
Methods: Narrative review of litera ture on (measures of) needs of patients and 
caregivers and HRQoL determ inants im portant in dementia. Relating these needs 
to  individual goal setting  instrum ents and Maslow's Hierarchy o f needs model. 
Results: The Camberwell Assessment o f Needs fo r the Elderly (CANE) turns out to  
be a valid too l to  assess needs of dementia patients, suitable fo r research and clin i­
cal use. The Carers' Needs Assessment fo r Dementia (CNA-D) is a valid instrum ent 
to  assess needs of caregivers. Patients identified significantly fewer needs than 
(in)formal caregivers. The most im portant needs, tha t also determ ine large part of 
HRQoL, are need fo r inform ation; support w ith regard to  symptoms o f dementia; 
social contact and company; and fo r health m onitoring  and safety. Goal A tta inm ent 
Scaling in dementia is an im portant but not yet valid outcom e measure, w ith only 
few  data on feasib ility  in dementia patients.
Conclusions: There are several instrum ents to  assess needs of dementia patients 
and caregivers. Domains of unm et needs and HRQoL overlap. The Hierarchy Model 
o f Needs in Dementia (HMND) offers a new theoretica l fram ew ork to  address the 
interplay between m eeting o f needs and im provem ent o f HRQoL in dementia. By 
identify ing  unm et needs in dementia-research, and focussing on unm et needs in 
dementia-care, much can be done to  improve HRQoL.
In tro du c tio n
Health-related quality of life (HRQoL) studies have lim ited influence on clinical de­
cision making,1 and HRQoL is rarely used as primary outcom e measure in dementia 
trials.2:3 One of the main reasons is the d ifficulty clinicians and researchers experience 
in unequivocal interpretation of HRQoL findings.4 The lack of a defin ition of m ini­
mal clinically im portant differences connected to  clinical anchors (MClDs) in HRQoL 
measures is a major barrier fo r application in trials. Nevertheless HRQoL assessment 
provides an ideal domain for patients and (in)formal caregivers to  express whether 
an intervention has made a meaningful difference to  the ir life. Conceptually MClDs 
in HRQoL are related to  needs and especially unmet needs. Dementia patients as 
well as the ir informal caregivers probably have more health needs than the general 
population, many of which are unrecognised and unmet by professionals and infor­
mal carers. However so far, both in clinical practice and research, the connection
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between HRQoL and needs assessment is not fu rther elaborated on. Unmet needs 
can be divided in subjective, ob jective, personal and societal needs. Subjective 
needs are the needs experienced by patients and caregivers, fo r example the  need 
fo r com fort and compassion. Objective needs are ob jectively diagnosed needs, fo r 
example in patients w ith clear signs o f neglect. Needs can also be distinguished 
on a personal and societal level, w ith the  la tter pointing fo r example at the op por­
tu n ity  o f having day care services fo r the patient and/or volunteer services to  help 
the inform al caregiver. In this review we concentrate on subjective unm et needs of 
dementia patients and the ir caregivers, experienced in domains of psychological 
distress, company, inform ation and daytim e activities. Reliance solely on assess­
ment o f needs by professional caregivers may lead to  under recognition o f perso­
nal unm et needs.5 A  patient-centred approach is a precondition to  be sensitive fo r 
tracing unm et needs. However, the issue of determ ination of needs and HRQoL in 
dementia and o lder patients in general is complex, also because of atypical illness 
and com plaint presentation. In case o f dementia, the  influence of cognitive im pair­
m ent on re liab ility  and va lid ity  o f se lf-reporting  capability and unawareness of defi­
cits also plays a role. Many dementia patients experience unm et needs w ith regard 
to  available care, which results in under use of services and support. Moreover, 
they frequently  experience needs w ith regard to  inform ation on the consequences 
o f dementia. L iterature on met and unm et needs is often lim ited to  practical issues 
and organisation o f care.
Goal A tta inm ent Scaling (GAS) may offer patients and caregivers the opportun ity  to  
discuss the ir needs and to  choose and prioritize im portant aspects of the ir HRQoL.6 
GAS enables inclusion of care recipients' views in the intervention and thus potentially 
enhances the effectiveness of interventions and ultim ately the HRQoL in dementia. 
W e designed the Hierarchy Model o f Needs in Dementia (HMND) based on the 
humanistic psychology o f Maslow, especially his theo ry  of m otivation and hierarchy 
o f needs. Maslow's model presents a global fram ew ork fo r quality of life and per­
ceived needs but has not yet been discussed in dementia care literature. The rela­
tionsh ip  between needs and HRQoL in dementia can be visualized by tw o  parallel 
pyramids: one depicting the levels of needs in dementia and the o ther showing the 
consequences when those needs remain unmet. This perspective could serve as a 
new model and a theoretica l fram ew ork to  study the interplay between needs and 
HRQoL. Ideally this could generate a new decision m odel fo r fu ture  research and 
appropriate allocation of finances and care fo r the increasing societal problem  of 
dementia. O ur study aims to  present an overview of (unmet) needs assessment in ­
strum ents, o f dem entia-re lated HRQoL determ inants, GAS and Maslow's Hierarchy 
o f needs Model, and to  introduce the HMND.
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M ethods
According to  the m ethodology o f narrative reviews,7 we searched the literature w ith 
the PubMed search term s 'Unm et needs AND  Dementia', 'Unm et needs AN D  De­
mentia AN D  Q uality  o f life' and 'Unm et needs OR Maslow's hierarchy of needs OR 
Goal A tta inm en t Scaling A N D  dementia AN D  quality o f life', and the references of 
the articles retrieved. Based on this inform ation we present an overview  of measure­
ment instrum ents fo r needs o f dementia patients and caregivers: the Cam berwell 
Assessment of Needs fo r the Elderly (CANE),“ Care Needs Assessment Pack fo r 
Dementia (CareNap-D),v and Carers' Needs Assessment fo r Dementia (CNA-D).11-1 
D ifferences in needs according to  patients and caregivers were analysed as well 
as HRQoL determ inants in dementia, by incorporating data from  tw o o f our earlier 
studies. In the first study spouses o f AD patients were assessed fo r the ir relevant 
individual domains o f HRQoL w ith the Schedule fo r the Evaluation of Individual 
Q ua lity  o f Life (SEIQoL).11 In a recent review we identified the domains most relevant 
fo r HRQoL according to  dementia patients.12 Next, we summarized the inform ation 
about the use of GAS in dementia. Finally we related these findings to  the concept 
o f Maslow's Hierarchy m odel of (unmet) needs and designed a new theoretica l 
fram ew ork of consequences o f (unmet) needs and HRQoL.
Results
M easu rem en t ins trum en ts fo r  needs o f  dem entia  pa tien ts
Two measurements instrum ents were found: CANE and CareNap-D.S;V M ild or m o­
derately severe dementia patients are able to  assess the ir own m et and unm et 
needs w ith the CANE. Reynolds et al. developed the CANE on the basis of the 
Cam berwell Assessment of Need (CAN), a w idely used needs assessment fo r peo­
ple w ith severe mental illness. Needs were assessed in 24 areas of life and cover a 
broad range of health, social and psychological domains.“The CANE turned out to  
be suitable fo r both research and clinical use and applicable in various settings and 
populations. It has good content, construct and consensual va lid ity  and d em on­
strates appropriate criterion validity. Reliability is high: kappa>0.85 fo r in ter-rater 
reliability. Correlations o f inter-rater and test-re test re liab ility  of to ta l numbers of 
needs identified by professionals were 0.99 and 0.93, respectively. The CANE p ro­
ved to  have good feasib ility, as it easily could be used by a w ide range of profes­
sionals w ithou t form al tra in ing.
The CareNap-D consists of 57 activity and behavioral items and is used to  evaluate the 
status of care needs as 'No-M et-Unm et needs' in seven domains of functioning.9 The 
CareNap-D is a reliable and valid multidisciplinary assessment of needs for people 
with dementia living in the community and the ir carers. Inter-rater reliability was good
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and kappa statistic demonstrated that agreement for 76.2% of items in the CareNap-D 
was good. There was low intra-item variance and high agreement on the items.13
M easurem en t ins trum en ts fo r needs o f  caregivers
One instrum ent was identified fo r assessing carer's needs: CNA-D. This sem i-struc- 
tured research interview  includes 18 problem areas w ith several possible in te rven­
tions. Inter-rater and test-re test reliability, concurrent and content va lid ity  were 
investigated among dementia caregivers and professionals. Significant positive 
associations were found between Zarit Burden Inventory, number o f problems and 
num ber o f unm et needs according to  the CNA-D. Kappa statistic dem onstrated 
tha t agreem ent between interviewers was good. The CNA-D is a valid and reliable 
instrum ent fo r comprehensively assessing the needs of dementia caregivers.111
Needs in dem entia
The most frequently  m entioned unm et needs by dementia patients and the ir in for­
mal caregivers can be summarized as the unm et need fo r inform ation, fo r support 
w ith regard to  symptoms of dementia, fo r social contact and company; and fo r 
health m onitoring  and perceived safety.14 Table 1 provides an overview of domains 
of personal needs of dementia patients and inform al caregivers.
Needs accord ing to  pa tien ts
Hancock et al. identified the unm et needs of dementia patients in care homes, 
using the CANE. They had a mean of 4.4 unm et and 12.1 met needs. Environmental 
and physical health needs were usually met. However, sensory or d isability (inclu­
ding m ob ility  problems and incontinence) needs, mental health needs, and social 
needs, such as company and daytim e activities, were o ften unmet. Unmet needs 
were associated w ith psychological problems (anxiety and depression).15 Patients 
reported a relatively higher num ber o f unm et needs than caregivers and professi­
onals, especially fo r psychological distress, company and inform ation, daytim e ac­
tiv ities and eyesight/hearing problems.5 In com m unity dwelling dementia patients, 
assessed on the CareNap-D, 13 of 33 needs were unmet. High levels of unmet needs 
were identified in the domains behavior, mental state, and social interaction. In­
creasing age, lower M ini-M enta l State Exam ination score, and living alone were 
associated w ith greater to ta l levels of unm et needs.16
Needs accord ing to  caregivers
Carer needs include support w ith (daily) activities and supervision. Care giving can
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result in social isolation, psychological stress and depression. Caregivers of A lz­
heimer's disease patients living at home most often needed physiotherapy fo r the 
patient, financial support, house-cleaning and home respite care during holidays. 
O fficial services poorly met caregivers' needs fo r support and help.17
D iffe rences be tw een  needs accord ing to  pa tien ts  and caregivers
Hancock et al. compared rating by (in)formal caregivers on how older people with 
mental health problems perceived the ir own needs, using the CANE.1“ Patients 
identified significantly fewer o f the ir needs (5.5) than e ither s ta ff (8.1) or carers (8.3) 
did. The kappa's indicating level of agreem ent between professional/care user, 
care user/caregiver and caregiver/care user were low, indicating tha t patient-re- 
ported outcomes should be given a high priority. O rre ll et al. compared the ratings 
of needs of dementia patients in care homes w ith the C AN E.5 They concluded that 
patients' views on the ir needs should be sought and tha t assessment by inform al 
caregiver and professionals may lead to  under recognition of unm et needs.
Q ua lity  o f  life  de te rm inan ts in dem entia
Spouses o f AD  patients were assessed fo r the  relevant individual domains of the ir 
quality  of life by means of the  SEIQoL.11 The most frequently  m entioned de te rm i­
nants were physical fitness of patient, and state o f the ir marriage and family. In 
another explorative study we identified the  domains most relevant fo r HRQoL ac­
cording to  dementia patients, professional caregivers and the  literature.12 Patients 
and professionals have d iffe rent perspectives. Some domains were not m entioned 
by professionals (i.e. 'sense of aesthetics in living environm ent', 'financial s ituation ' 
and 'being o f use/ giving meaning to  life'), and not selected in the measuring in ­
strum ents ('security and privacy', and 'self-determ ination and freedom '). W e sum ­
marized these domains in Table 2, and also expressed which items were perceived 
as domains fo r unm et needs as well. The results suggest considerable overlap 
between the tw o paradigms o f HRQoL and needs assessment.
G oal A tta inm e n t Scaling in dem entia
Goal A tta inm en t Scaling (GAS) offers patients and (in)formal caregivers the oppor­
tu n ity  to  select the relevant domains of HRQoL and has been used as an outcom e 
measure in clinical dementia tria ls.6;|V;2U GAS can be considered as an opera tiona li­
zation of the unm et need w ith highest priority. In long-term  care GAS is a feasible 
and responsive measure.21 In a systematic review empirical support was found fo r 
the valid ity o f goal setting  fo r use in physical rehab ilita tion settings, but research 
dem onstra ting its reliability, sensitiv ity  and feasib ility  seems lim ited .22 In this review
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on clin im etric aspects and feasib ility  o f GAS in dementia, we found mixed results 
fo r responsiveness, content validity, in ter-rater re liab ility  and construct/convergent 
validity. GAS proved to  be useful on im portant aspects o f an outcom e measure, but 
the evidence is not strong enough yet to  state tha t GAS is an applicable outcom e 
measure in this population.23
M aslow 's H ierarchy M od e l o f  Needs
Maslow's Hierarchy M odel o f Needs (MHMN) is based of the humanistic psycho­
logy of Maslow, especially his theo ry  o f m otivation and hierarchy of needs. W hen 
related to  the enum eration of HRQoL domains and the unm et needs, it enables 
understanding of these objectives in view o f more universal human needs.24 The 
MHMN is o ften depicted as a pyramid consisting of d iffe rent levels, comprising five 
fundam ental human needs. The lower level deals w ith physiological basic needs 
(food, drinks, shelter, and warmth), while the top  levels are associated w ith psy­
chological needs: safety, love and belongingness, self-esteem  and needs of self- 
actualization (the desire to  become everyth ing tha t one is capable of becoming). 
The lower fou r layers of the pyramid, i.e. physiological, safety and security, love 
and belonging, and esteem, are what Maslow called 'deficiency needs'. Deficiency 
needs must be met first.
H ierarchy M ode l o f  Needs in D em entia
Maslow's m odel has not yet been discussed in dementia care litera ture .24 W e re­
lated the theoretica l and general perspective of the MHMN (unmet) needs to  the 
needs and HRQoL in dementia. W e visualized this re lationship by means of tw o 
parallel pyramids, one depicting the levels of needs in dementia and the other 
showing the consequences on f.i. HRQoL when needs remain unm et (see Figure 1). 
The Hierarchy M odel o f Needs in Dementia (HMND) provides a comprehensive ap­
proach fo r needs assessment and the design of interventions to  achieve goals that 
meet the wishes of patients and caregivers. The physiological basic needs include 
maintaining personal hygiene, housing and feeding. Safety-needs deal w ith pre­
vention of harm caused by wandering, apraxia, agnosia, disturbance in executive 
function ing  or decreased judgm ent capacities. Love and belonging-needs deal 
w ith affection, love and acceptance in the face of a progressive neurodegenerative 
illness, which hinders patients to  have social contacts tha t may result in receiving 
signs of love, acceptance and affection. Self-esteem -needs concern fears fo r loss 
o f mastery and independency; esteem, respect, and appreciation fo r the patient, 
who experiences rapid loss of societal roles. And on top  of all these needs we posi­
tion  self-actualization, a 'being'-need, which m otivates or drives behavior.
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Discussion
The striving fo r completion of unmet needs is, similar to  learning theory and altered 
stress thresholds theory, one of the relevant psychologically oriented paradigms in 
dementia care.25 Quality of life refers to  the needs tha t are considered most impor­
tant. Goal attainm ent scoring is the concrete next goal on a very or the most im portant 
unmet need. These needs can be related to  each other using a hierarchical model. 
Needs can be assessed in one of tw o  ways: e ither by adopting an ep idem iolog ical 
approach and perform ing a survey, or by examining health service usage. Despite 
many provisions of care directed at improving HRQoL, there still remain a high 
num ber o f unm et needs in dementia patients,26 and little  understanding o f why 
these needs remain unm et.27 Interventions should be tailor-m ade, to  fu lfil needs 
in a manner tha t matches a person's cognitive, physical, and sensory abilities, and 
the ir lifelong habits and roles. Sometim es people w ith dementia are unable to  
clearly or consistently verbalize symptoms or complaints. Thus, in patients w ith se­
vere dementia it may be d ifficu lt to  know the  content and extent o fth e ir  needs. The 
consequences of need-driven, dem entia-com prom ised behavior (C-NDB) theory  
shows the effects of behavioral symptoms and results o f unm et needs.2“ Behavioral 
symptoms may be expressions of unm et (non-)physiologic needs or goals. Unmet 
needs analysis can guide the trea tm en t o f behavioral problems in dementia. Open 
ended discussion can also produce unexpected inform ation tha t is outside the 
goals of the researcher, but relevant to  the people being studied, reflecting the 
unique nature o f each person's experience w ith dementia.
O lder people apparently to le ra te  unm et needs.27 However, in dementia cascading 
effects occur, in which not meeting too  many orig inal needs results in new needs 
and behavioral sym ptom s.2“ Unmet needs will affect HRQoL w ith consequences fo r 
care and caregivers and increasing risks fo r ins titu tiona liza tion. It has been shown 
tha t determ ining unm et needs may be useful in identify ing  dementia patients at 
r is k fo r nursing home placement and death.311 In residential care environm ental and 
physical health needs were usually met. However, sensory or physical d isability (f.i. 
m ob ility  problems, incontinence) needs, mental health needs, and social needs 
(f.i. company, daytim e activities), were o ften unmet. Unmet needs were associated 
w ith psychological problems, such as anxiety and depression which may decrease 
HRQoL.15 Care services have been developed w ith little  evaluation as to  how needs 
have been met by these services. Professionals should be aware tha t in dementia 
care o ften only the basic levels of needs are partially met, tha t many needs remain 
unm et and tha t much can be done to  improve HRQoL.15 The first goal is to  ad­
dress the  m ost simple goals, but the ultim ate goal is to  also m eet more complex 
(e.g. em otional and social) unm et needs in such a way tha t this improves HRQoL.
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The aim of in terventions should be to  move the  care from  basic to  more complex 
levels. Behaviors associated w ith dem entia may be expressions o f unm et needs or 
goals. Despite many provisions, there still remains a high degree of unm et need.26 
Identification of these needs provides a conceptual fram ew ork and local, regional 
and national overviews of most im portan t problems fo r fra il e lderly subjects. The 
higher the pyramid level o f H NM D a patient can reach, the higher his or her HRQoL, 
and probably the less d isturbing behavioral and neuropsychological symptom s oc­
cur. Assistance to  caregivers can reduce the  severity o f patients' symptom s and 
delay institu tiona liza tion . Because this assistance requires provision of m ultip le 
health care and social services, a coordinated system of care, guided by need and 
HRQoL is warranted. Patient-based assessment will assist healthcare providers to  
prioritize needs according to  what the users themselves consider to  be most im ­
portant, beneficial, and acceptable.1“
Thus, we propose a new theoretica l fram ew ork by combining GAS and HNMD to  
address the needs and HRQoL of dementia patients and the ir caregivers at the 
highest achievable level. W e strong ly recommend to  address needs and HRQoL 
sim ultaneously in research and clinical practice. Dementia is a still incurable chro­
nic disease, but patients and caregivers probably w ill benefit from  a coordinated 
system of care and psychosocial and com m unity-based in te rven tion protocols, 
guided by (unmet) needs and HRQoL assessment, carried out by a case manager. 
Besides im provem ent o f HRQoL, prioritiz ing  o f needs also helps to  achieve the 
most effic ient a llocation of health and social care resources.
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Table 1. Domains o f personal needs o f dementia patients (P) and in fo rmal caregivers (C)
Psychosocial needs Physical and practical needs
Inform ation on dementia (P,C) Physical health (P,C)
C ognition (P) Senses (vision and hearing) (P)
Behavior and mental state (P,C) Physical ab ility (m obility and falls) (P)
Em otional support (P,C) Self-care (P)
Em otional distress (depression and anxiety) (P,C) Toile ting (P)
Social interactions, company (P,C) Incontinence (P)
Marriage, fam ily (C) Accom m odation (P,C)
C om m unity living; institu tionalization (P) House-care (P,C)
Safety (P) Food preparation (P)
Respite care (C) Help with supervision (C)
Day-tim e activities (P)
Table 2. Domains o f qua lity  o f life judged by patients as m ost im portan t in dementia
Psychosocial domains Physical and practical domains
M ental health Physical health*
A ffect Security and privacy*
A ttachm ent* Financial s ituation*
Self-esteem  /se lf-im age
Being useful/ giving meaning to  life*
Enjoym ent o f activities*
Se lf-determ ination and freedom *
Social contact*
Sense o f aesthetics in living environm ent
Spirituality
*Domains judged as relevant for quality of life and also directly or indirectly mentioned as (unmet) needs, according to own 
research and literature.5:12:14' 18:29:31:32
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Figure 1. New m ode l o f levels o f needs, and consequences o f  unm et needs in dementia
____ A____
Self-actualisation 
Being use-/meaningful, 
freedom, spirituality
~7 \
Esteem needs 
Self-esteem /self-image, 
responsibility, privacy 
/  \  
Belongingness and love needs 
Social contact, attachment, 
affect, enjoyment activities
/ r
Safety needs 
Security, financial situation
Biological and physiological needs 
Basic life needs, physical and mental health
V ~~7
Unmet goals of patients or caregivers
\  r
Behavioral symptoms
/
Increased caregiver burden
I
Decreased HRQoL 
\  7
Institutionalization
y
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Given the com plexity  o f dementia, there is emerging consensus tha t patient-repor- 
ted outcomes such as health-re lated quality of life (HRQoL) are warranted fo r com ­
prehensive outcom e measurement. HRQoL measurement dem onstrates w hether 
interventions are perceived as meaningful by patients and caregivers,1 and will play 
a key role in assessing outcom e o f disease-m odifying interventions once they be­
come available. However, several issues threaten accuracy o f HRQoL assessment 
in fra il elderly. These issues are under recognized, especially in dementia. In this 
le tte r we want to  high light relevant issues in measurement procedure and choice 
of instrum ent.
The impact of declining inte llectual capacities, semantic knowledge and episodic 
memory, as well as varying deficits of judgm ent and insight, may comprom ise de­
mentia patients' judgm ent and add to  inter- and intra-ind ividual variation in HRQoL 
rating. Behavioral and noncognitive symptoms are also of influence.2 Judgments 
about what is im portant to  HRQoL may change as dementia progresses: what 
seems im portant in early stages (e.g., preservation of inte llectual capacity) may 
seem un im portant in late stages (when safety and com fort may take on primary 
im portance).3 Furtherm ore, anosognosia (unawareness of deficits), is frequently  re­
ported as cause fo r less reliable repeated self-reports and discrepancies between 
self- and proxy-rating.4
Q uality  of life, health status and HRQoL represent three d istinct constructs. In qua­
lity  o f life rating patients give greater emphasis to  mental health. In health status 
rating, physical function ing is more im portan t.5 HRQoL is a more narrow concept 
than quality  o f life and reflects individuals' perception of the impact o f a health 
status, e.g. dementia, on the ab ility  to  perform  usual tasks and effects on everyday 
life, physical, social and em otional w ell-be ing .6
The first question to  be answered is which HRQoL measures are preferable. HR­
QoL measures can be categorized into disease-specific and generic instrum ents. 
Disease-specific instrum ents target to  measure consequences o f specific diseases, 
whereas generic instrum ents can be used in all health areas but lack the sensi­
tiv ity  of disease-specific instrum ents. Furtherm ore, most -  if not all -  of present 
dementia HRQoL instrum ents are constructed w ith in a measurement fram ew ork 
tha t precludes expressing the measures as single overall metric measure. Summary 
values are im portant because they can be compared w ith effects o f o ther diseases/ 
interventions and fac ilita te  economical decision-making.
Second, several factors should be taken into account in interpreting  HRQoL ou tco­
mes in dementia. In general, persons w ith chronic diseases o ften report a relatively 
high HRQoL, when observers judge the ir life to  be undesirable. This is known as 
d isability paradox.7 Response sh ift may contribute to  this phenom enon. Response
86
sh ift is change in self-evaluation due to  recalibration (changes in internal m easure­
ment standards), reprio ritiza tion (changes in values or im portance o f domains con­
s titu ting  HRQoL), or reconceptualization (redefin ition of HRQoL). A ltog e the r the 
relation between (severity of) dementia and HRQoL is ne ither simple nor direct. 
Third, the  question who should rate HRQoL is especially crucial in dementia. Can 
caregivers express patients' perceptions?“ On the one hand caregivers rate pa­
tien ts ' HRQoL lower.7 This may be explained by the ir own health problems, mood, 
burden and by differences in perspectives. On the other hand the judgm ent of 
patients, who have the actual experience of living w ith dementia, may be(come) in ­
fluenced by cognitive lim ita tions. Nevertheless, reliable rating is probably feasible 
until late dementia-stages, if scales are well chosen. Patients' own op in ion should 
remain the gold standard fo r as long as possible.11-1 Use of parallel proxy-measures 
from  the s tart o f a longitud inal study prevents the necessity fo r substitu ting  pa- 
tien t- by proxy-rating when patients are no longer able to  judge the ir HRQoL. This 
reduces bias o ve rtim e  and prevents missing data.
As patient-reported  outcom es become more established, these m easurement is­
sues need to  be addressed. Until now HRQoL is infrequently  used as outcom e in 
dementia research.11 An im portant reason is the subjective nature of the concept, 
which makes tha t this type of 'risky' outcomes are only applied if s tric tly  obliged 
by regulatory bodies. Nevertheless, HRQoL should play a key role in assessing ef­
ficacy of new treatm ents in fra il elderly, especially dementia patients. However, 
measurement remains cumbersome and the issues described should be addressed 
to  arrive at valid and reliable outcomes. W e plead fo r application of HRQoL measu­
rem ent as im portant outcom e measure in dementia in tervention trials and intend 
to  in itia te  an international working group 'HRQoL measurement in fra il e lderly and 
dementia'. The first aim is to  design a HRQoL instrum ent w ith low cognitive burden 
combining advantages o f disease-specific and value-based generic HRQoL instru­
ments, covering the relevant domains. The instrum ent should be applicable fo r 
self- and caregiver-report, and produce a single metric figure expressing the over­
all HRQoL of individual patients. Fo rth is  purpose novel measurement methods are 
available and will be applied.
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ABSTRACT
C ontext: Twelve patients w ith mild to  m oderate A lzheim er's Disease (AD) and the ir 
caregivers were interviewed w ith the Schedule fo r the Evaluation o f Individual Q ua­
lity  o f Life (SEIQoL). The SEIQoL measures quality  o f life by taking into account the 
relevant determ inants fo r a particular individual.
Methods: The subject rates five areas in life most im portant to  the quality  o f life. 
The relative contribution of each area to  the overall quality o f life is then calculated 
w ith a m ultip le  regression analysis programm e developed fo r the purpose. Next 
the SEIQoL Index score, va lid ity  and re liab ility  are computed.
Results: One patient was unable to  com plete the interview. The remaining (8 w o­
men, 3 men, mean age 71.3 years) had a mean SEIQoL Index score of 79.9 (median: 
85.4), which is comparable to  healthy Dutch elderly. The caregivers (10 spouses, 
2 daughters, mean age 67.4 years), on the other hand, had a lower SEIQoL Index 
score: 62.2 (median: 63.8). Va lid ity  and re liab ility  were good fo r both groups. 
Conclusion: Caregivers in this pilot study experienced a lower quality of life than AD 
patients and healthy Dutch elderly. The SEIQoL allows quantitative measurement of 
com pletely individualized quality of life fo r AD patients and the ir caregivers.
Introduction
Q uality  o f life is im portant fo r everyone, but no less fo r patients w ith dementia: 'not 
knowing where I am does not mean I do not know what I like'!1 The quantification 
of quality  o f life there fo re  receives more a tten tion  partly because there are so few 
good methods available.
In the last few  years, clinical and scientific in terest in dementia has been increasing. 
Developm ents in the pharm acotherapeutic area have spurned more interest. The 
im portance of making the diagnosis and determ ining the  e tio logy of dementia are 
im portant factors leading to  an increase in the num ber of M em ory Clinics in the 
N etherlands.213 Valid methods are available to  measure the effects o f in te rven ti­
ons (e.g. dementia pharmacotherapy) on cognitive, behavioral and general func­
tion ing .46 Yet, measuring impact on quality o f life is a scarcely developed fie ld .7;S 
To date, most assessments of quality o f life of the patient are indirect, by the care­
g iver7 A lthough the op in ion of caregivers is im portant it should not replace the 
judgm ent of persons w ith dementia themselves. Many elderly people are able to  
answer questions about the ir quality o f life despite the presence o f significant cog­
nitive deficits.1
The quality  o f life o f dementia caregivers is equally im portant. They suffer from  
higher levels of stress and psychological m orb id ity  than caregivers of non-dem en-
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ted chronically ill patients.111 The quality  o f life of the caregiver is o ften indirectly 
estim ated from  the  am ount of burden he or she experiences. Obviously, a direct 
measurement is preferable.
This p ilot study describes the individual quality of life o f patients w ith mild to  m ode­
rate dementia of the Alzheimer's type and the ir informal caregivers simultaneously 
and with the same method. A  similar study, to  our knowledge, has not been previ­
ously done in the Netherlands. For the measurement of quality of life we used the 
Schedule for the Evaluation of Individual Quality o f Life (SEIQoL). The SEIQoL has 
been previously used in healthy elderly as well as patients w ith mild dementia. The 
m ethod is useful and reliable as long as the patient's insight is still good and the ir 
cognitive impairment is still mild.11 The SEIQoL measures fully individualized quality 
o f life quantitatively on a continuous scale from  0 to  100. The m ethod is based on 
Judgm ent Analysis, a technique derived from  the Social Judgm ent Theory.1214 Judg­
ment Analysis quantifies the contribution of d ifferent factors to  the overall quality of 
life assessment. The SEIQoL has been extensively validated in both older and youn­
ger people.1315 The Dutch translation of this sem istructured interview was recently 
validated w ith healthy Dutch elderly. Strong test-retest reliability makes it applicable 
fo r the evaluation of interventions.16The responsiveness in prospective intervention 
studies has previously been shown.17 In this p ilot study we present the results of the 
measurement of quality of life of patients and the ir caregivers w ith the SEIQoL and 
compare the results w ith the previous measurement of quality of life of healthy Dutch 
elderly.16 W e also present some of the results of the neuropsychological assessment 
o f the patients to  indicate the severity of the ir cognitive impairment.
Methods
Patients and  careg ivers
Twelve com m unity-dwelling patients and the ir inform al caregivers referred to  the 
O u tp a tien t M em ory Clinic o f the Slingeland Hospital between March and July of 
1999 participated in the study. Patients were diagnosed w ith probable A lzheimer's 
Disease (AD) according to  the DSM-IV and NINCDS-ADRDA criteria.1“ Participants 
gave inform ed consent and the Internal Review Board o f the Slingeland Hospital 
approved this research.
Meaurements
SEIQoL
Participants were interviewed w ith the SEIQoL in a standardized sem i-structured 
form at. Standard instructions fo r possible problems are provided in conducting the 
interview. The firs t step in the SEIQoL is Cue Elic itation. Respondents are asked to
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name five areas of life ('cues') considered m ost im portant in assessing the ir overall 
quality  of life. Suitable cues are aspects of life, not individuals. If the participant 
mentions general cues very sim ilar to  quality o f life (e.g. satisfaction, quality  of life) 
the interview er tries to  elic it more specific cues. Sometim es it is necessary to  provi­
de suggestions from  a standard list. W hen the interview  is repeated in intervention 
studies, previously selected cues are used this second tim e.
The second step is to  rate the  current level fo r each cue (see Figure 1) on a vertical 
visual analogue scale (VAS) labeled on the lower and upper extremes respectively 
by the term s 'As bad as could possibly be' and 'As good as could possibly be.' 
The ratings were recorded in the  form  of a bar chart, each bar representing a cue 
nom inated by the individual. A long the left hand side of the rectangle is a scale 
ranging from  'worst possible' (0) on the bo ttom  to  'best possible' (100) on the top. 
The height of the bar indicates the value ('cue level'). Next the value of the  overall 
quality  o f life at tha t m om ent is indicated by a cross on a horizontal VAS, which 
runs from  the worst to  the best life one can imagine (0-10). In order to  quantify the 
relative im portance of each cue, respondents are then asked to  estim ate the overall 
quality  o f life assigned to  30 hypothetical case profiles on a horizontal VAS (0-10) 
under the profile. The case profiles are random ly com puter generated in advance 
and the five bars are labeled w ith the own five cues chosen by the  respondent. This 
is illustrated in Figure 2. A  to ta l of 30 cases is necessary to  reliably quantify the 5 
cues, 20 of these being unique profiles and 10 of these being randomly interspersed 
repeat profiles, which are needed to  determ ine judgm ent reliability. The 10 pairs of 
judgm ents are correlated to  provide a reliability coefficient (Pearson r). Judgments 
on the 30 hypothetical cases were analyzed in the standard manner using Policy PC 
(1986), a program based on m ultip le regression analysis.1' This program extracts 
the cue weights tha t indicate the  relative im portance of each area fo r the overall 
quality  o f life o f the individual. Next, the SEIQoL Index score (0-100) is calculated 
by m ultip ly ing the five cue levels by the matching cue weights and summing up the 
products. Policy PC also d irectly estimates R2, the variance in quality  o f life jud g ­
ments explained by the set of cues used. R2 values of 0.7 or above are considered 
as acceptable.20
Neuropsychological assessment
Neuropsychological assessment of the patients included the Min ¡-Mental State 
Exam ination (MMSE) and the Dutch adaptation of the Cam bridge Cognitive Exa­
m ination (CAMCOG).21;22The MMSE (0-30) is a w idely used screening too l fo r iden­
tify ing  cognitive im pairm ent. A  score o f 24/30 is o ften used as cu t-o ff po in t fo r 
suggesting mild cognitive im pairm ent.23 CAMCOG (0-106) is the cognitive part
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of the  Cam bridge Exam ination of Mental D isorders o f the  Elderly: CAM DEX. The 
C AM D EX was developed to  help in early diagnosis and determ ine the severity of 
dementia in the elderly.24
Results
A to ta l o f 24 individuals were examined, 12 patients and 12 caregivers. One patient 
(MMSE score 15/30, CAM COG score 46/106) was excluded from  the evaluation due 
to  her insufficient understanding o f the m ethod. The o ther 11 patients, including 8 
women (72.7%) had a mean age of 71.3 years (SD: 3.9). The mean MMSE score (0-30) 
was 22 (SD: 3.9) and the score on the CAM COG (0-106) averaged 74.5 (SD: 10.4). 
The 12 caregivers (10 spouses, 2 daughters) had a mean age of 67.4 years (SD: 12.8). 
The results o f assessment of quality o f life are summarized in Table 1. Patients had 
an average SEIQoL Index score of 79.9 (median 85.4; range: 55.3-100). For caregivers 
the average score was 62.2 (median 63.8; range: 43.9-79). The average R2 was 0.79 
and 0.84 respectively. The average Pearson r was 0.74 fo r patients and 0.83 fo r 
caregivers.
One patient and one caregiver had a low Pearson r, 0.34 and 0.43 respectively. A 
low Pearson r value can indicate a lack of understanding, fa tigue or boredom , or 
change o f judgm ent during the interview.
The task too k  and average of 37 ± 11 m inutes fo r patients and 23 ± 8 m inutes fo r 
caregivers to  complete. Both groups needed one or more suggestions in about 
1/3 o f the cases in choosing the cues. Com m only used cues in both groups were: 
marriage, health, children, enterta inm ent, relig ion and finance. The patient group 
required more guidance to  com plete the  interview. For example, fo rg e tting  the 
orig inal task required intervention However, the judgm ents were perform ed inde­
pendently.
Discussion
Eleven of the 12 patients examined in this study com pleted the interview  w ithou t 
any problem. One patient had insufficient understanding of the  m ethod. Internal 
va lid ity  (R2) and internal re liab ility  (Pearson r), in both groups, were higher than in 
healthy Dutch elderly.16 Browne et al. found tha t both R2 and Pearson r had a low 
but significant correlation w ith height o f the MMSE score.25 The SEIQoL appears 
reliably applicable in patients w ith mild to  m oderate dementia of the  A lzheim er 
type. Caregivers, m ostly the partners, experienced a lower quality o f life than AD 
patients and healthy Dutch elderly.
The literature also shows tha t the SEIQoL is a reliable measure of quantitative ra­
ting  of the effec t of interventions. Thus, the m ethod may be used in the decision
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on the  continuation of a once established treatm ent. The SEIQoL also measures 
the effects o f burden of care on quality  of life o f the caregiver. The uniqueness of 
the m ethod, although complex and labor intensive, is the ab ility  to  evaluate quan­
tita tive  and individual quality o f life o f both patients and caregivers simultaneously. 
This makes it a valuable too l in clinical research.
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Figure 1. SEIQoL interview ; elicited cues and current judgm en t o f quality o f life
Ratings o f five ind iv idually selected cues (e.g. health, finances, contacts, family, relig ion)
100
ratings
40
20
my life is: 
as bad as it could 
possibly be
health finances contacts fam ily relig ion
as good as it could 
- X ------------------  possibly be
Figure 2. Judgm ent o f  30 hypothetical case profiles and calculation o f weights by Judgm ent Analysis
Judgment o f 30 hypothetical case profiles
100
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40
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(labeled by individually 5 selected cues)
life (...) is: 
as bad as it could 
possibly be
as good as it could 
__  possibly be
10 18 309 33
V
=weights extracted by judgment analysis (scale 0-100: 0=not at all important, 100=very important; sum weights of 5 cues=100)
100
Table 1. SEIQoL interview results o f Alzheimer's patients, caregivers and healthy Dutch elderly
N SEIQoL Index (SD) R2 (SD) Pearson r (SD)
Patients 11 79.9(14.8) 0.79 (0.08) 0.74(0.17)
Caregivers 12 62.2(10.5) 0.84(0.10) 0.83(0.14)
Healthy elderly16 32 76.3(11.0) 0.73(0.13) 0.68 (0.22)
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ABSTRACT
Objectives: The objective of the study was to  explore, in a sample o f spouses of 
m ild -m oderate A lzheim er disease (AD) patients, predictors of quality  o f life (QoL) 
by rating QoL and burden.
Methods: The authors assessed 97 spouses in a cross-sectional study w ith the 
Schedule fo r the Evaluation of Individual Q ua lity  o f Life (SEIQoL), Self-Rated Bur­
den scale (SRB), perceived stress scale (EDIZ) and Zarit Burden Interview  (ZBI). Pa­
tien t cognition was rated w ith the M ini-M enta l State Exam ination (MMSE). Factors 
best predicting QoL were analyzed w ith m ultip le regression analysis.
Results: 87 (53% male, mean 72 years) fu lfilled  the SEIQoL internal re liab ility  criteria, 
and had a mean SEIQoL score of 68.6±14.8. Most im portant QoL domains were con­
d ition of patient (31%) and marriage (26%). Caregiver burden scores on SRB (0-100), 
EDIZ (0-9) and ZBI (0-48) were 44.1 + 23.5 (n=67), 4.9±2.2 (n=53) and 13.1 ±6.2 (n=53) 
respectively. Mean patient MMSE score (0-30) was 20.3±4.2.
Conclusions: Spouses experienced lower Q oLthan  AD  patients and healthy elderly 
(historical controls), and perceived m oderate levels of burden. Patient cognition is 
a significant predictor o f caregiver QoL. Burden, measured by ZBI, is significantly 
negatively correlated w ith SEIQoL. The results underline the im portance of im ­
p lem enting health services known to  improve QoL and alleviate burden, and to  
explore new effective interventions.
Introduction
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized 
by im pairm ent o f cognitive performance, d isability in instrum ental and basic activi­
ties o f daily living and deterioration in global functioning, which is often accompa­
nied by neuropsychiatric symptoms. Measuring quality of life (QoL) is an im portant, 
challenging, and growing area of dementia research.1 Caring fo r people with dem en­
tia is associated with well-docum ented increases in distress and decrease in mental 
health and w ell-be ing .2 Caregivers of demented patients experience higher levels 
o f stress and psychological m orb id ity  compared to  caregivers o f non-dem ented 
elderly persons. Particularly, the patients' behavioral symptoms, and im pairments 
in instrum ental activities of daily living, cause caregiver strain. The degree of this 
strain is referred to  as caregiver burden, which is higher in early onset dem entia .3 
QoL measures so far largely focused on QoL in the patients. However, assessment 
o f QoL and perceived burden in the caregiver is equally im portant, especially if the 
patient still lives in the community.
W alker et al. carried out systematic reviews on measures fo r assessment of the 
impact o f disease, and instrum ents tha t claim to  measure QoL in drug trials. They
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found no validated m ethods o f assessing the QoL of both dementia patients and 
the ir carers at the same tim e .4 To our knowledge, three m ethods are available tha t 
can validly assess QoL in dementia patients as well as the ir caregivers: the Sche­
dule fo r th e  Evaluation of Individual Q uality  o f Life (SEIQoL), the patient and caregi­
ver version of the Q uality  o f Life-A lzheim er's Disease scale (QOL-AD) and the  QoL 
scale developed in the  PIXEL stud ies.5 7 More o ften QoL of caregivers is measured 
ind irectly w ith mood or depression scales. Theoretically, a d irect m easurement of 
subjective QoL, however, is a b e tte r too l, because positive factors and stressors 
affecting the personal QoL are probably highly variable among caregivers. Also, in 
addition to  qualitative data, the measurement should best be quantitative, perm it­
ting evaluation of effects of interventions on QoL. The SEIQoL, which is devised from 
a technique known as Judgm ent Analysis, orig inating in Social Judgment theory, 
fu lfills these criteria .“ It measures the level o f function ing in five self-nom inated 
aspects of life (qualitative inform ation) and the relative weight or im portance at­
tached to  these areas. Thus, the SEIQoL allows quantitative measurement of ind i­
vidualized QoL and can be used to  m on itor changes in QoL. According to  Joyce 
et a I., the advantages o f SEIQoL are tha t: 1. cues and weights are evaluated by 
each individual in his own preferred language, so no translation is needed fo r the 
respondent, and a problem characteristic of conventional methods is thus avoided;
2. the SEIQoL score is probably no more culture-bound than systolic blood pressure 
or body temperature; 3. there is sufficient com m onality in the numerical estimates 
fo r the observations to  be entered into statistical analyses of the kind perform ed by 
W HO  and other organisations.7 Being a highly individualized measure of QoL as well 
as being language- and culturefree makes SEIQoL appear suitable fo r use in dem en­
tia patients and caregivers, allowing fo r comparison between the tw o groups.
The SEIQoL has been applied in dementia patients,10:11 but hardly any data are avai­
lable fo r spousal caregivers. Also, fo r this population there are no data on the rela­
tionsh ip  between QoL and the ir perception of burden. It seems plausible to  expect 
tha t perceived QoL and burden will be inversely related, and tha t both will depend 
on the severity o f cognitive im pairm ent of the patient. Coen et al did measure 
carer individually perceived QoL (IQoL), rated w ith the SEIQoL-DW, and burden in 
28 carers o f AD  patients. Increased patient behavior disturbance appeared to  be a 
major fac to r when the  carer's situation worsened over tim e.12 In 2002 these inves­
tigators studied caregiver characteristics and IQoL factors d istinguishing low- and 
high-burden caregivers. In the high-burden caregiver group daughters were over­
represented, QoL was lower and the patients were more behaviorally d isturbed. O f 
the many QoL factors elic ited from  caregivers, only 'tim e fo r self' and 'finances' d if­
fered significantly between the groups. A  need fo r more tim e away from  the patient
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is a major QoL concern fo r highly burdened caregivers, and a perceived lack of 
adequate inform al support and/or financial constraints are contribu tory  factors.13 
In our cross-sectional study, caregiver SEIQoL scores are related to  various care­
giver burden measures (Zarit Burden Interview  - ZBI, Self-perceived pressure from  
informal care scale - EDIZ, and Self-Rated Burden scale - SRB), and cognition of the 
patients (M in i-M ental State Exam ination - MMSE). SEIQoL scores will also be com ­
pared to  scores of healthy e lderly and AD patients, which we measured in an earlier 
study. Knowledge about these relationships is necessary to  be able to  measure 
impact of interventions on caregiver QoL and burden and in understanding the 
value of caregivers' QoL and the best way to  select starting points fo r the in itia tion 
of psychosocial in terventions in dementia care practice.
Research questions we sought to  answer are as follows: 1. W hat are the most p ro­
m inent domains determ ining QoL in caregivers of patients w ith mild to  m oderate 
AD. 2. Are there any differences in QoL between the caregivers of AD  patients, the 
patients themselves, and healthy non-caregiving elderly? 3. How are the d iffe rent 
measures of caregiver burden related to  the caregiver SEIQoL? 4. Does patient 
cognitive status affect caregiver QoL? The research questions did not involve other 
patient related factors than cognition, thus behavior and functional status of the 
patients were not included in the outcom e measures.
Methods
P artic ipan ts  and  design
Spouses of patients who received the diagnosis o f mild to  m oderately severe AD 
after investigations at the ou tp a tien t m em ory clinic of the Slingeland Hospital 
between 1999 and 2006 participated in the study. Patients were diagnosed w ith 
probable AD  according to  the DSM-IV and NINCDS-ADRDA criteria. The degree 
of severity o f dementia according to  the Clinical Dementia Rating (CDR; 0-3) scale 
was 1-2.14'16 Subsequently, 112 spouses completed measures of QoL and burden. 
Cognitive function of the patients was assessed w ith the MMSE (0-30). Subjects 
were excluded from  fu rth e r analysis if the ir internal va lid ity  score of the SEIQoL was 
below 0.7, and if the SEIQoL ratings explained less than 70% of the to ta l variance in 
QoL (see below). Participants gave inform ed consent and the Internal Review Board 
of the Slingeland Hospital approved this research.
Assessment of quality of life
Participants were interviewed w ith the SEIQoL in a standardized sem i-structured 
form at by the same interview er (C.S-D). The firs t step in the SEIQoL is cue e lic ita ­
tion . The respondent is asked to  name five areas of life (cues) m ost im portant to  his/
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her overall QoL ('W hat are the five most im portant areas o f your life at present?'). 
Responses can be classified into one of the generally agreed QoL domains: C og­
nitive, A ffective, Social, Physical, Ecological and Religious (CASPER model; h ttp :// 
www.brunsw ik.org). The respondent may be prom pted by the researcher if fewer 
than 5 cues have been named.“ The second step is determ ining current level fo r 
each cue ('How would you rate yourself on each of these areas at the moment, on a 
scale from  the worst possible to  the best possible?') by drawing a bar fo r each cue 
(written in the appropriate space under a rectangle). A long the left hand side of the 
rectangle there is a scale ranging from 'worst possible' (0) on the bottom  to 'best pos­
sible' (100) on the top .“ Step 3 is the relative weighting or importance of each cue to 
the overall QoL. In o rd e rto  quantify the  relative importance of each cue, respondents 
are asked to  estimate the QoL they would expect to  be enjoyed by 30 hypothetical 
individuals ('cases'). Each case profile is based on the cues chosen by the respondent 
and random, computer generated, values of these. A  total of 30 cases is necessary to 
reliably quantify the 5 cues, 20 of these being unique profiles and 10 of these being 
randomly interspersed repeat profiles, which are needed to a llow the estimation of in­
ternal reliability. The cue weights are extracted by multiple regression analysis.17 Next, 
the SEIQoL Index score (0-100) is calculated by multiplying the five cue levels by the 
matching cue weights and summing up the products. SEIQoL scores of the respon­
dents in the present study were compared to  the results of tw o historical reference 
groups, AD patients and healthy elderly, assessed in an earlier study.l1;1“
Assessment of caregiver burden in a subgroup of the participants
Three caregiver burden scales were applied: EDIZ (self-perceived pressure from  infor­
mal care, developed in Dutch; 0-9),19 Zarit Burden Interview scale fo r burden of caregi­
vers, short version (ZBI; 0-48), both having higher scores fo r higher burden,20 and SRB 
(Self-Rated Burden scale) for rating of subjective feeling of burden on a visual analo­
gue scale (VAS; range 0-100; 0 fo r lowest, 100 fo r highest burden). The stress measu­
red by EDIZ refers to  the demands the spouse perceives w ith respect to  the personal 
interests, the psychological and psychosocial complaints, and to  the stressors in the 
caregiving situation. ZBI assesses the feelings of burden of caregivers in caring fo r the 
person with dementia. ZBI identifies three dimensions of burden: effect on the social 
and personal life of caregivers, psychological burden and feelings of guilt.
Statistical analysis
The SEIQoL Policy PC package estimates the  internal valid ity (R2) which indicates 
the am ount o f variance in the overall QoL judgm ent policy (i.e. variance in length of 
the bars) explained by the five cues. R2 values of 0.70. or higher, which dem onstrate
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the construct va lid ity  o f Judgm ent Analysis in this context, are considered accepta­
ble.21 Intra-subject re liab ility  is expressed as the correlation coeffic ient (Pearson r), 
which had to  be 0.7 or more in each caregiver to  be elig ib le fo r this study. Charac­
teristics o f caregivers who were included and who had to  be excluded were com pa­
red using ANO VA. SEIQoL scores of the caregivers were compared w ith historical 
reference groups using a Cochrane review meta-analytical program (ReviewMana- 
ger), considering tha t these are respondents from  a d iffe rent study. W e perform ed 
m ultip le  regression analysis to  assess which factors best predict SEIQoL scores.
Results
A ll AD patients lived at home w ith  the ir spouse as the principal inform al caregi­
ver and received no or lim ited professional care. The patients had a mean age 
of 73.5 years, standard deviation (SD) 7.2 years, and the ir mean MMSE score was 
20.3 (SD: 4.2). The characteristics o f the caregivers and results o f QoL assessment 
are presented in Table 1. O f 112 spouses fu lfilling  the inclusion criteria, 15 (13%) 
were unable to  nom inate the five necessary cues and were excluded. O f the rem ai­
ning 97 participants, 87 (90%) com pleted the SEIQoL reliably, w ith a mean R2 score 
of 0.82 and a mean Pearson r score of 0.85. Ten subjects had R2 and /or Pearson 
r scores <0.70, they were excluded from  fu rth e r analysis because of unreliable 
judgm ent. The excluded subjects were significantly o lder and predom inantly fem a­
le. The mean SEIQoL score fo r the 87 spouses was 68.6 (SD: 14.8). Female caregivers 
had slightly but nonsignificantly higher scores (M=70.6, SD=13.3, N=41) than male 
caregivers (M=66.8, SD=16.0, N=46), w ith F(1.85)=1.45, MSe=217.6, and p=,23.
The elic ited cues are summarized in Table 2. C ond ition of partner and Marriage, 
both being aspects of Relation (CASPER domains: Social and A ffective) were most 
frequently  nom inated as the m ost im portan t domains o f QoL. The next im portant 
determ inant was Family (CASPER domain: Social). In the  subgroup o f fem ale care­
givers m ost im portan t determ inants were Family and C ond ition o f partner, while 
in the subgroup o f male caregivers C ond ition of partner and Marriage were most 
im portant. D ifferences between fem ale and male caregivers are slight. The cue 
heights and weights o f the first elic ited cues are presented in Table 3.
The SEIQoL scores o f the caregivers in the present study were compared w ith his­
torical reference groups. In our previous studies, mean SEIQoL score fo r patients 
w ith mild AD  was 79.9 (SD=14.8; N=12; mean age 71.3, SD=3.9 years; mean MMSE 
score 22, SD=3.9) while fo r the healthy e lderly population it was 76.3 (SD=11.0; 
N=32; mean age 77.3, SD=5.5 years).11;1a SEIQoL scores o f spouses in the present 
study were significantly lower than e ither the scores o f AD  patients (Z=2.42, p<.05), 
or the scores of healthy e lderly (Z=2.59 , p<.05).
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Burden analyses were perform ed in a subgroup o f N=46 participants fo r which 
reliable caregiver burden measures were collected. The results are presented in 
Table 4. Mean scores were: SEIQoL M=69.2 (SD=15.2); ZBI M=12.9 (SD=6.3); EDIZ 
M=4.7 (SD=2.3) and SRB M=45.6 (SD=25.0). Mean patient MMSE fo r this subgroup 
was 19.5 (SD=4.8). Caregiver gender d ifferences were not significant. However, 
females scored higher on all dependant variables including the spousal MMSE. 
Overall, correlation between patients' MMSE and caregivers' SEIQoL was positive 
and significant (r=.287, N=46, p<.05). A t the same tim e correlation between ZBI and 
caregiver SEIQoL was negative and significant (r=-243, N=45, p=.05). Correlations 
o f the o ther tw o  burden measures (EDIZ, SRB) w ith SEIQoL were not significant. Re­
gression analysis, using Enter method, showed tha t MMSE showed a strong trend 
towards being a significant predictor o f SEIQoL (Beta=.29, t=1.99 p=.05) from  the 
firs t simple model, in which the other burden variables were excluded, to  the most 
complex m ultivaria te model, in which it was entered tog e th e r w ith ZBI, EDIZ and 
SRB scores (Table 5).
Discussion
The aims of the study were to  investigate which domains determ ine QoL in spousal 
caregivers of AD  patients, and to  explore differences in SEIQoL between caregi­
vers, AD  patients and healthy non-caregiving elderly. In a subgroup of caregivers 
caregiver QoL was also related to  d iffe rent measures of caregiver burden, and pa­
tien t cognitive status.
The domains C ond ition of patient and Marriage were the most prom inent d e te rm i­
nants fo r QoL in this study. Some differences between fem ale and male caregivers 
were observed w ith respect to  the primacy o f the nom inated cues. These slight 
gender differences deserve a tten tion  in fu ture  research. They may be im portant 
in deciding on the most suitable interventions fo r caregivers. The reported qua­
litative findings are only partly in line w ith o ther SEIQoL studies and literature in 
patients w ith physical problems and healthy elderly. Here domains Family, Health, 
Social contacts, Hobbies, Psychological well-being, Leisure activities and Living 
environm ent were most frequently  nom inated.1“1” “26 Apparently, in case of dem en­
tia o ther domains o f QoL are im portant fo r the spouse. These differences deserve 
atten tion  in fu tu re  studies.
In the present study SEIQoL scores o f spouses of AD  patients were significantly 
lower compared to  historical controls o f e ither patients w ith mild AD, or healthy 
elderly. This suggests a negative impact of caregiving in dementia. One o f the ex­
planations may be ou rfind ing  tha t cognition of the patient is a significant predictor 
o f QoL of the spousal caregiver. W e are inclined to  in terp re t the data quite straight
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forward in tha t the quality o f life o f caregivers is indeed lower than quality of life of 
patients and healthy elderly, because of the ir heavy burden.
Two o ther possible explanations fo r the higher QoL in patients are response shift 
and anosognosia. Response shift (RS) is the psychological change in perception 
of QoL fo llow ing  a change in health status. RS is the  result o f changes in internal 
standards of measurement, recalibration of the measurement scale, changes in va­
lues or p rio ritiza tion of domains w ith in a construct, or changes in the defin ition 
or conceptualization of tha t construct.27 One of the causes of RS is adaptation to  
illness.2“ It has been clearly evidenced tha t longitud inal measurements in dementia 
patients do not result in significant changes in QoL over tim e, while cognition de­
terio ra tes.27 This make RS in dementia patients highly likely.311 Besides RS, unaware­
ness o f deficits (anosognosia, lack of insight) may also play a role. Anosognosia has 
been frequently  reported  in later stages of dem entia ,31 and may be associated w ith 
d isruption of frontal-subcortica l circuits. Unawareness may be one of the causesfor 
discrepancies between reports from  patients and caregivers.32 However, the  fact 
remains tha t QoL of caregivers is lower than tha t o f healthy elderly, who were even 
older. This still underlines the burden of caregiving.
Caregiver gender differences regarding QoL, burden and spousal cognitive status 
were not significant. However, females scored higher on all variables, including the 
spousal MMSE. Speculatively, these higher scores could imply that, despite higher 
caregiver burden compared to  male caregivers, females experience higher levels 
o f QoL which may be due to  a less severe dementia o f the patient. However, fu rth e r 
research is needed in order to  reliably explore this possibility. Overall, the re la tion­
ship between patient cognition and caregiver SEIQoL was positive and significant, 
while the re lationship between caregiver burden on ZBI and SEIQoL was negative 
and significant, as can be expected. The three measures of burden did correlate 
significantly w ith each other.
Next to  our study, tw o  other studies have attem pted to  relate QoL and burden of 
caregivers o f dementia patients. Serrano-Aguilar et al. related health-re lated QoL 
(European Q uality  o f Life -5D; EQ-5D) and burden (ZBI) o f 237 informal caregivers 
o f AD  patients. Variables having negative correlation w ith QoL were burden, tim e 
com m itted to  care, and age.33 Coen et al. divided caregivers o f dementia patients 
into low- and high-burden groups. In the high-burden group caregiver QoL was 
lower and the patients displayed more neuropsychiatric symptoms.13 Thus, in ad­
d ition to  cognitive im pairm ent, the presence of neuropsychiatric symptoms may 
represent such a high burden tha t it may significantly a ffect caregiver QoL.34 These 
authors found a negative correlation between only one burden measure (ZBI) and 
caregiver QoL (EQ-5D and IQoL respectively).13133 O thers measured ZBI versus no
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form al QoL measure.35 37 Riedijk et al. studied the general QoL measure SF-36 and 
tw o  burden measures: Burden due to  Neuropsychiatric Disturbance of the Patient 
and VAS Burden, and also found no differences.3“ In sum, it is unlikely tha t the ab­
sence of a relationship is due to  invalid ity o f the burden measures we applied. 
There are several lim ita tions to  this study tha t need to  be recognized. An im portant 
lim ita tion  concerns the study design, a cross-sectional analysis in a convenience 
sample. However, the participants are representative of the population o f caregi­
vers o f AD  patients referred to  a m ultid iscip linary m em ory clinic. 21% of the par­
tic ipants had to  be excluded because the SEIQoL results were unreliable by con­
ventional criteria. App lication of the short, more simple, version of the  instrum ent 
using direct w eighting (DW) may result in less exclusion o f respondents.37 Burden 
was only assessed in a subgroup, but w ithou t selection bias. W e choose not to  ap­
ply SEIQoL in assessing QoL of AD  patients cared fo r by the caregivers because on 
average, the ir cognitive decline does not allow fo r reliable usage o f the long form  
o f SEIQoL instrum ent.11-1 A  final lim ita tion  m ight be tha t we only related caregiver 
status to  patient's cognitive and not to  behavioral or functional status.
In conclusion, in addition to  the C ond ition of the partner, Marriage, and Family 
were seen as domains strongly affecting QoL, w ith slight differences between male 
and fem ale caregivers. Caring fo r persons w ith dementia is a challenge in many 
respects. Possibly, negative effects of the partner condition can be compensated 
by well function ing  fam ily ties and adaptations in marital relationship.
Evidence of the  impact o f dementia caregiving on caregiver QoL warrants tha t 
new in tervention programs (including drug trials) are evaluated fo r the ir impact 
on caregiver QoL and burden. Because most interventions have domain-specific 
outcomes, clinicians must ta ilo r interventions according to  the  specific needs of 
the individual caregivers and address the domains they find most im portant. Our 
results fu rth e r underline the im portance of im plem enting health services already 
known to  improve QoL of the  principal caregiver, like occupational therapy or o ther 
forms of providing assistance to  caregivers.4U;41
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Table 1. Results o f SEIQoL* measurement in spouses o f Alzheimer patients
Valid SEIQoL scores Invalid SEIQoL scores*
Number of spouses 87 10
Mean age (years)* 72.2 ± 7.3 76.1 ± 4.9
Male vs. female* 53% vs. 47% 10% vs. 90%
Mean SEIQoL Index score 68.6 ± 14.8 63.4 ± 16.4
R2 0.82 ± 0.07 0.59 ± 0.08
Pearson r 0.85 ± 0.07 0.52 ± 0.17
*Schedule fo r the Evaluation o f Individual Q uality o f Life (0: very low-100: perfect QoL). 
+Scores were invalid for R2 and/or Pearson r<0.70.21 *p<0.005
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Table 3. Scores fo r absolute (level) and relative (weight) importance o f m ost im portan t 
quality o f life domain (cue 1) o f spouses (N=87)
Domain N Mean cue level (0-100) Mean cue weight (0-1.00)
Condition of partner 27 51 ± 19 0.41 ±0.08
Marriage 23 78 ± 19 0.38 ±0.07
Family 17 83 ± 17 0.37 ±0.05
Health 12 64 ±20 0.34 ± 0.08
Spirituality/religion 3 79 ± 14 0.29 ± 0.04
Financial situation 1 77 0.42
Relatives 1 88 0.37
Social life/relations 1 75 0,30
Car driving 1 81 0.29
W ork 1 77 0.27
Note: the SEIQoL Index score (0-100) is calculated by multiplying the cue levels by the matching cue weights o f all 5 cues and 
summing up the products
Table 4. Mean scores and SD fo r caregiver quality o f  life (SEIQoL), Burden (SRB, EDIZ and  
ZBI), and pa tien t cognition (MMSE) fo r the 46 respondents in the final set, sp lit by gender
Sex Mean Std. Deviation N
SEIQoL Female 71.6 14.5 24
Male 66.5 15.8 22
Total 69.2 15.2 46
SRB Female 46.5 26.8 24
Male 44.6 23.5 22
Total 45.6 25.0 46
EDIZ Female 4.8 2.6 24
Male 4.6 2.1 22
Total 4.7 2.3 46
ZBI Female 13.8 6.7 24
Male 11.9 6.0 22
Total 12.8 6.3 46
MMSE Female 20.5 4.9 24
Male 18.5 4.7 22
Total 19.5 4.8 46
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Table 5. Regression coefficients obtained using enter method with SEIQoL as 
dependent variable and MMSE, ZBI, EDIZ and SRB scores as predictors in 
four progressively more complex models
Model Unstandardized
Coefficients
Standardized
Coefficients
t Sig. 95% Confidence 
Interval fo r B
B Std. Error Beta Lower
Bound
Upper
Bound
'I * (Constant) 51.539 9.124 5.649 .000 33.151 69.927
MMSE .901 .453 .287 1.987 .053 -.013 1.815
ZBI
EDIZ
SRB
2+ (Constant) 59.341 10.218 5.807 .000 38.734 79.947
MMSE .859 .447 .273 1.923 .061 -.042 1.759
ZBI -.543 .341 -.227 -1.593 .118 -1.230 .144
EDIZ
SRB
3* (Constant) 56.442 10.984 5.139 .000 34.276 78.608
MMSE .922 .457 .294 2.019 .050 .000 1.844
ZBI -.761 .450 -.317 -1.689 .099 -1.669 .148
EDIZ .944 1.267 .142 .745 .460 -1.613 3.501
SRB
45 (Constant) 56.803 11.502 4.939 .000 33.575 80.031
MMSE .914 .467 .291 1.956 .057 -.030 1.858
ZBI -.750 .463 -.313 -1.619 .113 -1.686 .186
EDIZ 1.000 1.363 .151 .734 .467 -1.752 3.752
SRB -.013 .107 -.022 -.122 .904 -.230 .203
*  Predictors: (constant), M M SE;+ Predictors: (constant), MMSE, ZBI; * Predictors: (constant), MMSE, ZBI, EDIZ; 
§ Predictors: (constant), MMSE, ZBI, EDIZ, SRB
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CHAPTER 8
ASSESSMENT OF QUALITY OF LIFE 
AS OUTCOME IN DEMENTIA AND  
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ABSTRACT
Objectives: To provide a systematic review of the use of quality  o f life (QoL) mea­
sures as outcom e in pharmacological and non-pharm acological in tervention trials 
in patients w ith Mild C ognitive Im pairm ent (MCI) or dementia, and the ir proxies. 
To record the responsiveness of the applied QoL measures, to  detect m inimal im ­
portan t differences.
Design and methods: Randomized controlled tria ls (RCTs) were identified from  a 
search o f the Specialized Register of the Cochrane Dementia and Cognitive Im pro­
vem ent Group in April 2006. This register contains records from  major healthcare 
databases like CENTRAL, MEDLINE, EMBASE, CINAHL and PsyclNFO. W e also 
checked references and systematic reviews, covering the period until Septem ber 
2006. Primary and secondary endpoints were screened fo r QoL scales and it was 
registered w hether inform ation on responsiveness was provided.
Settings: C om m unity-dwelling  and institu tionalized patients w ith MCI/dem entia, 
and the ir proxies.
Results: W e found 117 pharmacological and 108 non-pharm acological RCTs. One of 
the pharmacological and fou r o f the non-pharm acological studies used QoL as p ri­
mary outcome, and tw o  and three as secondary endpoint, respectively. A ltog e the r 
QoL was assessed in only 4,4% of the RCTs; tw o  RCTs reported on responsiveness 
of QoL.
Conclusions: This review provides evidence tha t QoL instrum ents are seldom used 
as outcom e measures in RCTs in dementia and MCI and tha t in form ation on res­
ponsiveness is scarce. QoL measures should be applied more o ften in clinical trials 
as currently no disease m odifying drugs are available, while there are valid and re li­
able QoL measures fo r dementia tha t reflect the aims o f palliative care and provide 
transparent inform ation about patient's and caregiver's trea tm ent benefits.
Introduction
As A lzheim er's disease (AD), the most common cause of dementia, is one of the 
principal causes o f d isability and decreased quality o f life (QoL) among older adults, 
there is a strong need fo r effective and effic ient interventions, w ith meaningful 
outcomes on individual and societal levels.1 W hile  cognition has been previously 
viewed as the  best outcom e measure of efficacy in clinical trials in dementia and 
Mild Cognitive Im pairm ent (MCI), at present a substantial number o f researchers 
agree tha t measuring QoL is just as im portant as measuring cognition, disease 
severity, sym ptom response, behavioral disturbance, functional ab ilities, caregiver 
burden and resource utiliza tion .2’3 Rockwood et al. raised the question w hether a
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trea tm en t e ffect on cognition is really clinically im p ortan t.4 Less extremely, many 
authors stated tha t cognitive sym ptom response no longer suffices in anti-dem en- 
tia tria ls.3 However, patients, proxies, clinicians, investigators and drug companies 
all have d iffe rent interests, resulting in d iffe rent defin itions of a positive response 
to  treatm ents. Furtherm ore, small changes on responsive psychometric cognitive 
tests, even if sta tistica lly significant by including large numbers of patients, may 
not be clinically relevant. Registration authorities already require tha t response 
criteria are defined unambiguously in registered tria l designs, which requires to  
define the changes in the outcom e variables considered to  be clinically re levant.5 3 
Interpreting health-re lated QoL outcomes from  clinical trials can be d ifficult. The 
m inimal im portant d ifference (MID) represents the smallest change tha t patients or 
proxies perceive as an advantage, or tha t could lead patient or clinician to  consider 
a change in trea tm ent. The responsiveness of outcom e measures fo r these MIDs 
defines the sample size needed fo r trials to  detect such a difference.
Research e ffo rts  are expanding towards novel types o f interventions and towards 
pre- and early sym ptom atic phases, e.g. MCI, to  be able to  intervene as early as 
possible. Current regularly available trea tm en t focuses on early s tart o f cholines- 
terase inhib itors, N -m ethyl-D -aspartate receptor-targeted therapy, trea tm en t of 
co-m orb id ities and neuropsychiatricsym ptom s and psychosocial interventions. The 
final goal o f these interventions is to  improve QoL o f patients and proxies, as cure 
is still ou t o f range.7 Rating o f QoL in dem entia-tria ls first requires critical reflection 
on the available scales.111 In general, three m ethods are used: self-rating (patient-re- 
ported outcomes; PROs), proxy-rating, and proxy observation scales. Persons w ith 
MCI and m ild -m oderately severe dementia can be considered good inform ants 
o f the ir own subjective states. So at these stages PROs should be judged as the 
gold standard. A t more severe stages proxy measures or d irect observation may be 
preferred. The disadvantage of proxy-ratings is tha t they filte r a subjective measure 
through the op in ion o f another person, w ith his or her own expectations, mood, 
burden of care, and a specific prior re lationship w ith the person being rated.1113 O f­
ten it is not fu lly  clear w hether a proxy rates QoL of the patient as if he or she were 
the patient, or by taking into account what they know about the value system of 
the patient. D irect observation in more severe dementia may be subject to  sim ilar 
reporting  biases. Acknow ledging the  problem of potentia l bias of proxy-reports, 
PRO is preferable and much e ffo rt should be put into acquiring this. In case PRO 
is impossible, observational evaluation by an uninvolved professional caregiver 
may be the best alternative.11 Thus, using state of the art m ethods problem atic is­
sues can be suffic iently solved to  use QoL measures in randomized controlled trials 
(RCTs). It is unknown how often these m ethods are elected as prim ary or secondary
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outcomes at a stage where there is no form al ob ligation of reg istration authorities 
to  do so. The aim of the present study is to  system atically review how often QoL 
measures are used as endpoints in MCI and dementia intervention trials, in patients 
as well as proxies, and to  report on the ir responsiveness. Furtherm ore the selec­
ted scales will be placed in the context of the  currently available QoL measures.
Methods 
Search s tra te g y
The trials were identified in April 2006 using the search strategy of the Dementia 
and Cognitive Im provement Group of the Cochrane Review Groups (h ttp ://w w w . 
m rw .in te rsc ience .w iley .com /cochrane /c lab ou t/a rtic les /D E M E N TIA /fram e .h tm l). 
This register contains records from  major health care databases like CENTRAL, 
MEDLINE, EMBASE, CINAHL and PsyclNFO, as well as many ongoing tria l databa­
ses and is updated regularly. A dd itiona lly  reference lists o f the intervention studies 
and reviews selected were checked fo r studies until O ctober 2006.
Inc lus ion  and  exc lusion crite ria
Patients were required to  suffer from  dementia or MCI. Papers focussing on proxies/ 
informal caregivers could also be included. Patients were com m unity-dwelling or 
institu tionalized. A ll types of interventions, both drug and non-drug therapy, could 
be included if the tria l design was a randomized controlled tria l (RCT). Papers in 
non-English language were excluded.
Data e x tra c tio n  s tra te g y
Results o f the searches were entered into a standard case record form . Two re­
searchers (L.E. and M.v.d.S.) independently screened the titles  and abstracts and 
selected articles fo r inclusion in the study. In case of disagreem ent between the 
tw o  researchers, the tw o  other authors were involved and papers were finally inclu­
ded if based on consensus. Data extraction was more detailed fo r those articles, in 
which a QoL measure was one o f the endpoints. Details extracted in these studies 
included a description of the type of study, intervention, o ther primary and se­
condary outcom e measures, the type of QoL measure, outcom e on QoL and data 
quantifying responsiveness.
Q u a lity  o f  life
QoL measures cover a range of domains: physical status, functional ab ility  inclu­
ding role function ing, social and com m unity interactions, economic status, psycho­
logical status, well-being, somatic sensation and life satisfaction.141'5 Basically, QoL
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is recognized as a concept representing individual responses to  the physical, m en­
tal and social effects of illness on daily living, which influence the  extent to  which 
personal satisfaction w ith life circumstances can be achieved. It is an abstract and 
broad concept encompassing physical well-being, perceptions of well-being, sa­
tisfac tion and sense of self-w orth. S lightly more promising defin itions are possibly: 
the ab ility  o f patients to  manage the ir lives as they evaluate it. Or: the degree of 
need satisfaction w ith in the physical, psychological, social, activity, material and 
structural area.16:17 In this review an instrum ent was judged to  be a QoL instrum ent 
if it was a published measure validated fo r measuring QoL as defined in one of the 
abovem entioned defin itions.
Responsiveness
Responsiveness/sensitivity to  change is the  ab ility  o f an instrum ent to  detect small 
but im portant clinical changes.1“ One of the problems is to  account fo r the score 
variab ility  (often im provem ent) occurring in stable subjects. Dem onstrating res­
ponsiveness is necessary to  determ ine the  MID, which can be calculated using an- 
chor-based or d istribution-based m ethods. Anchor-based m ethods assess which 
changes on the scale correspond w ith another, external criterion (anchor). This 
defines the clinical relevance. D istribution-based m ethods quantify and take into 
account the  variab ility  in a stable population, using e ffect size, standardized res­
ponse mean and standard error o f m easurem ent.“11' Anchor-based approaches do 
not take m easurement precision into account, while d istribution-based methods 
do not provide a good indication of the im portance o f the observed change.211 To 
judge w hether a QoL measure is responsive it should be compared w ith changes 
in o ther endpoints w ith in the same study. Therefore, we also registered effect sizes 
(and responsiveness measures) o f the other outcom e measures. W e aimed to  re­
gister all possible responsiveness measures on QoL measures or calculate effect 
sizes, if possible.
Results
The results are summarized in Table 1. W e identified 225 RCTs tha t satisfied the 
inclusion criteria, 10 (4,4%) used QoL as outcom e measure. For pharmacological 
studies a to ta l o f 117 papers satisfied the inclusion criteria. In 114 studies (97%) QoL 
was not an outcom e variable. One drug study used QoL as a prim ary and tw o  as 
a secondary outcome. Two QoL measures were applied, one dementia-specific: 
Q ua lity  of Life-A lzheim er Disease Scale (QOL-AD; 2 studies) and one non-dem en- 
tia specific: Patient-rated scale according to  Blau (PRB).
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P harm aco log ica l in te rven tion s
One RCT evaluated the effects o f testosterone (75 mg applied daily to  the skin) on 
cognition, neuropsychiatric symptoms, global function ing  and QOL-AD as primary 
outcome in 16 male patients w ith mild AD and 22 healthy elderly men. Testosterone- 
treated AD  patients had significantly greater im provem ents in caregiver-rated 
QOL-AD scores. In the control group, a nonsignificant trend toward greater im ­
provem ent in self-rated QOL-AD score was observed in the testosterone-treated  
group compared w ith placebo. No significant d ifference between the groups was 
detected in the other outcom e measures. The authors state tha t the  results should 
be considered prelim inary, a major lim ita tion is the small sample size and the  fact 
tha t QoL in AD was reported by proxies.21 In the second tria l m ild -to-m odera te 
AD  patients received the nonsteroidal anti-in flam m atory drugs (NSAIDs) rofecoxib 
and naproxen or placebo. NSAIDs had no significant e ffect on QOL-AD, cognition, 
Clinical Dementia Rating scale or neuropsychiatric sym ptom s.22The th ird  study ap­
plied the PRB, evaluating patients' perceptions of the ir well-be ing .23 The instrum ent 
is not validated in dementia. Donepezil treated patients w ith mild to  m oderate AD, 
produced statistically significant im provem ents in cognition and global fu n c tio ­
ning. The Intention-to-Treat (ITT) sample receiving placebo or 5 mg donepezil sho­
wed statistically significant im provem ent on the PRB. However, patients receiving 
10 mg donepezil dem onstrated worsening. The fu lly  evaluable population showed 
no significant differences in PRB scores. C lin ically m eaningful im provem ents were 
reported fo r cognition, no such inform ation was provided fo r Q oL.24 Inform ation on 
responsiveness of the QoL measures was not provided in these three studies, and 
could not be calculated because o f lack of clear effect on QoL.
Two other relevant drug studies are w orth m entioning. The first study, not included 
because of lack of control group, reported on responsiveness o f the QoL in Late 
Stage Dementia scale (QUALID) in a doub le-b lind  RCT of tw o  antipsychotics (olan­
zapine and risperidone) fo r treatm ent o f dem entia-re lated behavioral symptoms 
in 31 patients. QUALID scores had a significant positive relationship w ith im prove­
ment in behavioral symptoms, and a negative association w ith adverse medication 
e ffec ts.25 The second study (included in the 'pharmacological RCTs w ithou t QoL as 
outcom e' group) measured the extent to  which individualized goals of trea tm ent 
was met, by means of Goal A tta inm ent Scaling (GAS). 128 AD patients were treated 
w ith galantam ine or placebo. As primary efficacy param eter trea tm en t goals set 
before trea tm en t were scored and evaluated every 2 months. The clinician-rated 
GAS scores showed a significantly greater im provem ent among patients in the 
galantam ine group than in the controls. The patient-caregiver-rated GAS scores 
showed a sim ilar im provem ent in the galantam ine group. However, because o f the
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im provem ent also seen in the placebo group, differences between groups were 
not statistically significant.26
N o n -p h a rm a co lo g ica l in te rve n tion s
For non-pharmacological studies a to ta l o f 108 studies was identified, 101 (94%) 
studies had no QoL related outcom e measures. Four studies used QoL as a primary 
and three as a secondary outcome. Six types of QoL measures were applied, four 
dementia-specific: Dementia Care Mapping (DCM; 2 studies), QOL-AD (2 studies), 
A lzheim er Disease Related QoL scale (ADRQL) and Dementia Q uality  o f Life scale 
(DQoL). Two scales were non-dem entia specific: psychosocial domain o f the Func­
tiona l Lim itation Profile (FLP) and Euro Q uality  o f Life (Euro-QoL).
In the first study 72 patients w ith severe dementia received arom atherapy w ith M e­
lissa essential oil or placebo. Changes in clinically significant ag ita tion and QoL- 
indices (% o f tim e spent socially w ithdrawn and % of tim e engaged in constructive 
activities, measured w ith DCM) were compared. QoL-indices improved significantly 
more in active treatm ent. 35% of patients receiving Melissa and 11% treated w ith 
placebo experienced a significant reduction in ag ita tion .27
The second study used a single-blind, paralle l-groups design, in 101 nursing home 
residents w ith severe dementia. This RCT investigated w hether a reminiscence 
program would lead to  higher levels of psychosocial well-being. Primary outcom e 
measures were cognition, functional performance, Social Engagement Scale (SES) 
and W ell-be ing /lIl-be ing  Scale (WIB), which is one of the three measures in the 
DCM. Outcom es were examined at baseline (TO), im m ediate ly (T1), and after six 
weeks (T2). No significant differences were found fo r cognition and functional per­
formance. The in tervention produced a significant e ffec t size of 0.374 fo r the SES 
score at TO and T2 (with only 60% power), and of 0.476 fo r the WIB score at TO and 
T1. The power of this tes t reached 80%. However, no significant changes were ob ­
served in the per protocol sample. In view of the narrow spread of the scores, the 
changes in the scores may be interpreted as having some clinical significance.2“
In the th ird  study a significant im provem ent was found in psychosocial health-re- 
lated QoL in carers o f 50 com m unity-dwelling dementia patients a fter attending 
a m em ory clinic, as measured by the psychosocial domain of the FLP at 6 months 
(p<0.05), including im provem ent in the subgroups o f alertness behavior (p<0.05) 
and social interaction (p<0.01). The im provem ent in social interaction was m ain­
tained at 12 months (p<0.05). There was no significant d ifference in carer psycholo­
gical m orbid ity, burden or knowledge of dem entia .27
The last study investigated w hether comm unity-based consultants (STAR-caregi- 
vers) could be tra ined by consultants (master's-level healthcare professionals) to
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teach fam ily-caregivers a systematic behavioral approach fo r reducing mood and 
behavioral problems in 95 AD  patients. The fam ily-caregivers were assigned to 
tra ined STAR-caregivers or usual care control groups. Com m unity-based consul­
tants successfully im plem ented a behavioral in tervention w ith the fam ily-caregivers. 
Caregivers receiving STAR-C tra in ing  showed significant im provem ents in depres­
sion, burden, and reactiv ity to  behavioral problems. The frequency and severity 
o f behavioral problems reduced significantly, and QoL in patients and proxies, as­
sessed w ith the QOL-AD patient and proxy version, im proved.311 No inform ation on 
responsiveness or effect size was presented or could be calculated.
Three studies had QoL as secondary outcome. The first partia lly masked RCT eva­
luated the efficacy of a reminiscence-based in tervention in 37 dementia patients, in 
reducing apathy and improving QoL, assessed w ith the ADRQL. Despite a substan­
tia l im provem ent in apathy-scores, there was no clear advantage to  the reminiscen- 
ce-based in tervention on QoL.31 In the second study participants were randomized 
to  receive Cognitive Stim ulation Therapy (CST) or treatm ent as usual. 201 people 
w ith dementia living in residential homes or attend ing day centres were assessed 
using the QOL-AD (self-report version) and measures of cognition, dementia level, 
mood, dependency and comm unication, at baseline and eight weeks later. The 
in tervention had a significant positive effect on to ta l QOL-AD score: mean d iffe ­
rence pre and post in tervention 1,3 fo r the experim ental and -0 ,8  fo r the control 
group (F=6,87, p<0,01). CST also produced statistically significant im provem ent in 
cognition.32 A t baseline, higher QoL was significantly correlated w ith lower levels of 
dependency and depression, but not w ith cognitive function or dementia severity. 
Im provem ent in QoL was associated w ith being female, low QoL at baseline, redu­
ced depression and increased cognitive function. M ediation analysis dem onstra­
ted tha t CST is related to  change in both QoL and M ini-M enta l State Examination 
(MMSE) and change in MMSE is significantly related to t change in QoL (correlation 
fo r to ta l group 0,25, p<0,01). Changes in cognitive function m ediated the effects 
o f trea tm en t in improving QoL. These results suggest tha t w hilst QoL in dementia 
appears to  be independent o f level o f cognitive function, interventions aimed at 
improving cognitive function can, nonetheless, have a direct e ffect on Q oL.33 The 
last study, FACT, is a tw o-b y-tw o factoria l RCT, examining the effec t o f a walking 
program aimed at improving cardiovascular endurance, and vitam in supplem enta­
tion  w ith B6, fo lic  acid and B12, on the  rate of cognitive decline of independently 
living elderly w ith MCI. O nly the study design is available yet. Primary endpoints 
are measures of cognitive function. Secondary outcomes include tw o  QoL measu­
res: DQoL and Euro-Q oL.34
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Discussion
QoL is m entioned as one of the primary outcom es of in terest in dementia drug 
trials in a recent Cochrane update on cholinesterase inh ib itors fo r A D .35 However, 
our review shows tha t QoL measures are used in only 4,4% of all dem entia /M C I 
related RCTs as outcom e measure. W here QoL measures were included, m ost pa­
pers included not enough details to  quantify  responsiveness or clinical relevance. 
In non-pharmacological RCTs QoL was measured few  tim es more, and resulted in 
positive outcom e more o ften than in pharmacological in tervention studies (5 out 
o f 7 vs 0 out o f 3, respectively).
The responsiveness of outcom e measures in dementia tria ls still lacks a firm  em pi­
rical base, but is crucial fo r the in te rp re ta tion  of effectiveness of trea tm ents.4 From 
the included sample of RCTs we cannot draw valid conclusions on responsiveness, 
but some data are available from  other naturalistic or validation studies. The QUALID 
seems to  be sensitive to  both trea tm en t and adverse effects o f m edication.25 Also, 
data were reported on the  responsiveness of GAS. In 15 people the mean gain in 
GAS-scores was compared to  changes in cognition, global function ing and clinical 
impression. GAS had the largest relative efficiency and the largest e ffect size.4:36 
GAS can be considered as a m ethod to  assess aspects of clinical meaningfulness 
and could be an interesting instrum ent fo r dementia research, tha t encompasses 
QoL aspects.37 In a cross-sectional study comprising 101 people w ith dementia and 
the ir 99 family caregivers, QoL(measured bythe DEMQOL-Proxy), cognition, functional 
im pairm ent, behavioral and psychological symptoms in dementia (Neuropsychia­
tric  Inventory; NPI), and carer mental health were assessed. In a m ultivaria te m o­
del, decreased QoL was statistically significantly correlated w ith higher (worse) NPI 
scores and younger age o f the patient.7 Furtherm ore, three longitud inal studies of 
QoL change in dementia are published.1U;3“;3v In the first study QoL was assessed in 
47 dementia patients w ith the ADRQL and reassessed tw o years later. The ADRQL 
turned out to  be a sensitive measure of change in QoL and seems appropriate 
as endpoint in in tervention studies.111 In the  second study longitud inal change in 
QoL in 60 dementia patients was assessed w ith QOL-AD, DQoL and EuroQoL-5 
D imensions, at baseline and one-year later. There was no mean change in QoL. 
However, around half of the people had increases or decreases in the ir QoL. The 
only significant predictor o f QoL at fo llow -up  was initia l QoL. The main finding of 
this study was tha t people w ith dementia did not perceive tha t the ir QoL declined 
over a period of one year.3“ Patterson et al. evaluated QoL of subjects w ith MCI 
around the tim e o f conversion to  AD  using the QOL-AD. Converters did not d iffe r 
at baseline w ith respect to  self-rated or in form ant-ra ted QoL. A fte r 1 and 2 years 
inform ant-rated QoL was significant lower fo r converters. There was no difference
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fo r self-rated QoL, a lthough converters fe lt more depressed than non-converters.3v 
Lastly DCM is a valid too l fo r th e  longitud inal evaluation of QoL in care settings and 
some abbreviation o f the  m ethod may fac ilita te  its use more w idely.41-1 
O ur study is the  first systematic review o f the use of QoL as endpoin t in MCI and 
dementia trials, an increasingly im portant research area. To our knowledge all pre­
sently published RCTs were included. The m ajor lim ita tion is tha t many studies 
do not provide clear inform ation on effect sizes, responsiveness and most im por­
tan t: MID. Nevertheless reliable QoL scales are available. In a previous study we 
found no QoL instrum ent tha t was valid fo r the entire course o f dem entia .41 Four 
instrum ents represented domains o f QoL im portant to  patients and domains p ro­
fessional caregivers focus on, best. Two were self-rating instrum ents: SEIQoL,42 44 
applicable in mild to  m oderate dementia patients as well as proxies, and QOL-AD, 
remaining applicable during disease progression.45 The CQOL-AD version asses­
ses QoL of the proxy. If se lf-report is not possible the observational instrum ents 
Qualidem , fo r mild to  severe dem entia ,46 and DSDAT (D iscom fort scale-Dementia 
of A lzheim er Type) fo r severe dementia can be applied.47
In this systematic review we showed tha t QoL instrum ents are seldom used as e f­
fectiveness endpoints in MCI and dementia trials, and tha t in form ation on respon­
siveness is scarce. QoL measures should be applied more often in clinical tria ls as 
currently no disease m odifying drugs are available, while there are valid and re lia­
ble QoL measures fo r dementia tha t reflect the aims of palliative care and provide 
im portant inform ation about patient's and caregiver's perspective of trea tm en t be­
nefit. QoL assessment is the only fo rm at fo r patients, caregivers and professionals 
to  express w hether an in tervention really caused a relevant d ifference to  the pa­
tien t's  life.3“ Therefore, QoL should increasingly be seen as an im portant outcom e 
in dementia research. W e recommend fu rth e r e ffo rts  and research aimed at deter­
m ination o f the MID of existing QoL measures and at including QoL assessment in 
both patients and the ir proxies as effectiveness endpoints in all in te rvention trials.
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ABSTRACT
C ontext: Dementia is still incurable and this makes health-re lated quality o f life (HR- 
QoL) an im portant palliative outcome. Better understanding o f key determ inants of 
patients' and inform al caregivers' QoL can help to  improve dementia care. 
Objectives: To assess if and how QoL of patients and caregivers are associated. To 
iden tify  determ inants of the ir individual QoL.
Design, setting and participants: Cross-sectional analysis (baseline data) of the 
AD-Euro study, a m ulticentre randomized controlled tria l comparing (cost-)effec- 
tiveness of trea tm ent and care-coordination o f m ild -m oderate dementia patients 
and caregivers by m em ory clinics vs. general practitioners. Dutch com m unity-liv ing 
dyads were recruited from  January 2008 through June 2009. Relationship between 
patient and caregiver QoL was evaluated using m ultivariable logistic regression. 
Main outcome measures: Health-related (EuroQol-5D-VAS) and dementia-related QoL 
(QOL-AD). Baseline characteristics, general and dementia-related determinants. 
Results: There was a m odest but significant correlation between patient and care­
giver HRQoL (univariable r=.17; p=.027), but not between the ir dem entia-re lated 
QoL (univariable r=.07; p=.353). In the univariable linear regression analysis only 
patient factors determ ined patient HRQoL, while caregiver HRQoL was determ ined 
by both patient en caregiver factors. The bivariable m odel indicated tha t associa­
tions between HRQoL were decreased by patient factors but augm ented by care­
giver factors. In the m ultivariable regression model w ith patient HRQoL as depen­
dent variable, the patient's own factors com orb id ity  ((3=-.547; p=.035) and mood 
((3=-2.593; p=.000) remained significant, but caregiver factors lost significance. 
W hen caregiver HRQoL was the  dependent variable, only caregiver's mastery 
((3=-.529; p=.030) and mood ((3=-. 382; p=.009) remained significant, whereas pa­
tien t factors lost significance.
Conclusions: There was only a m odest association between HRQoL of patients and 
caregivers. HRQoL of each depended particularly on the ir own personal characte­
ristics. O ur main message is tha t HRQoL in dementia care may be best served if 
one specifically addresses the  individual determ inants of health status o f patients 
as well as informal caregivers.
Trial Registration clinicaltrials.gov Identifier: NCT00554047 
Introduction
As long as a cure fo r dementia is lacking, re lief o f symptoms and im provem ent of 
well-being o f people suffering from  dementia remain the most im portant the ra ­
peutic targets. This justifies a palliative policy. According to  the defin ition of the
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W orld  Health Organisation (WHO), improving the  quality o f life o f patients and the ir 
fam ilies are specifically part o f palliative care. Dementia is a devastating disease 
w ith adverse effects on health and quality o f life o f dementia patients as well as 
the ir informal caregivers.1 Dementia patients and the ir inform al caregivers are c lo­
sely connected. This makes it desirable to  investigate the re lationship between the 
quality  o f life fo r both groups.
Q uality  o f life o f dementia patients is influenced by the severity and nature of the 
disease itse lf.2 4 Additionally, the presence of dem entia-re lated complications, co­
m orbid ity, and lim ita tions in daily life performance may play an im portant role. 
M ood disturbances,516 neuropsychiatric sym ptom s,2:6:7and functional lim ita tions all 
po tentia lly  reduce quality  of life, but the ir impact has not been quantified .2:4:5:S 
Many informal caregivers lack proper dementia care tra in ing as well as professional 
inform ation and support fo r care-giving tasks. However, providing care has been 
proven to  be an im portant risk fac to r fo r the physical, em otional, social and finan­
cial w ell-being o f informal caregivers.
For example, it has recently been shown that stress in dementia caregivers leads to  a 
chronic low-grade hypercoagulable state that increases cardiovascular disease risk.7 
Neuropsychiatric symptoms of patients,11-1'11 burden and hours of informal care,"-’^ se lf- 
esteem and perceived social support also are im portant fo r the caregivers' quality of 
life.11"1'3 Moreover, to  ensure long term  informal care, it is crucial to  invest in improving 
quality of life of informal caregivers as an im portant precondition fo r care provision, 
because most people w ith dementia are living in the community.
Given the im portance of maintaining quality o f life in dementia patients and caregi­
vers and the reciprocal relationship between patients and caregivers, it is remarka­
ble tha t only three studies sim ultaneously examined the determ inants of quality  of 
life o f patients and inform al caregivers.11'141'5 They suggested a positive relationship 
between the quality o f life o f the pair members. However, the studies were small 
and had m ethodological drawbacks. In the firs t study the caregivers rated both 
the ir own quality of life and the quality o f life of the care recipients.11 In the last 
study the factors underlining the quality of life re lationship were not explored.15 
The fact tha t empirical in form ation on quality o f life in dementia is scarce can be 
partly explained by the d ifficu lty  to  reliably measure quality o f life. Empirical re­
search is hindered by a lack of unequivocally defined dimensions and determ inants 
o f the  concept.
Dementia patients o ften require form al and inform al care. Including care fo r the 
(quality o f life of the) informal caregivers is needed fo r successful care provision 
and dementia management. Therefore, factors affecting the associations between 
quality  of life of dementia patients and the ir informal caregivers should be iden­
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tified . The aim of our study was to: 1) Explore the re lationship between quality  of 
life o f dementia patients and the ir caregivers, and: 2) Compare the  strength of this 
re lationship w ith how strongly the disease related determ inants of patients and 
caregivers influenced the  quality o f life o f both parties.
Methods 
S tudy D esign
The AD-Euro study is a m ulticentre randomized controlled tria l tha t aimed to  com ­
pare (cost-) effectiveness o f post-diagnosis trea tm en t and care-coordination of de­
mentia patient-caregiver pairs by m ultid iscip linary m em ory clinics versus general 
practitioners. Details o f the study design have been published elsewhere.16 In this 
study, a cross-sectional analysis o f baseline quality o f life data and the ir potential 
determ inants was perform ed.
P artic ipan ts
175 Pairs o f com m unity-dwelling persons w ith dementia and the ir inform al caregi­
vers were enrolled in the study and have been included in the analysis. W e included 
consecutive patients w ith a new dementia diagnosis fu lfilling  DSM-IV-TR criteria 
w ith a Clinical Dementia Rating (CDR) scale score 0.5-2.17;1a Patients were excluded 
if data co llection was impossible, in case of those w ith a short life expectancy, 
those awaiting nursing home admission, or patients who had a defin ite indication 
fo r specific m em ory clinic fo llow -up  (e.g. rare dementia diagnosis), and there fore 
could not be randomized.
Measurements 
Q u a lity  o f  life
The primary outcom e of the study was quality o f life. W e investigated quality of 
life w ith tw o  instruments. First w ith the European Q uality  of life-5 Dimensions 
Visual Analogue Scale (EQ-5D-VAS) fo r general health-re lated quality  o f life (HR- 
QoL),1v and second w ith the Q uality  o f Life-Alzheimer's Disease scale (QOL-AD) 
fo r dem entia-re lated quality  of life.20 The EQ-5D is a generic too l fo r assessing 
the current health state. The instrum ent consists of tw o  parts: self-adm inistered 
health index, and VAS. The health index represents the perspective of the general 
population (u tility  aspect of the EQ-5D), while the EQ-5D VAS shows the  perspec­
tive of individual subjects. The EQ-5D-VAS was there fo re  preferred as the outcom e 
measure. The VAS assigns a global value to  current health state on a 100-point 
scale, w ith 100 representing the 'best imaginable health state' and 0 representing 
the 'worst imaginable health state'. The QOL-AD is a dementia-specific 13-item
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measure w ith scores ranging from  13 (poor) to  52 (excellent). W e used the patient 
self report version (PQOL-AD) fo r patients. Caregivers reported on the ir own qua­
lity o f life w ith the caregiver version of the QOL-AD tha t can be used in clinically 
nondem ented samples.21
Figure 1 provides an overview  of theoretica l relationships between quality o f life 
and determ inants of quality o f life o f dementia patients and informal caregivers. 
The model proposed tha t quality o f life of a m em ber of the pair, be it patient or 
caregiver, is d irectly dependent on his or her own set o f determ inants. In addition, 
there may be a direct link between the determ inants of the tw o  members o f the 
patient-caregiver pair and between the quality o f life o f the patient and the care­
giver.
D e te rm ina n ts  o f  p a tie n ts
Determ inants of patients tha t we investigated were: age, sex, marital status, m ate­
rial well-being, re lationship w ith caregiver, living situation and household com po­
sition. The relevant dem entia-re lated determ inants were: cognition, m ood, stage 
of illness, behavioral disturbances, physical health, co-m orb id ity  and functional 
performance. Cognitive function was measured w ith the M ini-M enta l State Exa­
m ination (MMSE).16 Mood of patients was assessed w ith the Geriatric Depression 
Scale-15 (GDS), a depression screening instrum ent.22 Severity o f dementia was as­
sessed w ith the Clinical Dementia Rating scale (CDR).1“ Neuropsychiatric symptoms 
were assessed w ith the Neuropsychiatric Inventory Questionnaire (NPI-Q).23 The 
Cum ulative Illness Rating Scale-Geriatrics (CIRS-G) was used to  quantify  chronic 
medical illness burden. CIRS-G provides a review of medical problems by 14 organ 
systems, w ith common problems of elderly w ith emphasis on m orbid ity, yielding a 
cumulative score.24 Functional performance has been measured w ith the Interview 
on Daily living activities in Dementia Diagnosis (IDDD) tha t assesses both the pa­
tien ts ' in itia tive (IDDD-in itia tive) to  perform  daily activities and the am ount o f help 
actually needed (IDDD-help).25
D e te rm ina n ts  o f  careg ivers
W ith  the caregivers we investigated the determ inants: age, gender, marital s ta­
tus, material w ell-being, relationship w ith patient and living arrangements. Socio­
economic state was assessed w ith the ISEI-92, based on Standard Occupational 
C lassification (SOC).26 Caregivers' depression was evaluated w ith the Center fo r 
Epidem iologic Studies Depression Scale (Ces-D).27 Caregivers' distress associated 
w ith neuropsychiatric symptoms of patients was rated on a 0-5-po in t distress scale 
o f the NPI-Q .23 Pearlin Mastery Scale (PMS) was applied to  measure capacity and
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structure o f coping.16 Environmental determ inants fo r caregivers were: caregiver 
tim e, resource utilization, socio-econom ic state, social support and social network. 
The Inventory fo r Measuring Social Involvement (ISB) was used to  measure social 
support.16
S ta tis tica l analysis
Descriptive statistics were used to  summarize sample characteristics. Pearson cor­
relations between patients' and caregivers' HRQoL (EQ-5D-VAS) and patients' and 
caregivers' dem entia-re lated quality  of life (QOL-AD) were calculated. Univariable 
linear regression analysis was used to  compare the associations between the sig­
nificantly correlated quality o f life measures in the firs t analysis w ith the effects of 
o ther possible determ inants of patients' and caregivers' quality  of life.
Bivariable linear regression analyses w ith one outcom e variable (quality o f life mea­
sure o f patient and caregiver, separately) and one independent variable (the ind iv i­
dual determ inants of patients and caregivers) were used to  iden tify  the factors pos­
sibly explaining the re lationship between the  quality  o f life measures of patients 
and caregivers.
Finally, m ultivariable linear regression was used to  build models w ith the  po ten­
tia l predictive and explaining factors tha t were identified in the univariable and 
bivariable analyses. Both caregivers' and patients' quality  o f life measures were 
modeled as dependent variable. The significant variables in the univariable model 
tha t remained significant in m ultivariable analyses, as well as all variables found to 
explain the relationship between patient and caregiver quality o f life in the bivaria­
ble analyses, were kept in the final m ultivariab le model.
E th ica l A sp e cts
The study was approved by the Medical Ethics C om m ittee  of Radboud University 
N ijmegen Medical Centre. W ritten  consent o f both all patients and caregivers was 
acquired before s tart o f the study.
Results
Sam ple d e m o g ra p h ics  and  characte ris tics
Baseline characteristics of the 175 patient-caregiver pairs are presented in Table
1. 54% O f the caregivers were spouses, 41% were daughters or sons (-in-law) and 
5% had another re lationship w ith the patient. On average, caregivers provided 5.1 
hours per week of (instrum ental) activities o f daily life support (range 0-35 hours). 
Most patients had A lzheim er's disease and a m ajority  o f patients had mild dem en­
tia. A lm ost three-quarters of caregivers were women. Scores fo r dem entia-re lated
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quality  o f life (QOL-AD) were sim ilar fo r patients and caregivers, while scores fo r 
HRQoL (EQ-5D-VAS) were slightly b e tte r fo r caregivers.
Regression m ode ls  fo r HRQoL
Patient and caregiver HRQoL assessed w ith EQ-5D-VAS were significantly correla­
ted (Pearson r=0.17, p=.027; Table 2). However, no association was found between 
patient and caregiver dem entia-re lated quality  o f life, assessed w ith QOL-AD 
(Pearson r=0.07, p=.353). Therefore, we only fu rth e r investigated the relationship 
between patient and caregiver HRQoL.
F ind ings from  un ivariab le  analyses
Univariable analysis revealed significant associations between patient HRQoL (pa­
tien t EQ-5D-VAS as dependent variable; Table 3a) and fou r patient determ inants: 
severity o f dementia (CDR score, r= 0.16, p=.037), co-m orb id ity  (CIRS-G score, 
r=0.27, p=.000), mood (GDS score, r=0.44, p=.000) and function (IDDD-help score, 
r=0.17, p=.029). More severe stage of dementia and higher levels o f patient co­
m orb id ity  (disease burden), depression, and dependency from  help of others were 
associated w ith decreasing patient HRQoL. No significant univariable associations 
were found between patient HRQoL and caregiver determ inants.
Univariable regression analysis w ith caregiver HRQoL (EQ-5D-VAS) as dependent 
variable (Table 3b) showed statistica lly significant associations w ith three patient 
determ inants: behavioral symptoms (NPI-B-score, r=0.28, p=.000), mood (GDS- 
score, r=0.16, p=.035) and function (IDDD-in itia tive-score, r=0.17, p=.023), and four 
caregiver determ inants: mood (CES-D-score, r=0.40, p=.000), feelings of mastery 
(PMS-score, r=0.38, p=.000), social involvem ent (ISB-score, r=0.31, p=.000) and dis­
tress (NPI-Q-D-score, r=0.33, p=.000). Lower levels of caregiver mood and mastery, 
higher levels o f distress, and lower levels o f mood and function ing o f the patients 
they cared fo r were associated w ith decreasing caregiver HRQoL.
F ind ings from  b iva riab le  analyses
Results o f bivariable analyses (see Table 4) entering separate patient variables 
into a m odel regressing patient HRQoL (dependent variable) on caregiver HRQoL 
(independent variable), showed tha t patients' co-m orb id ity  (CIRS-G), IDDD-help, 
IDD D-initiative, and mood (GDS) decreased the association between patient and 
caregiver HRQoL (CIRS-G: (3=0.17; IDD D-initiative: (3=0.17, IDDD-help: (3=0.17 and 
GDS: (3=0.10 fo r the estim ate o f the effec t o f caregiver HRQoL on patient HRQoL). 
Entering caregiver variables into the model augmented the association between 
patient and caregiver HRQoL. The relevant caregiver determ inants were mood
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(CES-D-score: (3=0.267), feelings of mastery (PMS-score: (3=0.245) and social involve­
ment (ISB-score: (3=0.220).
Results of bivariable analyses entering determ inants into a model regressing care­
giver HRQoL (dependent variable) on patient HRQoL (independent variable), sho­
wed tha t these e ither augmented or dim inished the re lationship between caregiver 
and patient HRQoL fo r the same seven determ inants (CIRS-G, IDDD-help, IDDD- 
in itiative, GDS, CES-D, PMS, and ISB).
F ind ings from  m u ltip le  regress ion  analyses
In the multivariable model (Table 3a) patient HRQoL was regressed on caregiver HR­
QoL and the determ inants tha t were identified in the univariable and bivariable ana­
lyses. Patient com orbid ity (CIRS-G-score, (3=-0.547, p=.035) and mood (GDS-score, 
(3=-2.593, p=.000) remained significant determ inants in the multivariable analysis. 
Dementia severity (CDR) lost statistical significance and was therefore not included in 
the final model. The caregiver determ inants mood (CES-D), mastery (PMS) and social 
involvement (ISB), as well as the patient determ inants IDDD-help (despite losing sta­
tistical significance as a predictor) and IDDD-initiative, were kept in the final model 
on the basis of the ir effect in the bivariable analyses. Compared w ith the ir univariable 
relationship, the association between patient and caregiver HRQoL decreased from
0.19 to  0.17 and lost significance in the multivariable analyses.
In the m ultivariable model in Table 3b caregiver HRQoL was regressed on patient 
HRQoL and the determ inants tha t were identified in the univariable and bivaria­
ble analyses. O nly caregivers' mood (CES-D-score, (3=-0. 382, p=.009) and mas­
te ry  (PMS-score, (3=-0.529, p=.030) were significant determ inants in the  m ultivari­
able analysis. The o ther univariable predictors of caregiver HRQoL (patient NPI-B, 
patient GDS, patient IDDD-initiative, caregiver ISB and caregiver NPI-Q-D) all lost 
statistical significance. Despite losing statistical significance as predictors, the 
patient determ inants com orb id ity (CIRS-G), function (IDDD-in itia tive) and mood 
(GDS), and the caregiver predictor ISB were kept in the final model on the basis of 
the ir e ffect in the bivariable analyses. Compared w ith the ir univariable relationship, 
the association between caregiver and patient HRQoL decreased from  0.15 to  0.12 
and lost significance in the m ultivariab le analyses.
Discussion
The purpose of this study was to  investigate the re lationship between quality of 
life o f dementia patients and the ir caregivers and to  iden tify  the characteristics of 
patients and caregivers tha t affected the ir quality o f life. W e also compared the 
strength of the relationship o f o ther patient and caregiver determ inants which in ­
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fluenced the quality o f life. W e found a statistically significant but small association 
between HRQoL in this large sample of patient-caregiver pairs and no relationship 
between patient and caregiver dem entia-re lated quality  o f life. Remarkably, the 
scores on the EQ-5D-VAS o f the caregivers are rather high and thus good. This may 
be related to  the relatively mild severity o f the dementia which had, as of yet, little  
e ffec t on quality  o f life of caregivers. W e also saw tha t HRQoL was m inimally de­
term ined by inter-individual, but m ostly by intra-ind ividual characteristics. Patient's 
HRQoL was mainly dependent on the patient's own determ inants (i.e. disease se­
verity, mood and co-m orbidity), and not on caregiver determ inants. Caregiver's 
own determ inants (particularly mood and feelings o f mastery) had a much stronger 
effect on the ir own HRQoL than patient determ inants.
The results of our study (i.e. no association between dem entia-re lated quality of 
life, only m odest association between HRQoL) seemed to  contradict the findings of 
three recently published studies.11:14;1E Thomas et al. showed tha t dem entia-re lated 
quality  of life o f caregivers was significantly related to  patient's quality  of life and 
vice versa.11 However, patient dem entia-re lated quality  o f life was rated by the care­
givers, which may have introduced a correlation through inform ation bias. Also, the 
study populations were not comparable w ith ours and some of the studies applied 
d iffe rent quality o f life measures fo r patients and caregivers than our study.
In the Inouye et al. study, which found a m oderate association between patient and 
caregiver dem entia-re lated quality o f life,15 the  patients were already in trea tm ent 
fo r over 3 years, while our patients were newly diagnosed. The patients in this study 
also had much lower lower quality o f life scores than the patients in our study, while 
the scores of caregivers were comparable.15 This difference may be explained by 
our finding tha t disease severity was a predictor o f patients' and not caregivers' 
HRQoL. Finally, Gallrach et al. found tha t patient dem entia-re lated quality of life 
was a predictor o f caregiver quality  of life and vice versa.14
The strengths of our study were the comprehensive approach in which we analyzed 
how a w ide range o f variables were related to  the HRQoL o f dementia patients 
and caregiver simultaneously, and the considerably larger and more hom ogeneous 
sample of patient-caregiver pairs than those o f previous studies. In spite of these 
strengths, one lim ita tion deserves comm ent. The study was cross-sectional, so d i­
rection of causation could not be ascertained.
W e showed tha t in a large sample of dementia patient-caregiver pairs the ir HRQoL 
was only m odestly interre lated. W e dem onstrated tha t patients as well as caregi­
vers each have the ir own personal determ inants of HRQoL. Further observational 
and intervention studies are needed to  draw defin ite conclusions on the impact of 
these findings. O u rs tud y  underscoresthe im portance o f ongoing medical manage­
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ment in dementia to  maintain the dementia patient's physical health and coexisting 
medical conditions tha t take into account the im plications of the ir cognitive im ­
pa irm ent.2“ O ur study also lends support to  the fact tha t explicit and separate a t­
ten tion  should be paid to  the  caregivers. The results provide an empirical basis fo r 
dementia care tha t offers suffic ient am ount of tim e and a tten tion  to  patients and 
caregivers separately. Success o f most care plans, as well as continued living in the 
com m unity o f dementia patients, rests largely on inform al caregivers. O ur findings 
tha t HRQoL o f both parties was predom inantly dependent on the ir own personal 
determ inants stress the need fo r dementia specialists and general practitioners to 
trea t the dyad of the patient w ith dementia and his or her caregiver. The benefits 
o f proper care and treatm ent fo r caregivers have already been shown, so the  in ­
strum ents are known and available.:v;3uThe results of this study should encourage 
health care professionals to  actually make e fforts  fo r th e  im p lem entation of already 
existing knowledge and op portun ities  to  improve dementia care.
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F igu re  1. Q u a lity  o f  Life and  D e te rm in an ts  in D em en tia
DETERMINANTS DETERMINANTS
PATIENT -<--------------->■ CAREGIVER
QUALITY OF LIFE w I QUALITY OF LIFE
PATIENT "•L------- CAREGIVER
146
Table 1. Demographics and characteristics o f dementia p a tien t and caregiver dyads
Characteristics Patients (N = 175) Ca reg ivers (N = 175)
Age, mean (SD), years 78 (6) 64(13)
W om en, No. (%) 106 (61) 123 (70)
Living alone, No. (%) 61 (35)
Alzheimer's disease, No. (%) 105 (60)
Vascular dementia, No. (%) 15(9)
Mixed or o ther dementia, No. (%) 55 (31)
Stage o f dementia CDR 0,5, No. (%) 8(5)
Stage o f dementia CDR 1, No. (%) 139 (79)
Stage o f dementia CDR 2, No. (%) 28 (16)
MMSE, mean (SD) 22.7 (3.9)
CIRS-G, mean (SD) 9 (4.5)a
GDS-15, mean (SD) 2.6 (2.4)b
NPI-Q-B, mean (SD) 7.4 (6.1)-=
ID DD-initiative, mean (SD) 12.8 (7.2)d
IDDD-help, mean (SD) 18.5 (15.5)d
NPI-Q-D, mean (SD) 9.7 (9.1)d
CES-D, mean (SD) 9.5 (7.6)d
PMS, mean (SD) 16.6 (4.4)d
ISB, mean (SD) 12.2 (3.1)d
PQOL-AD /  CQOL-AD, mean (SD) 36.1 (4.3) 38 (4.2)-=
EQ-5D-VAS, mean (SD) 72.4 (15.3)d 79.7 (13.5)
aN = 168; bN = 172; CN=174; dN=173. Abbreviations: SD, standard deviation; CDR, Clinical Dementia Rating scale (0-3); MMSE, 
M ini-Mental State Examination (0-30); CIRS-G, Cumulative Illness Rating Scale-Geriatrics (0-56); GDS-15, 15-item geriatric 
depression scale (0-15); NPI-Q-B, Neuropsychiatric Inventory Questionnaire, Behavior (12-36); IDDD, Interview on Daily living 
activities in Dementia Diagnosis: initiative (0-36), help (0-44); PQOL-AD, Patient version Quality o f Life-Alzheimer's Disease 
scale (13-52); EQ-5D-VAS, European Quality o f life-5 Dimensions Visual Analogue Scale (0-100); CES-D=Center for Epide­
miologic Studies Depression scale (0-60); PMS=Pearlin Mastery Scale (7-35); ISB, Inventory for Measuring Social Involvement 
(4-16); NPI-Q-D, Neuropsychiatric Inventory Questionnaire, Distress (0-60); CQOL-AD, Caregiver version QOL-AD (13-52)
Table 2. Pearson correlations o f p a tie n t and careg iver qua lity  o f  life measures
PQOL- AD P-EQ-5D-VAS CQOL-AD C-EQ-5D-VAS
PQOL-AD 1
P-EQ-5D-VAS (N) 0.562= (173)
P <0.001 1
CQOL-AD (N) 0.071 (174) 0.005 (172)
P 0.35 0.95 1
C-EQ-5D-VAS (N) 0.131 (175) 0.168b (173) 0.479= (174)
P 0.08 0.03 <0.001 1
Abbreviations: P, patients; C, caregivers; QOL-AD, Quality o f Life-Alzheimer's Disease scale; EQ-5D-VAS, European Quality 
o f life-5 Dimensions Visual Analogue Scale. C orre la tion  is significant at the 0.01 level (2-tailed); C orre la tion  is significant 
at the 0.05 level (2-tailed)
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Table 3a. Reg ression models w ith pa tien t EQ -5D -VAS as dependen t variable
Univariab le model Multivariable model
Independent variable ßa P R2 N ß P R2 N
C-EQ-5D-VAS 0.19 0.03 0.03 173 0.17 0.08 0.26 164
Patient variables
CIRS-G -0.91 <0.001 0.07 168 -0.55 0.04
CDR -6.67 0.034 0.03 173
MMSE 0.09 0.78 <0.001 173
GDS -2.99 <0.001 0.20 171 -2.59 <0.001
IDDD-initiative -0.25 0.12 0.01 171 0.05 0.78
IDDD-help -0.17 0.03 0.03 171 -0.10 0.24
NPI-Q-B -0.13 0.51 0.003 172
Age -0.10 0.63 0.001 173
Gender -3.52 0.14 0.013 173
Caregiver variables
CES-D 0.12 0.44 0.003 171 0.12 0.51
PMS 0.09 0.74 0.001 171 0.29 0.33
ISB -0.03 0.93 <0.001 171 -0.02 0.95
Hours a week -0.13 0.45 0.003 172
NPI-Q-D -0.02 0.88 <0.001 171
Age 0.07 0.44 0.004 173
Gender -0.28 0.91 <0.001 173
Education 0.66 0.53 0.002 172
a(3 unstandardized coefficient. Regression analysis w ith EQ-5D-VAS scores o f patients as dependent variables, by entering 
objective variables in the model analysis. Abbreviations: CDR, Clinical Dementia Rating scale; MMSE, M ini-Mental State Examina­
tion; CIRS-G, Cumulative Illness Rating Scale-Geriatrics; NPI-Q-B/D, Neuropsychiatric Inventory Questionnaire, Behavior/Distress; 
IDDD, Interview on Daily living activities in Dementia Diagnosis; EQ-5D-VAS, European Quality o f life-5 Dimensions Visual Analo­
gue Scale; CES-D, Center fo r Epidemiologic Studies Depression scale; PMS, Pearlin Mastery Scale; ISB; Inventory for Measuring 
Social Involvement
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Table 3b. Regression m ode/s with careg iver EQ -5D-VAS as dependen t variable
Univariab le model Multivariable model
Independent variable ß= P R2 N ß P R2 N
P-EQ-5D-VAS 0.15 0.03 0.03 173 0.12 0.08 0.22 164
Caregiver variables
CES-D -0.72 <0.001 0.16 173 -0. 38 0.009
PMS -1.18 <0.001 0.15 173 -0.53 0.03
ISB 1.35 <0.001 0.10 173 0.37 0.26
Hours a week -0.27 0.07 0.02 174
NPI-Q-D -0.50 <0.001 0.11 173
Age -0.10 0.19 0.01 175
Gender -3.38 0.13 0.01 175
Education 1.37 0.14 0.01 174
Patient variables
CIRS-G -0.24 0.26 0.01 168 0.10 0.65
CDR -0.57 0.84 <0.001 175
MMSE -0.32 0.24 0.008 175
GDS -0.91 0.04 0.03 172 -0.45 0.31
ID DD-initiative -0.32 0.02 0.03 173 -0.22 0.17
IDDD-help -0.09 0.19 0.01 173 0.001 0.99
NPI-Q-B -0.63 <0.001 0.08 174
Age -0.14 0.43 0.004 175
Gender 2.38 0.26 0.007 175
a(3 unstandardized coefficient. Regression analysis w ith EQ-5D-VAS scores o f caregivers as dependent variables, by entering 
objective variables in the model analysis. Abbreviations: CDR, Clinical Dementia Rating scale; MMSE, M ini-Mental State Examina­
tion; CIRS-G, Cumulative Illness Rating Scale-Geriatrics; NPI-Q-B/D, Neuropsychiatric Inventory Questionnaire, Behavior/Distress; 
IDDD, Interview on Daily living activities in Dementia Diagnosis; EQ-5D-VAS, European Quality o f life-5 Dimensions Visual Analo­
gue Scale; CES-D, Center fo r Epidemiologic Studies Depression scale; PMS, Pearlin Mastery Scale; ISB; Inventory for Measuring 
Social Involvement
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Table 4. B ivariable regression m ode l w ith pa tien t and caregiver EQ-5D -VAS as dependen t variable
Bivariable model; P-EQ-5D-VAS dependent variable Bivariable model; C-EQ-5D-VAS dependent variable
Independent variable b p R2 N Independent variable b p R2 N
Patient variables Patient variables
C-EQ-5D-VAS
CIRS-G
0.17
-0.87
0.06
0.001 0.09 168
P-EQ-5D-VAS
CIRS-G
0.12
-0.13
0.06
0.56 0.03 168
C-EQ-5D-VAS
CDR
0.19
-6.44
0.03
0.04 0.05 173
P-EQ-5D-VAS
CDR
0.15
-0.26
0.03
0.93 0.03 173
C-EQ-5D-VAS
MMSE
0.19
0.13
0.03
0.67 0.03
173 P-EQ-5D-VAS
MMSE
0.15
-0.24
0.03
0.36 0.03 173
C-EQ-5D-VAS
GDS
0.10
-2.87
0.22
<0.001 0.21 171
P-EQ-5D-VAS
GDS
0.09
-0.90
0.22
0.07 0.05 171
C-EQ-5D-VAS
ID DD-initiative
0.17
-0.19
0.05
0.23 0.04 171
P-EQ-5D-VAS
ID DD-initiative
0.13
-0.29
0.05
0.04 0.05 171
C-EQ-5D-VAS
IDDD-help
0.17
-0.15
0.05
0.05 0.05 171
P-EQ-5D-VAS
IDDD-help
0.13
-0.07
0.05
0.32 0.03 171
C-EQ-5D-VAS
NPI-Q-B
0.19
-0.01
0.04
0.968 0.03 172
P-EQ-5D-VAS
NPI-Q-B
0.14
-0.60
0.04
<0.001 0.10 172
C-EQ-5D-VAS 
Age patient
0.19
-0.07
0.03
0.74 0.03 173
P-EQ-5D-VAS 
Age patient
0.15
-0.15
0.03
0.41 0.03 173
C-EQ-5D-VAS 
Gender patient
0.20
-3.93
0.02
0.10 0.04 173
P-EQ-5D-VAS 
Gender patient
0.16
2.61
0.02
0.21 0.04 173
Caregiver variables Caregiver variables
C-EQ-5D-VAS
PMS
0.25
0.37
0.009
0.19 0.04 171
P-EQ-5D-VAS
PMS
0.16
-1.17
0.009
<0.001 0.18 171
C-EQ-5D-VAS
ISB
0.22
-0.32
0.02
0.42 0.03 171
P-EQ-5D-VAS
ISB
0.16
1.29
0.02
<0.001 0.12 171
C-EQ-5D-VAS 
Hours a week
0.18
-0.08
0.04
0.66 0.03 172
P-EQ-5D-VAS 
Hours a week
0.14
-0.28
0.04
0.06 0.05 172
C-EQ-5D-VAS
CES-D
0.27
0.31
0.005
0.07 0.05 171
P-EQ-5D-VAS
CES-D
0.17
-0.72
0.005
<0.001 0.19 171
C-EQ-5D-VAS 
Education caregiver
0.19
0.41
0.03
0.70 0.03 172
P-EQ-5D-VAS 
Education caregiver
0.14
1.25
0.03
0.17 0.04 172
C-EQ-5D-VAS
NPI-Q-D
0.21
0.08
0.02
0.54 0.03 171
P-EQ-5D-VAS
NPI-Q-D
0.15
-0.49
0.02
<0.001 0.14 171
C-EQ-5D-VAS 
Age caregiver
0.20
0.09
0.02
0.34 0.03 173
P-EQ-5D-VAS 
Age caregiver
0.15
-0.09
0.02
0.26 0.04 173
C-EQ-5D-VAS 
Gender caregiver
0.19
0.43
0.03
0.87 0.03 173
P-EQ-5D-VAS 
Gender caregiver
0.15
-3.65
0.03
0.10 0.04 173
A b b rev ia tions: CDR, Clinical D em entia  Rating scale; M M SE, M in i-M en ta l State Exam ina tion; CIRS-G, C um ula tive  Illness Rating 
Scale-Geriatrics; N P I-Q -B /D , N europsychia tric  Inventory Q uestionna ire , Behavior/D istress; IDDD, In te rv iew  on Daily liv ing 
activ ities in D em entia  D iagnosis; EQ-5D-VAS, European Q u a lity  o f life -5  D im ensions V isual A na log ue  Scale; CES-D, C enter for 
E p id e m io log ic  S tudies Depression scale; PMS, Pearlin M astery Scale; ISB, Inventory fo r M easuring Social Invo lvem ent
A b b rev ia tions: CDR, Clinical D em entia  Rating scale; M M SE, M in i-M en ta l S ta te  Exam ina tion; CIRS-G, C um ula tive  Illness Rating 
Scale-Geriatrics; N P I-Q -B /D , N europ sychia tric  Inventory Q ue stio nn a ire , B ehavior/D is tress; IDDD, In te rv iew  on D aily living 
activ ities in D em entia  D iagnosis; EQ-5D-VAS, European Q ua lity  o f life -5  D im ensions V isual A na log ue  Scale; CES-D, C enter for 
E p id em io log ic  Studies Depression scale; PM S, Pearlin  M astery Scale; ISB, Inventory  fo r M easuring Social Invo lvem ent
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ABSTRACT
Objectives: Disease-specific health-re lated quality  o f life (HRQoL) index measures 
are urgently needed to  advance dementia research. Index measures quantify HR­
QoL into one single m etric figure. A  dementia-specific HRQoL index instrum ent 
was not available. W e designed the Dementia Q ua lity  of life Instrum ent (DQI) and 
report on va lid ity  and feasibility.
Study design and setting: Expert Delphi procedure; survey under 241 dementia 
professionals; cross-sectional study in 145 m ild -m oderate dementia patient-care- 
giver dyads. Setting: ou tp a tien t clinics, nursing homes, patient residences. Measu­
rements professionals: ranking/rating of five dementia-specific DQI domains: M e­
mory, O rien ta tion, Independence, Social Activ ities, Mood; sim ultaneously rating of 
nine DQI-derived health states on a visual analogue scale. Measurements patients- 
caregiver dyads: DQI feasib ility  and concurrent validity.
Results: A ll professionals judged the domains to  be relevant. Differences in ranking/ 
rating behavior were small. Mood was ranked/rated as most, O rien ta tion as least 
im portant health domain. Concurrent valid ity was moderate. Com pletion rates fo r all 
domains were above 98% for patients and 100% fo r caregivers on patients. 
Conclusions: Professionals judged all domains as relevant. Subgroup differences 
can be explained by the ir d iffe rent working backgrounds. The DQI proved valid 
and feasible fo r patients and caregivers. Introducing the DQI Index will advance 
dem entia-re lated HRQoL measurement, by overcoming the shortcom ings o f gene­
ric and non-index instrum ents.
Introduction
Dementia is a major public health concern due to  its increasing incidence. It is a 
devastating cond ition fo r patients and caregivers. Assessing meaningful treatm ent 
benefits is complex. Many researchers state tha t cognitive response no longer suf­
fices in anti-dem entia trials.1 There is emerging consensus tha t adding patient-re- 
ported outcom es such as health-re lated quality  o f life (HRQoL) is warranted.2 There 
are tw o  fundam entally  d iffe rent approaches to  HRQoL measurement. The first is 
the standard 'questionnaire ' approach, using descriptive or profile instrum ents.3 
The second is the 'index' approach, using preference-based instrum ents.45 
Descriptive instrum ents summarize m ultip le  dimensions o f health status and are 
based on classical test theory.6 A  small set o f related items covers the content of 
various health domains and a score fo r each dimension is generated. One such 
frequently  used descriptive instrum ent is the SF-36.7
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Index measures quantify m ultip le  health domains into one single metric figure. In 
the case o f HRQoL, index measures quantify  the desirab ility o f a certain health 
state.“ The generated values, variously called utilities, (strength of) preferences, or 
weights, are o ften unambiguous; e.g., a value of 1.0 stands fo r 'perfect health', 0.0 
fo r 'death'. HRQoL values w ith metric characteristics are especially useful because 
they provide vital in form ation fo r health outcom e research and economic evaluati­
ons. The EuroQ ol-5 D (EQ-5D) is the  most w idely used HRQoL index instrument.'''11-1 
It includes the five dimensions M obility, Self-care, Usual activities, Pain/D iscom fort 
and A nxiety/D epression.
Based on the extent to  which illnesses are covered, both types of HRQoL measures 
can be categorized into disease-/domain-specific or generic instrum ents. The first 
ta rget individual diseases or specific health problems, while generic instrum ents 
are more universal and cover general health aspects.
Recently, Riepe et al. concluded tha t current HRQoL instrum ents, which have been 
useful in o ther contexts, are ill-suited and insuffic iently validated to  play a major 
role in dementia research, decision making and resource allocation.11 They reported 
tha t six cost-effectiveness studies, using quality-adjusted life years (QALY) m ea­
surements, were unsatisfactory, and tha t large gaps existed between published 
measurements of HRQoL and the quality standards required by guidelines. Their 
conclusion was supported by the consensus sta tem ent of the International Psycho- 
geriatric Association tha t generic HRQoL index measures, such as the EQ-5D, are 
not validated satisfactorily in dementia and tha t this called into question previous 
health economic analyses.12 The so lu tion seems to  be a disease-specific HRQoL 
index instrum ent. Such instrum ents have been developed fo r various diseases but 
not fo r dementia.1317 W e there fo re  designed a dementia-specific index instrum ent, 
the Dementia Q uality  o f life Instrum ent (DQI).
The DQI is a classification system based on the conceptual fram ew ork o f the EQ- 
5D. However, we substitu ted the generic EQ-5D domains by more dementia rela­
ted domains tha t are b e tte r able to  describe dementia status. This study presents 
content evidence to  support the construct va lid ity  o f the  DQI by detailed des­
cription of the steps tha t were taken to  ensure tha t the selected domains indeed 
represented the construct.1“ Additionally, we undertook a survey under dementia 
professionals on the contents of the instrum ent. Next, relations to  o ther variables 
were examined in dementia patients and the ir inform al caregivers by correlating 
DQI scores w ith scores from  tw o  well-validated quality  o f life instrum ents, one ge­
neric and one dementia-specific. Finally, we report on the  feasib ility  o f the DQI in 
dementia patients and caregivers.
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M ethods
D e ve lo p m e n t o f  the  D Q I
The fo llow ing  specific features and global constraints were form ulated beforehand.
1. Classification of the dementia health states should be based on a lim ited set of 
key domains to  prevent cognitive overload. 2. Each separate domain should consist 
o f a lim ited num ber o f levels to  fac ilita te  rating. 3. A ll items should be unequivo­
cally understandable. 4. Consistency th roughout domains and levels is mandatory.
5. Responses should be uniform  as much as possible. The EQ-5D, fo r which broadly 
acknowledged valuation procedures are available to  eIicitate corresponding va­
lues, is w idely used due to  its ease in use: answers to  only five questions result in 
a HRQoL value. The fo rm at of the  EQ-5D meets the above described criteria and 
was used as a tem plate.
The first step was to  iden tify  the construct and corresponding content. W e searched 
the literature, databases, ProQolid (w ww.proqolid .com ) and systematic reviews on 
qualifications of HRQoL in dementia, fo r previously published instrum ents, and on 
HRQoL domains considered im portant in dementia. W e also used qualitative and 
quantita tive inform ation from  our earlier HRQoL research in Dutch dementia pa­
tien ts  and professionals.1' This generated a pool o f potentia l scale items. The next 
step was expert evaluation and reduction of items by in itia ting  a Delphi procedure. 
The selected items were subjected to  discussion and challenge w ith in the AD-Euro 
study group to  establish an operational consensus on valid items. The AD-Euro 
study is a m ulticentre randomized controlled tria l (RCT) tha t aimed to  compare 
(cost-)effectiveness of post-diagnosis trea tm en t and care-coordination o f dem en­
tia patients-caregiver pairs by m em ory clinics versus general practitioners.21-1 The 
experts (N=6; tw o geriatricians, master o f science in nursing, psychologist, psy­
chometrician and ep idem io log ist),211 examined the items and selected the best in 
several rounds. A fte r each round, a summary from  the previous round was provided 
and judged again. Finally, consensus was achieved in a group m eeting resulting in 
a set of domains judged to  fu lfill content valid ity criteria.
P artic ipan ts
Professionals were elig ib le fo r this validation study if they were working regularly 
w ith dementia patients in the fie ld of diagnosis, care, treatm ent, coordination, and/ 
or counseling. Professionals were divided in subgroups, namely clinical geria tric i­
ans (and residents), elderly-care physicians, nurses/nursing assistants and social 
workers/psychologists. Participants were recruited after a brief in troduction during 
a national conference and by mail through the secretary o f the ir professional as­
sociations.
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Additionally, 145 pairs o f com m unity-dwelling  persons w ith dementia and the ir in ­
form al caregivers o f the AD-Euro RCT were included in the current study, by perfor­
ming a cross-sectional analysis o f data at T=6 months. Patients w ith a new dem en­
tia diagnosis fu lfilling  DSM-IV-TR criteria and a Clinical Dementia Rating (CDR; 0-3) 
scale scores 0.5-2 were included: 0.5 fo r questionab le/very mild, 1 fo r mild, 2 fo r 
m oderate and 3 fo r severe dem entia .2122 Patients were excluded if data collection 
was impossible, in case o f a short life expectancy or awaiting nursing home admis­
sion, and in case of a defin ite indication fo r specific m em ory clinic fo llow -up  (e.g. 
rare dementia diagnosis).
V alida tion  o f  D Q I dom a ins in p ro fess iona ls
The survey consisted of three tasks. The first tw o  were ranking (Task 1) and rating 
(Task 2) of the domains of the DQI. For Task 1, we asked respondents to  choose the 
order o f im portance of the domains fo r dementia patients, from  1 (most im portant) 
to  5 (least im portant domain). For Task 2, respondents rated the  value of each se­
parate domain. The assigned rating was between 1 and 10. A  value of 1 meant that 
this domain is to ta lly  invaluable, 10 tha t it is very valuable fo r dementia patients. 
Summarized: ranking indicates the order of im portance of the five domains. Ra­
ting  appreciates the value of each domain in itself. Task 3 (valuation) consisted of 
rating nine dementia health-states, each consisting o f the selected DQI domains 
combined w ith one out of the levels of severity o f im pairm ent per domain. These 
states were created in such a way tha t they largely covered the to ta l spectrum of 
dementia severity. For Task 3 respondents scored the nine states on a visual ana­
logue scale (VAS) w ith poles ranging from  0 (worst imaginable health) to  100 (best 
imaginable health).
V alida tion  o f  D Q I o u tcom es in p a tie n ts  and  careg ivers
Concurrent va lid ity  fo r the DQI was examined by comparing the  scores of the DQI 
to  scores of the generic EQ-5D+C,2325 and the dementia-specific Q uality  o f Life- 
A lzheim er's Disease (QOL-AD) Scale.26 The EQ-5D+C is an extended version of 
the EQ-5D w ith an additional cognitive dimension. The outcom e measures were 
collected through personal interviews. If patients were able to  com plete the tasks 
by themselves, they were instructed to  do so, if not, a research assistant supported 
w ith the com pletion. Caregivers were given instructions and perform ed the tasks 
independently.
S ta tis tica l analysis
For data analyses of the professionals, Kruskal-Wallis tests were perform ed to  exa­
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mine differences in ranking behaviors. D ifferent rating behaviors fo r the separate 
health domains were assessed w ith one-way ANOVAs. The same analysis was used 
to  explore possible differences in rating behaviors fo r the assessment o f the con­
structed DQI health states. A dd itiona l Tukey post-hoc tests were perform ed to  
examine professional sub-group differences.
To examine the concurrent validity, Spearman rank correlations were calculated 
between DQI and EQ-5D+C,2425 and between DQI and QO L-AD.26 It was hypothe­
sized tha t the fo llow ing  DQI (higher score=worse HRQoL) versus EQ-5D+C (higher 
score=worse HRQoL) scores on sim ilar domains would show positive (correlation 
coeffic ient >0.2) and significant (P<0.05) correlations: M em ory/C ognition , O rien ­
ta tion /C og n ition , Independence/Self-care, Independence/Usual activities, Inde­
pendence/Cognition, Social activities/Usual activities, M ood/Pain-D iscom fort, and 
M ood/Anxiety-Depression. Furtherm ore, it was hypothesized tha t the fo llow ing  
DQI (higher score=worse HRQoL) versus QOL-AD (higher score=better HRQoL) 
correlations were negative correlations ( >-0.2) and tha t they would be significant 
(P<0.05): M em ory/M em ory, O rien ta tion /M em ory , Independence/Physical health, 
Independence/Ab ility to  do chores around the house, Social activities/Energy, 
Social ac tiv ities/Ab iIity  to  do things fo r fun, and M ood /M ood . Additionally, it was 
hypothesized tha t correlations on patient-data would be low erthan caregiver-data, 
because of the cognitive effects o f dementia.
Data were analyzed using SPSS (version 17; SPSS, Inc., Chicago, IL). Patient-caregiver 
inter-rater agreem ent was examined by quadratic-weighted Kappa coefficients. 
Feasib ility o f the DQI, EQ-5D+C and the QOL-AD were assesed by a missing values 
analysis. Descriptive statistics were used to  examine baseline characteristics.
Results
D esign  o f  the  D Q I
The firs t step in the design of the DQI resulted in the p ro totype (Figure 1). By con­
sensus five domains were selected, which were deemed to  comply w ith the fo r­
mulated constraints and criteria: Mem ory; O rien ta tion  (in tim e and/or place); In­
dependence (in daily activities); (engagement in) Social activities; and M ood. The 
present status o f the  patient on these domains is form ulated as a simple sta tem ent. 
The resulting descriptions are combined w ith one of three severity levels: level 
1= no problems; level 2= some problems; level 3= extrem e problems. Thus, 11111 
represents the best health state, 33333 the worst. Theoretically, this set o f five d o ­
mains and three levels allows fo r 243 (35) d iffe rent health state descriptions across 
dimensions relevant in dementia.7 The second part o f the DQI consists o f a visual 
analogue scale (VAS). It is a vertical 200 mm 'therm om eter', w ith 0 indicating the
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w orst imaginable health state and 100 indicating the best imaginable health state 
(Figure 2).
Baseline characteristics
The mean age of the 241 professionals varied between 37±8 years (clinical g e ria tri­
cians) and 48±8 years (elderly-care physicians). Nurses were 42±2 years o f age, nur­
sing assistants 39±10, and social workers/psychologists had a mean age o f 44±13 
years. A lm ost tw o-th irds were nursing assistants (N =77) or nurses (N =70). A lm ost 
one-th ird  of the participants were physicians: 21% clinical geriatricians and 11% 
elderly-care physicians. A  smaller fraction consisted of social workers/psycholo­
gists (together 7% of total). A ll participants were working in general hospitals or 
nursing homes. The m ajority  o f professionals were fem ale (88% of to ta l, 77-96% of 
the various subgroups).
The mean age of the patients varied between 80±6 years, 58% was female. A lzhe i­
mer's disease was the most prevalent diagnosis (62%), fo llowed by mixed dementia 
(28%), vascular dementia (6%) and o ther (4%). Average patient CDR-scores were 1.1 
(SD 0.41). Patient-caregiver relationships were defined as partners (57%), children 
(37%) or o ther (6%). Caregivers were 66±13 years o f age, 71% was female.
Validation of D Q I dom ains in professionals 
Task 1: D om ain  R anking Task
Ranking of the domains showed fo r the  to ta l group tha t Mood was ranked as the 
most im portant health domain fo r dementia patients, fo llowed by Independence. 
Social activities, Memory, and O rien ta tion  were judged as less im portant. However, 
absolute d ifferences were rather small (Table 1). W e found differences in ranking 
behavior between subgroups of professionals. The mean ranking values varied 
from  1.74 (more im portant) fo r M ood by nursing assistants to  4.31 (less im portant) 
fo r M em ory by elderly-care physicians. Significant differences (P<0.05) were found 
fo r Memory, Independence, and Social activities. Elderly-care physicians ranked 
M em ory as the least im portant domain while nurses ranked it as most im portant. 
Independence was ranked least im portant by nursing assistants.
Task 2: D om ain  R ating Task
The results of the domain rating task of the to ta l group o f professionals showed 
exactly the same ordering as found fo r the ranking task (Table 1). Scores were highest 
(most valuable) fo r M ood (8.5) and lowest fo r O rien ta tion  (7.0). Rating behaviors 
d iffered between subgroups fo r Memory, O rien ta tion  and Independence. For M e­
m ory and O rien ta tion  the differences could be a ttribu ted  to  nurses, who judged 
these health domains as more valuable. D ifferences fo r Independence were fu lly
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caused by nursing assistants, who judged this domain as less valuable. Differences 
in rating behavior on the o ther domains were non-significant. Results of com pari­
sons between subgroups on rating as the least or most valuable domain showed 
significant differences (P<.05) fo r Memory, O rien ta tion  and Independence.
Task 3: H ealth  S tate V aluation Task
This task showed tha t DQI state 33333 was scored lowest w ith a value of 11.3 on the 
VAS (0-100) whereas DQI state 12211 was scored as the best state w ith a value of 
88.4 (Figure 2). Significant differences in scores between the subgroups of profes­
sionals were observed fo r states 12211, 21122, 12132, 22222, and 11133 (all P<0.05). 
For all these hypothetical health states, nursing assistants, nurses, or both valued 
these dementia states as b e tte r compared to  other subgroups o f professionals.
Validation of D Q I outcom es in patients and caregivers
The a priori hypothesized DQI versus EQ-5D+C correlations tha t were significant 
in both patients and caregivers were: M em ory/C ognition , O rien ta tion /C og n ition , 
Independence/Self-care, Independence/Usual activities, Independence/Cogni­
tion  and M ood/Depression-Anxiety. Patients had an average significant p of 0.28 
while caregivers had an average significant p of 0.44. The difference between these 
average correlations was significant (P<0.01). Correla tions tha t were hypothesized 
a priori but were not significant fo r patients were: Social activities/Usual activities 
and M ood/Pain-D iscom fort. These correlations were significant fo r caregivers.
A  priori hypothesized DQI versus QOL-AD correlations tha t were significant in both 
patients and caregivers were: M em ory/M em ory, O rien ta tion /M em ory , Indepen­
dence/Physical health, Social activities/Energy and M ood /M ood . Patients had an 
average significant p o f 0.33, while caregivers had an average significant p of 0.36. 
The difference between these average correlations was not significant (P>0.05). 
Correla tions tha t were hypothesized a priori but not significant fo r patients were: 
Independence/Ab ility to  do chores around the house and Social ac tiv ities /A b ility  
to  do things fo r fu n . These correlations were significant fo r caregivers. Patient/care­
giver in ter-rater agreem ent was slight (K<0.2) fo r M em ory and Independence, fa ir 
(K 0.2-0.4) fo r O rien ta tion  and M ood, and m oderate (K 0.4-0.6) fo r Social activities. 
Feasibility o f the DQI was assessed by com pletion rates. A ll five domains had a 
com pletion rate o f above 98.6% fo r patients, whereas fo r caregivers the com ple­
tion  rate was 100% in all domains. Patient com pletion rates fo r the EQ-5D+C were 
97.9% fo r Self-Care and C ognition, 98.6% fo r M ob ility  and Daily Activ ities and 99.3% 
fo r Pa in/D iscom fort and A nxiety/D epression. Caregivers had a com pletion rate of 
100% in all domains. Patient com pletion rates fo r the QOL-AD were 77.1% fo r M arri­
age (missing data was marked as 'not applicable'), 98.6% fo r Friends and A b ility  to
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do chores around the house, 99.3% fo r Self as a whole and 100% fo r the remaining 
domains. Caregivers had a com pletion rate of 90.9% fo r Marriage (missing data 
marked as 'no t applicable'), 99.3% fo r M ood and A b ility  to  do things fo r fun and 
100% fo r the  remaining domains.
D iscussion
HRQoL index measures are not validated satisfactorily in dementia. Therefore, 
previous health economic analyses have been called into question.1112 To face the 
upcoming medical and health economic challenges of dementia, a dementia-spe- 
cific index instrum ent seems necessary. This led us to  design the DQI. The present 
study provides evidence fo r va lid ity  and feasib ility  o f the DQI in dementia. Its deve­
lopm ent was based on a literature search, patient inform ation, and a Delphi proce­
dure among experts. The fo rm at was adapted from  the w idely used generic index 
instrum ent EQ-5D. A  survey under dementia professionals showed tha t the selec­
ted DQI health domains were considered as relevant and im portant fo r HRQoL of 
dementia patients. Overall rating values were well in the upper range from  1 (not 
valuable) to  10 (very valuable). Mood was judged as most im portant and O rien ta ­
tion  as least im portant domain. Small differences between professional subgroups 
could be explained by the ir d iffe rent professional backgrounds, d iffe rent types 
o f professional contact, and stage of dementia tha t they face while working with 
the ir patients. In more advanced stages of dementia o ther needs, priorities and 
symptoms emerge.
Our concurrent validation study, in dementia patients and in caregivers on pa­
tien ts, showed tha t the DQI (a dementia-specific HRQoL index instrum ent) cor­
related m oderately w ith the EQ-5D+C (a generic HRQoL index instrum ent) and the 
QOL-AD (a dementia-specific HRQoL instrument). Correlations were highest when 
the dimensions were (nearly) identical between the  instrum ents. The differences in 
correlations imply tha t the DQI indeed provides o ther in form ation than the  EQ-5D. 
Caregiver correlations were higher than patient correlations. This can probably be 
a ttribu ted  to  the cognitive effects of dementia. Nevertheless, patient-caregiver 
in ter-rater agreem ent was fa ir on average and the  results are in line w ith other 
instrum ents used w ith dementia patients and caregivers.272“ The feasib ility  of the 
DQI was very high and comparable to  that of the EQ-5D+C and the QOL-AD. Nearly 
all patients and all caregivers were able to  com plete the instrum ent. Therefore, we 
conclude tha t the DQI perform s well fo r evaluating HRQoL in a mild to  m oderate 
dementia population.
To advance the DQI into a standardized tw o-step  disease-specific index instru­
ment fo r describing and valuing dem entia-re lated HRQoL, our research will now
161
focus on generating values fo r each of the possible DQI states. These values will be 
generated in a large general population, w ith suffic ient o lder persons, to  derive an 
algorithm  tha t converts the five separate DQI domain scores into one single DQI 
index score. This metric figure will enable unequivocal in te rp re ta tion  of subjective 
dementia HRQoL states. The DQI Index is the 'raison d 'ê tre ' fo r the DQI. The EQ-5D 
does provide HRQoL values, but is too  generic (lacks content validity) to  acknow­
ledge the specific problems of dementia. The QOL-AD is dementia-specific, but 
has been developed to  produce a sum score fo r a set of separate domains. The DQI 
Index will advance HRQoL m easurement in dementia by overcoming both these 
shortcom ings, and there fo re  provide the field w ith an outcom e measure o f added 
value fo r evaluation research in dementia.
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Figure 1. DQ I health states: com binations o f 5 health domains and 3 levels o f  severity
M EM O R Y
1) N o m e m o ry  p ro b le m s
2) Som e m e m o ry  p ro b le m s
3) Severe  m e m o ry  p ro b le m s
O R IEN TA TIO N
1) N o d is o r ie n ta tio n  in t im e  o r p lace
2) Som e d is o r ie n ta t io n  in tim e  o r p lace
3) Severe  d is o r ie n ta t io n  in tim e  o r p lace
IN D EPEN D EN C E
1) N o p ro b le m s  w ith  d a ily  a c tiv it ie s
2) Som e p ro b le m s  w ith  p e rfo rm in g  d a ily  a c tiv it ie s
3) U nab le  to  p e rfo rm  d a ily  a c tiv it ie s
SO C IAL
A C TIV IT IE S
1) O fte n  e ng a g in g  in soc ia l a c tiv it ie s
2) Som e p ro b le m s  in e ng a g in g  in soc ia l a c tiv it ie s
3) N e ve r eng a g in g  in soc ia l a c tiv it ie s
1) N e ve r dep ressed
2) S o m e tim e s  dep ressed
3) A lw ays d ep ressed
For e xa m p le , '12122' c o rre sp o n d s  to  th e  d e m e n tia  h e a lth  s ta te :
N o m e m o ry  p ro b le m s
Som e d is o r ie n ta tio n  in tim e  o r p lace
N o p ro b le m  w it d a ily  a c tiv it ie s
Som e p ro b le m s  in e ng a g in g  in soc ia l a c tiv it ie s
S o m e tim e s  dep ressed
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Figure 2. Valuation: scoring o f  9 DQ I health states on a visual ana logue scale
B est im a g in a b le  
h ea lth  s ta te
11133
—  100
12211 ) =
12132 ) =
13311 ) =
= - 8 0  ( 21122 
70 
= -  60
50
22222
40 ( 33232
32313 )
30
20
10 ( 33333
W o rs t im a g in a b le  
hea lth  s ta te
The health states are described by five dementia health domains each combined with one of three 
severity levels: level 1 = no problems; level 2= some problems; level 3= extreme problems
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Table 1. Results o f ranking and rating o f Dementia Q ua lity  o f  life Instrum ent (DQI) domains
by professionals
Ranking Values; Range: 1 (highest importance) to 5 (lowest importance)
Memory Orientation Independence Social activities Mood
Total group 3.45* 3.70 2.32 3.31 2.22
Nurses 3.23 3.61 2.14 3.34 2.69
Nursing
assistants
3.34 3.61 2.86 3.46 1.74
Geriatricians 
and residents
3.48 4.00 1.98 3.12 2.39
Elderly-care
physicians
4.31 3.81 2.04 2.96 1.89
SW+and
psychologists
3.56 3.39 2.11 3.56 2.44
Rating Values; Range: 1 (not valuable) to 10 (very valuable)
Memory Orientation Independence Social activities Mood
Total group 7.2 (2.0)* 7.0 (1.6) 8.2 (1.5) 7.7 (1.3) 8.5 (1.4)
Nurses 7.9 (1.5) 7.5 (1.4) 8.5 (1.4) 7.8 (1.3) 8.3 (1.4)
Nursing
assistants
6.9 (2.3) 6.9 (1.5) 7.5 (1.5) 7.6 (1.4) 8.9(1.1)
Geriatricians 
and residents
7.0 (1.9) 6.6 (1.8) 8.4 (1.4) 7.6(1.1) 8.2 (1.4)
Elderly-care
physicians
6.7 (1.8) 6.9 (1.4) 8.4 (1.6) 7.7 (1.5) 8.8 (1.0)
SW and 
psychologists
7.4 (1.7) 7.5 (1.5) 8.6 (1.6) 7.7 (1.0) 8.6 (1.2)
*  M e a n ;+ Social w orkers; * M ean (Standard Deviation)
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SUMMARY
The aim of this thesis is to  translate the theoretica l overarching concept of quality 
o f life into practical im plications fo r dementia research and care planning. W e re­
cap previous and new knowledge and end w ith fu ture  plans and final remarks.
Q u ality  of life in dem entia. Theoretica l part
Chapter 2 discusses defin itions o f quality  o f life and the methods of assessment. 
It explains the phenom enon of response shift, a term  fo r the decrease in negative 
self-reports by dementia patients as the disease progresses. It shows tha t dem en­
tia caregiving affects quality of life of caregivers and recommends the use of qua­
lity  of life as an endpoin t in dementia in tervention studies. Chapter 3 describes 
the results o f a literature study on relevant domains of quality of life in d iffe rent 
settings. Four instrum ents best represented domains im portant to  patients, and 
domains p ertinen t to  professional caregivers. Two are self-rating instruments: the 
Schedule fo r the Evaluation of Individual Q uality  o f Life (SEIQoL), applicable in mild 
dementia, measuring individual quality of life o f patient and informal caregiver, and 
the Q uality  of Life-Alzheim er's Disease Scale (QOL-AD), which can be applied up 
to  m oderately severe dementia. Both enable m easurement of quality o f life of pa­
tien ts  as well as informal caregivers. For patients w ith advanced dementia receiving 
residential care, the observational instrum ents Qualidem  and D iscom fort scale- 
Dementia of A lzheim er Type (DSDAD) are recommended. Care-type, care-setting, 
severity o f dementia, and the specific domains of an in tervention determ ine which 
instrum ent is most appropriate in a specific situation. Chapter 4 presents available 
needs assessment instrum ents fo r dementia patients and caregivers, explores the 
interaction between unm et needs and quality  o f life, and relates these needs to 
individual goal setting instrum ents and Maslow's Hierarchy o f needs model. D o­
mains of unm et needs and quality  o f life overlap. O ur Hierarchy M odel o f Needs 
in Dementia (HMND) offers a new theoretica l fram ew ork to  address the interplay 
between meeting of needs and improving of quality o f life in dementia. By iden­
tify ing  unm et needs in dementia-research, and focusing on unm et needs in de- 
mentia-care, much can be done to  improve quality o f life. Chapter 5 addresses 
issues tha t threaten the accuracy of quality o f life assessment. It describes factors 
tha t hamper m easurement procedures in dementia and fra il e lderly patients. It il­
lustrates reasons fo r differences between se lf-report and proxy-rating, such as the 
subjective nature of the concept, the own experience of living w ith dementia, and 
the e ffec t o f changing inte llectual and o ther capacities. W hen interpreting  qua­
lity  of life outcomes in dementia, researchers must also take into account stage
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of disease, the disability paradox and response shifting. A ltog e th e r the relation 
between (severity of) dementia and HRQoL is ne ither simple nor direct. As patient- 
reported outcomes become more established, these m easurement issues need to  
be addressed.
Q u ality  of life in dem entia. Em pirical part
Chapter 6 reports the results o f a p ilot study of quality o f life measurement of twelve 
patients w ith mild to  m oderate A lzheim er's disease (AD) and the ir caregivers w ith 
the Schedule fo r the Evaluation on the Individual Q uality  of Life (SEIQoL). The SEI- 
QoL measures individualized quality  o f life by taking into account the relevant de­
term inants fo r a particular individual. Persons rate five areas in life m ost im portant 
to  the ir quality  o f life. A  m ultip le  regression analysis program me developed fo r 
the purpose then calculates the relative contributions of each area to  the over­
all quality of life. Next the researchers com puted the SEIQoL Index score, valid ity 
and reliability. One patient was unable to  com plete the interview. The remaining 
(8 women, 3 men, age 71.3 years) had a mean SEIQoL Index score (range 0-100) 
o f 79.9, which is comparable to  healthy Dutch elderly. The caregivers (10 spouses, 
2 daughters; mean age 67.4 years) on the o ther hand had a lower SEIQoL Index 
score: 62.2. Va lid ity  and re liab ility  were good fo r both groups. Thus, caregivers 
experienced a significantly (p<0.5) lower quality of life than e ither AD  patients or 
healthy Dutch elderly. Chapter 7 presents the results o f a cross-sectional study of a 
sample o f 97 spousal caregivers o f patients w ith mild to  m oderate AD. The SEIQoL 
assessed caregiver quality  of life. The three caregiver burden scales tha t were used 
are: self-perceived pressure from  informal care scale (EDIZ); Zarit Burden Interview 
scale fo r burden o f caregivers (ZBI); and SRB (Self-Rated Burden scale) fo r rating of 
subjective feeling of burden on a visual analogue scale. The mean SEIQoL score 
o f the spousal caregivers was 69±15. These scores were compared to  historical 
control scores o f healthy e lderly (76±11) and AD patients (80±15) and were s igni­
ficantly (p<0.05) lower. The most im portant quality of life domains were condition 
o f patient (31%) and marriage (26%). Spouses perceived m oderate levels of burden 
according to  the ir SRB, EDIZ and ZBI scores. The m ultip le regression analysis ind i­
cated factors tha t best predict quality o f life. In this sample, patient cognition was a 
significant predictor o f caregiver quality  o f life. Burden, measured w ith the ZBI, was 
significantly negatively correlated w ith caregiver quality  o f life.
It is not known how frequently  quality o f life is used as outcom e measure at a stage 
where there is no form al ob ligation of reg istration authorities to  do so. Chapter 
8 systematically reviews how o ften quality o f life measures are used as endpoints 
in pharmacological and non-pharmacological in tervention randomized controlled
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trials (RCTs) in MCI and dementia. In 117 pharmacological and 108 non-pharmaco- 
logical RCTs quality of life was assessed in only 4.4% of the RCTs. W e emphasize 
tha t quality  o f life measures should be applied more o ften in clinical trials because 
they reflect the aims of palliative care and provide transparent inform ation about 
patient's and caregiver's trea tm en t benefits. Chapter 9 presents the results o f a 
cross-sectional study in 175 pairs o f newly diagnosed m ild -m oderate stage dem en­
tia patients and the ir principal caregivers. Since disease-m odifying therapies fo r 
dementia are still lacking, quality of life is an im portant palliative outcome. Better 
understanding o f the key determ inants o f quality  o f life can help to  improve dem en­
tia care. Associations between patient and caregiver quality o f life were analyzed 
using linear regression analysis. There was a modest but significant correlation (uni­
variable r= 0.17, p=0.027) between health-re lated quality  o f life (HRQoL) assessed 
w ith the EQ-5D o f patients and caregivers, but not between dem entia-re lated qua­
lity  of life assessed w ith the  QOL-AD (univariable r=0.07, p=0.353). Especially the 
addition of patients' mood dim inished the association between HRQoL of patients 
and caregivers. W e also investigated which were the  individual determ inants fo r pa­
tien ts ' and caregivers' HRQoL. Caregivers' mood, mastery, social involvem ent and 
distress (univariable r=0.40, 0.38, 0.31 and 0.33) were more im portant than patient 
determ inants (univariable r=0.16 fo r mood and r=0.28 fo r behavioral symptoms) 
in explaining caregivers' quality o f life. Patients' quality o f life depended on the ir 
need fo r help from  others, severity o f dementia, mood and co-m orb id ity  (univaria­
ble r=0.17, 0.16, 0.44 and 0.27), and not on caregiver determ inants. In sum, quality of 
life o f dementia patients and caregivers were only m odestly associated. HRQoL of 
each depended particularly on the ir own personal characteristics. O ur main mes­
sage is tha t quality o f life in dementia care may be best served if the individual de­
term inants of health status o f patients as well as inform al caregivers are specifically 
addressed. Chapter 10 deals w ith the urgent need fo r a dementia-specific quality 
o f life measure to  advance the fie ld o f clinical research. The so lu tion appears to 
be a dementia-specific index instrum ent to  quantify  quality  of life into one single 
metric figure. This type o f measure is not yet available. W e there fo re  developed the 
Dementia Q ua lity  o f life Instrum ent (DQI), which can be used in medical practice, 
research, and policy making. The DQI has a fo rm at analogous to  the w idely applied 
generic index instrum ent EQ-5D. W e report on the design and construct valid ity 
o f the prototype. The im portant aspects of quality  o f life were drafted on the basis 
o f existing literature and on statem ents made by dementia patients, by caregivers 
and by health professionals in a varie ty o f settings. The fo llow ing  five health d o ­
mains are relevant fo r dementia: 'mem ory', 'orien ta tion', 'independence', 'enga­
gem ent in social activities' and 'mood'. The present status of the patient on these
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domains is form ulated as a statem ent, w ith three levels of increasing severity. The 
resulting 243 (35) d iffe rent states combine descriptions of each of five domains w ith 
one of three severity levels: 11111 represents best state, 33333 represents worst 
state. W e carried ou t a cross-sectional study in dementia patient-caregiver pairs 
and a survey of dementia professionals. In the patients and caregivers sample fea­
s ib ility  and concurrent valid ity of the DQI were examined. The professionals ranked 
and rated the five dementia-specific DQI health domains, and s im ultaneously rated 
nine DQI-derived health states on one visual analogue scale. C om pletion rates fo r 
all five domains were above 95% fo r patients and 100% fo r caregivers. Concurrent 
va lid ity  was acceptable. Professionals judged the DQI domains to  be relevant, and 
'm ood' as the most im portant one. Thus, the DQI proved feasible and valid.
Previous know ledge on the to p ic  of th is thesis
Most people regard dementia as a devastating end of life. Hugo Claus, a contem ­
porary Flemish author, suffering from  A lzheim er's disease, expressed this op inion 
in March of 2008. He deliberate ly chose to  end his own life by euthanasia. Q uality  
o f dying has received much a tten tion  recently (www.eiu.com). Both quality o f dying 
and quality o f life are im portant fo r good palliative care. People w ith progressive 
chronic diseases often report a higher quality  o f life than expected, probably be­
cause of the way they adapt and cope. Nevertheless, dementia profoundly th rea­
tens the  quality  o f life o f patients as well as the ir fam ily  and caregivers. Persons w ith 
dementia m ention happiness, sadness and loneliness as key areas fo r the  quality 
o f the ir life. Feeling attached, accepted and understood has a positive effect on 
quality  of life, as well as the  presence of a partner, social relationships and access to  
activities. Many patients report physical and mental health as essential factors.3V;4U 
Dementias are more complex than other chronic conditions such as hypertension 
and os teoarthritis. Dementias have m ultip le  etio log ies, especially when fam ilial A lz­
heimer's disease is compared to  non-fam ilial, or early onset dementia to  late onset 
dem entia.41“43 Given this complexity, there is emerging consensus tha t patient re­
ported outcomes such as quality  o f life are warranted fo r comprehensive outcom e 
measurement. Q uality  of life assessment demonstrates w hether interventions are 
perceived as m eaningful by patients and caregivers. However, the link between 
symptoms and quality o f life is not clear, simple or predictable.
Many clinicians consider quality o f life the most relevant global outcom e measure 
as long as dementias cannot be cured. Nevertheless quality  of life is rarely used 
as endpoint in research practice. In our research, as reported in this thesis, we 
notice the lack of defin itions of quality  of life, or its gold standard, and the chal­
lenges o f its measurement. Furtherm ore, decreased self-reporting  capabilities ge­
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nerally make ratings more cumbersome. Measurement problems associated with 
anosognosia,44:45 response sh ift,3U;4i" 4s and bias of proxy-rating have previously been 
proven.23;36;3SQ uality  of life is regarded as a problem atic outcom e measure, especi­
ally by the regulatory authorities such as Food and Drug A dm in istra tion (FDA) and 
European Medicines Agency (EMEA).
W hat do es this thesis add to existing know ledge?
This thesis provides an overview of current knowledge about m ethodologica l qua­
lity  o f life issues and about m easurement problems in fra il and demented elderly 
persons. It is im portant to  include both generic and dementia-specific quality of 
life indicators, because factors outside the  domain dementia are also very im por­
tan t fo r both people w ith dementia and the ir caregivers.
Q uality  o f life is an im portant top ic  in geriatric medicine including dementia care. 
This is true in considering it an endpoint as well as a starting  point of treatm ent, 
counseling, and selection and p rio ritiza tion of interventions. Besides employing 
quality  o f life instrum ents to  evaluate interventions, quality  o f life can also be used 
as a guide to  the selection of the type o f clinical in tervention based on the prefe­
rences of the individual. Providing choices to  patients has become a tenet o f good 
quality  clinical care.
Efficiency studies in macroeconomic research enable policymakers to  obtain pa­
tien t oriented relevant data fo r evidence based policy planning. The newly deve­
loped DQI has the potential to  become a more accurate quality  o f life outcom e 
measure fo r tria ls and economical decision making. The DQI can become the first 
dementia-specific HRQoL index measure allowing overall quantification o f relevant 
health domains into one single figure.
Q uality of life analysis, in clinical research, may contribute to  better targeted demen­
tia care for patients and caregivers. The concept of quality of life provides the oppor­
tun ity  for needs based and goal-oriented dementia care. Dementia is still an incurable 
disease. This justifies a palliative policy. According to  the W HO  definition improving 
quality of life o f patients and informal caregivers, and addressing the ir needs, are a 
specific part of palliative care. We introduced a theoretical fram ework to  address the 
interplay between meeting of needs and consequent improvement of quality of life 
in dementia: the Hierarchy Model o f Needs in Dementia (HMND; see chapter 4). We 
encourage a goal-oriented treatm ent based on analysis of needs of patient and care­
giver pairs. The method will be described in the section on future plans.
W e showed tha t caregivers experienced a worse quality o f life than healthy elderly 
and patients w ith mild to  m oderate A lzheim er's dementia (see chapter 7). Based on 
the principles of palliative care and the results described in this thesis, we advise
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clinicians tha t caregivers should be supported as well, to  prevent caregiver burnout 
and unnecessary early institu tiona liza tion  of dementia patients.
During the course of dementia a great deal o f he terogeneity exists regarding the 
m anifestation of, and the coping w ith, cognitive and non-cognitive symptoms, also 
dependent on type of caregiver and type of dementia. This means tha t dementia 
care should be individualized. Unfulfilled needs of patients as well as caregivers 
play an im portant role in decreasing quality  of life. By identify ing  unm et needs in 
dementia research, and focusing on unm et needs in dementia care, much can be 
done to  improve quality  o f life o f both patients and caregivers. Preparation of pa­
tien ts  and caregivers to  participate w ith professionals in making the best possible 
trea tm en t decisions, consistent w ith realistic goals o f patients and caregivers, will 
enable optim al dementia care. In the fu ture  plans section of this thesis we in tro ­
duce Dementia Personalized Care Planning (DPCP) as a practical too l.
Based on our data and the determ inants o f quality o f life in patients and caregivers 
(chapter 9), an im portant focus fo r patient care is adequate trea tm en t o f co-mor- 
b id ity  and mood, whereas the main focus during caregivers' guidance is to  streng­
then the ir sense of mastery and to  treat any caregiver depression. Longitudinal re­
search is needed to  confirm this. Based on this data the orig inal conceptual model 
o f quality of life (figure 2, page 23) was converted into a practical simplified model 
o f health outcom es in dementia w ith only the relevant determ inants (figure 3).
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Figure 3. Empirical m ode l o f  health outcomes in dementia
The explicit inclusion of quality of life of patients and caregivers into one single model 
is a new approach to  quality o f life understanding. In our cross-sectional analysis qua­
lity of life o f patients and caregivers is only modestly associated and both are primarily 
dependent on the ir own personal determinants. The consequence is that caregivers 
should be considered and treated like the second patients. High quality clinical de­
mentia care is combined care for patients and caregivers!
Recently a broad general intervention program by memory clinics showed no benefit 
in activities of daily living in patients with Alzheimer's disease and may, therefore, have 
little public health value.47 Apart from the question whether this study targeted the 
appropriate outcome, results may likely also be explained by the fact that dementia is 
a complex and heterogeneous condition. Consequently, to  have a beneficial effect on 
care management, interventions must target the specific and individual needs of pa­
tients, as well as caregivers. To advance the field of clinical dementia care we propose 
Dementia Personalized Care Planning (DPCP), as described in the future plans.
Future plans beyond this thesis
Involving quality of life in research and treatm ent o f dementia is necessary to  do justice 
to  the increasing health, societal and economical problems associated with dementia. 
Quality of life evaluation plays a key role in delivering successful dementia care, and 
in assessing the efficacy and efficiency of disease-modifying interventions once they 
become available. Research in quality of life can employ quantitative and qualitative 
methods. Quantitative methods have value in facilitating reproducibility in clinical
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research studies, but have a concomitant risk of losing the subtlety and distinctions 
experienced by patients living with health problems. Qualitative methods offer the 
opportunity for studying the lived experience of a disease and its treatm ent.51-1 The 
conclusion of this thesis is that the role of quality of life measurement in research, deci­
sion making and resource allocation is still insufficient. Inclusion of quality of life, be it 
quantitative or qualitative, is necessary to  meet the upcoming medical, social and eco­
nomic challenges associated with increasing prevalence of this still incurable disease. 
Frequency and burden of informal care will increase with the rising number of demen­
tia patients and declining availability of professional care. This adds to  the necessity to 
involve quality of life of caregivers in successful clinical care of the dementia patient. A 
communication style in which healthcare professionals acknowledge the needs of both 
parties and address physical health problems and psycho-social issues of patients as 
well as caregivers will contribute to  a higher satisfaction and better health outcomes. 
How can we involve quality o f life qualitatively and quantitatively in dementia care 
and research? A t this tim e, benefits can be gained by explicitly including quality of life 
assessment and treatm ent in clinical care fo r dementia patients and caregivers. For the 
future we intend to  further develop and introduce Dementia Personalized Care Plan­
ning (DPCP) to  realize the qualitative improvement and the Dementia Quality of life 
Instrument (DQI) to  achieve the quantitative improvement.
Our DPCP will be based on the choices and choosing (C-C) model of Gurland et al.3:51:52 
This model introduced a science base for understanding and guiding interventions 
that can assist people to  achieve the ir quality of life goals. The C-C process is the 
personal management of accessing choices and choosing among them. This leads 
to  rational and person-specific clinical interventions. People are then in a position to 
participate, with clinical help and guidance, in the relief of the ir distress.53The expec­
ted result is improved quality of life. DPCP is a pivotal procedure to  guide treatm ent 
based on personal needs and goals of both patients and caregivers. DPCP will be 
based on a standard protocol according to  the C-C model, supplemented with struc­
tured eliciting of realistic most urgent problems and needs that can be converted into 
corresponding concrete goals. These goals are used for care planning, treatm ent and 
evaluation during follow-up visits, to  enhance the chance o f successful combined care 
fo r patients and caregivers. In clinical practice the DPCP gives valuable information 
that can indicate areas in which patients and caregivers are most affected and help 
practitioners in making the best choices in patient care. DPCP has the potential to 
become a novel too l for post-diagnosis treatm ent by multidisciplinary memory clinics. 
Based on form er research, the 19 most frequently occurring needs and quality o f life 
domains in dementia were identified and translated into Dementia Need Cards. Dyads 
of dementia patients and caregivers will be offered 20 cards, including a 'wild card' to
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nominate one personal need not provided by the predefined ones. The dyads subse­
quently select three need cards most relevant fo r the ir situation at this moment. The 
needs are converted into corresponding concrete goals, on which realistic milestones 
are set. These goals and milestones may be applied for care planning and treatment in 
the upcoming half year, and fo r evaluation during regulatory memory clinic visits. This 
approach enables individualized post-diagnosis dementia care, may enhance efficient 
use of scarce resources, promote quality of life o f patients and caregivers, and add to 
prevention of caregiver burnout and unnecessary institutionalization.
And the next specific research step concerning the DQI is to  conduct a large general 
population study to  derive an algorithm that converts the five separate DQI domains 
scores into one overall metric health-related quality-of-life value, the DQI Index. This 
process is called valuation. A  grant from the Netherlands Organization for Health Re­
search and Development provides funds for the study which has recently started. The 
DQI Index will enable unequivocal interpretation of subjective dementia-related qua­
lity of life scores. The valuation system and DQI will together form the first dementia- 
specific health-related quality of life index instrument, applicable fo r evaluation o f ef­
ficacy and efficiency of large-scale intervention studies in dementia.
Final remarks
Quality of life deserves a leading role in dementia treatment. The challenge lies in 
convincing professionals and decision-makers to  recognize the integrated burden of 
the disease, including its interaction with co-morbidities and burden on caregivers. A 
paradigm shift in thinking about dementia is necessary: it is important to  recognize 
quality of life as the start- and endpoint of the palliative treatm ent of this still incurable 
chronic disease.
This thesis is intended to  contribute to  the awareness for quality o f life in all fields of 
dementia research and clinical practice. This will be beneficial fo r both patients and 
caregivers. Therefore, and from deep respect for the daily struggle of all dementia 
patients and the ir caregivers, this thesis is dedicated to  all persons confronted with 
dementia.
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A ch tergron d
Steeds meer mensen worden oud. Sommige mensen lijden daaronder: oud w or­
den wil iedereen, oud zijn wil niemand. O uder worden kan gepaard gaan met ach­
teruitgang van lichamelijke en /o f geestelijke functies, met verlies van onafhanke­
lijkheid, sociale contacten en rollen, gezondheid, geheugen, en de hierbij horende 
rouw. Veel mensen beschouwen dem entie als een afschrikwekkend levenseinde 
en als bedreiging voor de kwalite it van hun laatste levensfase. De schrijver Hugo 
Claus maakte d it in 2008 heel duidelijk  door, na een persoonlijke afweging van zijn 
(verwachte) kw alite it van leven, in het beginstadium  van de ziekte van A lzheim er 
bewust voor euthanasie te  kiezen. Kwalite it van leven en kw alite it van sterven lig­
gen dicht bij elkaar. Beide zijn belangrijke onderdelen van de palliatieve zorg die 
hoort bij een nog steeds onbehandelbare ziekte als dem entie. In d it proefschrift 
bespreken wij defin itie , theorie  en dagelijkse praktijk  van kwalite it van leven bij de­
mentie. W ij stelden de volgende onderzoeksvragen: welke valkuilen en problemen 
zijn er bij het meten van kwalite it van leven bij dem entie? W ie m oet de kwalite it 
van leven van mensen m et dem entie beoordelen? W elke meetschalen kunnen het 
best worden gebruikt? O ok brengen we verslag uit over ons eigen onderzoek en 
m ogelijke nieuwe ontw ikkelingen.
Definitie en meten van kw aliteit van leven
Er bestaat geen overeenstemming over wat kwalite it van leven precies is. Kwaliteit 
van leven is niet direct observeerbaar, maar uit zich in gedachten, gedrag en em o­
ties. O ok het meten ervan is moeilijk. Bovendien wisselt kwalite it van leven, zowel 
binnen één persoon als tussen mensen. De beste beoordelaar is de betrokkene 
zelf. Dementiegerelateerde kwalite it van leven is het deel van kwalite it van leven dat 
wordt bepaald door de dementie. Bij tw ijfe l over het oordeelsvermogen van mensen 
met dementie kan men een ander vragen hun kwalite it van leven te beoordelen. Bui­
tenstaanders kunnen dit echter slechts indirect afleiden, bijvoorbeeld uit iemands 
gedrag. Onderzoek laat zien dat mantelzorgers de kwalite it van leven van mensen 
met dementie slechter vinden dan de betrokkenen zelf (zie de alinea hieronder).
Het is belangrijk om onderscheid te  maken tussen oorzaken van kwalite it van leven 
en gevolgen van kwalite it van leven. Somberheid kan b ijvoorbeeld een gevolg zijn 
van een slechte kwalite it van leven. Het verschil is niet altijd  vast te stellen, maar is 
wel van belang. Oorzakelijke factoren kunnen nam elijk soms worden beïnvloed of 
behandeld om de kwalite it van leven te  verbeteren.
Theorie
Mensen met dem entie ervaren soms een betere kw alite it van leven dan b u iten­
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staanders verwachten én dan zijzelf tevoren hadden (kunnen) voorzien. Dit staat 
bekend als de 'd isab ility  paradox': het verschijnsel dat mensen met een ernstige 
chronische ziekte hun kw alite it van leven goed vinden, te rw ijl anderen dat leven 
onwenselijk achten. Het is een vorm van aanpassing en acceptatie die het onder­
werp euthanasie bij dem entie nog ingew ikkelder maakt. D it verschijnsel uit zich bij 
het meten van kw alite it van leven als zogenaamde 'response shift'. Response shift 
is het veranderen van de eigen waardering van kwalite it van leven door herijking en 
w ijziging van p rio rite iten  of concepten.
Dit alles, en het fe it dat dementie meerdere oorzaken kan hebben, maakt dementie 
een complexe ziekte. Dementie heeft nog meer dan andere ziekten invloed op aller­
lei facetten van het leven. De opvatting w int dan ookte rre in  dat ju ist bij een nog niet 
te  genezen ziekte als dementie mensen zelf moeten bepalen wat het belangrijkste 
behandeldoel is. Kwaliteit van leven meting is een goede manier om aan te tonen of 
een behandeling betekenisvol is voor mensen met dementie en mantelzorgers. Het 
verband tussen ernst van ziekte en kwalite it van leven is echter niet altijd duidelijk 
voorspelbaar. Bovendien wordt kwalite it van leven ook bepaald door andere factoren 
die niets met de ziekte te  maken hebben, zoals inkomen of woonomstandigheden. 
Kwalite it van leven is een belangrijke maar m oeilijke uitkom stm aat. Het is een sub­
jec tie f begrip, dat ob jectie f m oet worden gemeten. Bovendien bestaat er geen 
overeenstem m ing over wat kwalite it van leven nu precies inhoudt. Kwalite it van 
leven(meting) is complex. Daarom is een duidelijk  theoretisch model nodig.
M eetpraktijk kw aliteit van leven
Dit proefschrift geeft een overzicht van meetinstrumenten en meetproblemen bij 
kwetsbare ouderen en dementie. W ij hebben eerst onderzocht welke gebieden be­
langrijk zijn voor mensen met dementie en of we die gebieden ook terugvinden in 
bestaande meetschalen. Vier instrumenten leken het meest geschikt. D it waren twee 
zelfbeoordelingschalen: voor milde dementie de Schedule fo rth e  Evaluation of Indivi­
dual Quality of Life (SEIQoL) en voor matig ernstige dementie de Quality of Life-Alzhei- 
mer's Disease Scale (QOL-AD). Beide kunnen kwaliteit van leven van zowel patiënten 
als mantelzorgers meten. Bij ernstige dementie zijn observatieschalen beter bruikbaar: 
de Qualidem of de Discomfort scale-Dementia of A lzheimer Type (DSDAD).
Dem entie kan zelfbeoordeling  m oeilijker maken door afname van geheugen en 
oordeelsverm ogen. Maar ook beoordeling door mantelzorgers is problematisch. 
Zij ervaren de dem entie niet zelf, waardoor hun aanpassingsproces aan de ziekte 
anders verloopt. Inform ele mantelzorgers vinden de kwalite it van leven van mensen 
met dem entie slechter dan de betrokkenen zelf. W aarschijnlijk zijn mantelzorgers
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door de zorgtaken zodanig (over)belast dat d it hun oordeel negatiever maakt. Maar 
ook beoordeling door professionele verzorgers heeft nadelen en w ord t b ijvoor­
beeld beïnvloed door tevredenheid over het werk. Zelfbeoordeling  van kwalite it 
van leven bij dem entie heeft dus de voorkeur. Bij longitudinaal onderzoek, waarbij 
men mensen m eerdere ja ren volg t en onderzoekt, is g e lijk tijd ige beoordeling door 
patiënten zelf en hun mantelzorgers een optie. H iermee w ordt voorkom en dat er 
onvoldoende gegevens over het be loop zijn als de dem entie erger wordt.
O n d e rzo e k naar kw aliteit van leven bij dem entie
De AD-Euro studie is een Nederlands onderzoek naar doelm atigheid van zorg 
en kw alite it van leven bij mensen m et m ilde to t matig ernstige dem entie en hun 
mantelzorgers. De studie is uitgevoerd door A lzheim er Centra en geheugenpoli- 
klinieken. De he lft van de mensen werd na het stellen van de diagnose gedurende 
een jaar behandeld door de eigen huisarts en de andere he lft door de geheugen- 
polik lin iek. Uit de eerste analyse bleek dat er maar een beperkte relatie was tussen 
kw alite it van leven van patiënten en mantelzorgers. Kwalite it van leven van beiden 
werd ook voornam elijk bepaald door hun eigen kenmerken. Voor patiënten waren 
d it ziekte last en stem ming, voor mantelzorgers stem m ing en het gevoel de situatie 
te  beheersen. Op basis van deze resultaten pasten we het model voor kw alite it van 
leven bij dem entie aan (zie figuur 3, pagina 172).
Het geven van mantelzorg bij dem entie le idt vaak to t slechtere gezondheid en 
welzijn. Er bestaat grote variatie in optreden van en omgaan met dem entiesym pto- 
men. D it hangt ook af van het type zorgverlener en het type dementie. W e toonden 
in eerder onderzoek aan dat mantelzorgers hun kw alite it van leven slechter vinden 
dan gezonde ouderen en mensen m et dem entie (hoofdstuk 7). Kwalite it van leven 
van de m antelzorgers w ord t dus evenzeer beïnvloed. D it kan leiden to t  m antel- 
zorger burnout en onnodig snelle verp leeghuisopnam e. Aandacht voor kwalite it 
van leven van mantelzorgers is daarom belangrijk! Ons onderzoek geeft aan op 
welke factoren speciaal gele t m oet worden.
Bij het onderzoeken van kw alite it van leven is het gebruiken van de ju iste  m eet­
schaal erg belangrijk. Die meetschaal m oet ook geschikt zijn voor het berekenen 
van de kostene ffec tiv ite it van een behandeling. D it gebeurt m et specifieke instru­
m enten die iemands gezondheidstoestand op bepaalde gebieden m et enkele 
vragen in kaart brengen. Die gebieden zijn b ijvoorbeeld gezichtsvermogen, m o­
b ilite it, geheugen, em otie  en pijn. Hieraan w ord t vervolgens een waardering to e ­
gekend en dat is de u tilite it. D it is meestal een getal tussen nul en één, waarbij nul 
staat voor dood en één voor perfect gezond.
De DQI (Dementia Q ua lity  of life Instrument) die in d it proefschrift w ord t beschre­
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ven is een dem entiespedfiek waarderingsinstrum ent. Het brengt de gezondheids­
toestand dem entie in kaart. D it type m eetinstrum ent bestond wel voor andere 
ziekten maar nog niet voor dementie. Het invullen van de DQI is niet m oeilijk. We 
hebben de betrouwbaarheid ervan getest in de A D-Euro studie. O ok vroegen we 
dem entieprofessionals naar hun oordeel over de Ínhoud. De resultaten hiervan zijn 
beschreven in hoofdstuk 10. De volgende stap is het uitdrukken van de N ederland­
se waardering van de gezondheidstoestand dem entie gemeten met de DQI. Zon- 
MW  heeft hiervoor een subsidie verstrekt. B innenkort begint een onderzoek onder 
een deel van de Nederlandse bevolking. Daarna kan met m oderne analysetech­
nieken een a lgoritm e (computerrekenprogramm a) worden geconstrueerd dat de 
individuele scores op de DQI om rekent naar de maatschappelijke waardering er­
van. M et de com binatie van deze waardering en de tijdsduur van de betreffende 
gezondheidstoestand worden de zogenoem de 'kwalite it-van-leven gecorrigeerde 
levensjaren' (QALYs) berekend. In de afgelopen jaren zijn QALYs voornam elijk u it­
gerekend m et algemene meetschalen zoals de EQ-5D. In de toekom st kan de DQI 
h iervoor m ogelijk  worden gebru ikt bij dem entieonderzoek. Dit kan de maatschap­
pelijke last van dem entie in een getal uitdrukken. Het is dan ook m ogelijk  om de 
resultaten van verschillende behandelingen m et elkaar te  vergelijken.
Hoe nu verder?
Recent bleek uit een Frans onderzoek, de PLASA studie, dat het functioneren op 
het gebied van activ ite iten van het dagelijks leven van mensen met de ziekte van 
A lzheim er niet verbeterde na behandeling door geheugenpolik lin ieken.47 Deze 
studie vergeleek tw ee vormen van begeleid ing door geheugenpolik lin ieken: zeer 
gestructureerd versus ongestructureerd. In de A D-Eurostud ie vergelijken wij twee 
vorm en van ongestructureerde gebruikelijke behandeling, namelijk die door ge­
heugenpoliklin ieken en huisartsen.
Dem entie is een complexe en heterogene ziekte. W ij p leiten er dan ook voor dat de 
behandeling w ord t afgestemd op de individuele behoeften van mensen met de­
m entie en hun mantelzorgers. Het 'choice en choosing' (C-C) m odel geeft toegang 
to t m ogelijke keuzen en het h ieru it kunnen kiezen. Het kan mensen helpen bij het 
bereiken van hun kw alite it van levendoelen.3:51:52 D it s lu it aan bij ons theoretische 
model: het Hierarchy M odel of Needs in Dementia (HMND; zie hoofdstuk 4). Door 
signaleren van onvervulde behoeften en proberen deze te  verbeteren, kan veel 
worden gedaan voor de kw alite it van leven van patiënten en mantelzorgers. Goede 
zorg (h)erkent de behoeften van beide partijen. Gepaste behandeling van patiën­
ten en mantelzorgers draagt bij aan verbetering van kw alite it van zorg en leven. 
Om d it in de praktijk te  verwezenlijken kan Dementia Personalized Care Planning
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(DPCP) worden gebruikt. D it is een m ethode om de behandeling af te  stem men op 
persoonlijke behoeften en realistische doelen van patiënten en mantelzorgers. W ij 
w illen DPCP in de praktijk gaan gebruiken. Op grond van eerder onderzoek zijn de 
19 meest voorkom ende behoeften en gebieden van kwalite it van leven ge ïden ti­
ficeerd en om gezet in 'Dem entia Need Cards'. Uit deze kaarten kiezen patiënten 
en mantelzorgers er samen drie die het belangrijkst zijn voor hun huidige situatie. 
Daarna worden concrete en haalbare doelen afgesproken. Die worden gebruikt 
voor de planning van zorg en behandeling in de komende periode. Deze aanpak 
verg root de kans op inhoudelijke verbetering van de dem entiezorg. Door gericht 
te  proberen onvervulde behoeften te verm inderen kan kw alite it van leven worden 
verbeterd.
O pd rach t
De conclusie van d it p roefschrift is dat kwalite it van levenm eting nog niet zover is 
dat het een hoofdrol kan spelen bij onderzoek, behandeling en beslu itvorm ing. 
Maar het betrekken van kw alite it van leven bij onderzoek en behandeling van de­
m entie is onverm ijde lijk  om de medische, sociale en economische uitdagingen 
van het toenem ende aantal mensen m et deze nog steeds ongeneeslijke ziekte het 
hoofd te  bieden. Kwalite it van leven, kwalite it van zorg en kw alite it van sterven 
staan dicht naast elkaar en er is een omslag in dem entiezorg nodig. Zorg kan pas 
succesvol zijn als deze zich richt op het vervullen van individuele behoeften en op 
factoren waarvan door onderzoek is aangetoond dat ze belangrijk zijn voor kwali­
te it van leven. Gem iddeld zijn bij de zorg voor één dem ente oudere bijna 4 m ante l­
zorgers betrokken. De mantelzorglast w ord t g ro ter door het toenem ende aantal 
mensen m et dem entie en de afnem ende financiële m iddelen voor professionele 
zorg. Begeleiding en als het nodig is behandeling van mantelzorgers m oet dus een 
nadrukkelijk onderdeel van dem entiezorg worden.
Méér aandacht voor levenskwalite it is belangrijk om op de ju iste manier het hoofd 
te  bieden aan de medische, sociale en economische uitdagingen van dementie. 
Bovendien m oet begeleid ing van mantelzorgers een routinem atig  en dus normaal 
vergoed onderdeel van dementiezorg worden. Dit zal bij afname van de beschik­
bare beroepsbevolking zeker een doelm atige investering blijken!
Hopelijk draagt d it proefschrift bij aan bevordering van aandacht voor kwalite it 
van leven en zorg bij dem entie. Zowel patiënten als mantelzorgers hebben hier 
recht op. Het proefschrift w ord t dan ook opgedragen aan alle mensen die worden 
geconfronteerd met dementie.
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C U R R IC U LU M  V ITA E
Carla Schölzel werd op 12 maart 1951 in Am sterdam  geboren. Zij volgde het a the­
neum aan het Pius X  college in Am sterdam  en begon in 1969 met de studie ge­
neeskunde aan de Universiteit van Am sterdam. In haar eerste studiejaar trouw de 
ze met Justien. In 1976 begon ze aan de specialisatie Inwendige Geneeskunde in 
het Zuiderziekenhuis in Rotterdam, met als op le ider Prof. Dr. W.H. Birkenhager. In 
1982 volgde inschrijving in het specialistenregister Inwendige Geneeskunde. Van 
1982-1984 deed ze wetenschappelijk onderzoek op de afdeling Hem ato log ie van 
het Rotterdams Radiotherapeutisch Instituut in com binatie m et klinisch werk op de 
afdeling Hem atologie. Toen tro k  de volled ige patiëntenzorg toch weer en werkte 
ze enkele jaren als in tern ist in Leerdam. Na een kort intermezzo in het verp leeg­
huis begon ze in ju li 1989 aan de specialisatie Klinische Geriatrie in het Rijnstate 
Ziekenhuis in Arnhem , met als op le ider Dr. E. Bruijns. In februari 1994 volgde over­
schrijving naar het specialistenregister Klinische Geriatrie. Zij w erkt sinds 1994 als 
klinisch geriater in het Slingeland Ziekenhuis in Doetinchem  waar zij samen met 
anderen het Geriatrisch Onderzoek en Adviescentrum uitbouw de to t de huidige 
afdeling klinische geriatrie met geheugencentrum , valkliniek, dagkliniek, p o lik li­
niek en uitgebre ide consultfunctie. Het aantal m edewerker breidde zich in de loop 
van de jaren uit to t nu 5 klinisch geriaters, 2 psychologen, 2 psychodiagnostisch 
werkenden, 2 maatschappelijk werkers, 4 verp leegkundigen waaronder een ver­
pleegkundig consulent en een verp leegkundig specialist, en de uitgebre ide en 
gewaardeerde ondersteuning van doktersassistenten en secretaressen. Naast het 
klinisch werk was er (niet nodig, maar goed en leuk) gelegenheid om te p rom o­
veren, onder de stim ulerende leiding van vooral Prof. Dr. Marcel O lde Rikkert (en 
veel incasseringsvermogen en steun van het geliefde en onm isbare thuisfront!). 
Tijdens de afronding van d it proefschrift begonnen (iets te vroeg) de nieuwe u it­
dagingen al weer, zoals het samen m et Klaas Jansma en Pieter W olsw ijk  maken van 
een professionele film  over 'W inst en het verlies van ouder worden', het met de af­
deling pastoraal werk organiseren van een symposium over d it onderwerp in 2011 
en vooral de s tart van het Zowel NWA: het 'Zorg voor ouderen en welzijn N etwerk 
W est A chterhoek' (zie www.zowelnwa.nl). Kortom, geen gevaar voor het beroemde 
zwarte gat na deze dag!
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Het begon allemaal in het tuinhuis van Marja Jellesma. Daar ontstond het plan om 
misschien samen te  promoveren op het belangrijke onderwerp kwaliteit van leven. 
W e vonden allebei als enthousiaste klinisch geriaters dat het daar uite indelijktoch om 
ging. W e brainstormden hier over (na de gezellige gezinsmaaltijden in Oosterbeek) 
en begonnen ons eerste schrijfwerk. Samen keken we in Dublin bij Hannah McGee 
de SEIQoL kunst af (en bezochten we Ierse pubs). We ontwierpen en valideerden de 
Nederlandse versie van de SEIQoL. Dat was een goed begin. Maar onderzoek doen 
valt niet mee als er zoveel klinisch, organisatorisch en ander werk is. Dus wel een 
gezamenlijk artikel over d it onderwerp, maar geen promotie. Toen Marcel me een 
tijd  later aanbood om deze weg alsnog in te slaan aarzelde ik maar kort. N iet omdat 
promoveren nodig was, maar omdat wetenschappelijk werk zo leuk en kwaliteitsver­
beterend is! Dus Marja, nu staan we hier toch nog gezamenlijk, want niemand anders 
dan jij kan mijn paranimf zijn. De dag zou niet compleet zijn zonder jou! En hierna krij­
gen we hopelijk weer wat meer tijd  voor onze vriendschap en gezellige dingen. Net 
zo onmisbaar en geliefd als Marja is mijn maatje Klaas Jansma. Zonder jou zou mijn 
kwalite it van leven op het werk een stuk minder zijn. Ons trio  bestaande uit geriater, 
psycholoog en maatschappelijk werker (mijn andere maatje Marijke Maas, jam m er dat 
er geen drie paranimfen zijn!) heeft het geheugencentrum van het Slingeland Zieken­
huis gemaakt to t wat het nu is, inclusief het expertisecentrum voor jong dementeren­
den, onze gezamenlijke passie. A lleen jij, Klaas, kon de tweede paranimf zijn.
En dan natuurlijk mijn promotieteam : prof. dr. Marcel O lde Rikkert, dr. Paul Krabbe 
en dr. René Melis. Een kundiger, veelzijdiger, breder georiënteerde, aardiger, snel­
lere, altijd weer verrassende (etc. etc.) p rom otor dan Marcel kan niemand zich wen­
sen. Ik heb ongelooflijk  veel bewondering voor je! Ik reken erop dat ik ook na deze 
dag de weg naar Nijmegen zal blijven vinden, want samenwerken met jou is een 
groot plezier en een eer. Paul bracht zijn deskundigheid in op het gebied van (het 
meten van) health-related quality o f life, data-analyse en statistiek. Ik heb veel van 
je geleerd over d it voor een ongeoefende dokter moeilijke onderwerp. En niet te 
vergeten de m ooie figuren die je voor artikelen maakt en je gezellige verhalen over 
nieuwe huizen en nieuwe banen (nogmaals gefeliciteerd!). We gaan door met de 
valuatie van de DQI. René stimuleerde me iedere keer weer om een manuscript nog 
duidelijker en b e te rte  maken en wees me (een beetje) de weg in de moeilijke wereld 
van de regressieanalyse. Een epidem ioloog en didacticus 'pur sang'! En een ontzet­
tend aardig mens.
D it proefschrift werd beoordeeld door de manuscriptcommissie bestaande uit
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prof. dr. Myrra Vernooij-Dassen, prof. dr. Rose-Marie Dröes en dr. W im  Dekkers. Zij 
zijn allen zeer betrokken bij het onderwerp, vanuit verschillende invalshoeken. Myrra 
is expert op het gebied van psychosociale interventies bij dementie en onze gemeen­
schappelijke factor is het Alzheimer Centrum Nijmegen. Leve de Heidagen! Rose-Marie 
is expert op het gebied van kwaliteit van leven bij dementie. We hebben samengewerkt 
in de Leo Cahnwerkgroep over dit onderwerp en daar zijn een aantal goede artikelen 
en een afsluitend symposium uit voortgekomen. Wim verbindt geneeskunde, ethische 
aspecten en palliatieve zorg, alle onmisbare onderdelen van goede dementiezorg.
Ik dank ook de directie en mijn collega's van het Slingeland Ziekenhuis. Hoewel 
het to t stand komen van d it proefschrift grotendeels vrije tijdsw erk was, kreeg ik de 
gelegenheid om de indeling van mijn werkweek aan te  passen, zodat ik regelmatig 
naar N ijmegen kon. Promoveren zonder e-mail is tegenw oord ig  niet meer u itvoer­
baar. Maar ook de route naar N ijm egen is inm iddels zo bekend dat zelfs ik de navi­
gator met eindbestem m ing Radboud O ost allang niet meer nodig heb.
Als buitenpromovendus met een fu lltim e klinische baan elders maakte ik niet echt 
deel uit van de onderzoeksgroep van het Radboud. Toch voelde ik me er altijd wel­
kom. Ik werd iedere keer weer blij verrast door de aardigheid en belangstelling van 
de secretariaatsmedewerkers van de geriatrie en de onderzoekers. De meeste con­
tacten waren met he tteam  van de AD-Eurostudie, met onder andere Dr. Eddy Adang 
van de HTA afdeling die me op zijn heldere manier duidelijker maakte wat gezond- 
heidseconomisch onderzoek is. En natuurlijk Els Meeuwsen, hoofdonderzoeker van 
de AD-Eurostudie en mede promovendus. Succes en sterkte met de laatste loodjes. 
De laatste tijd  is Sander Arons erbij gekomen, promovendus mede dankzij onze Zon- 
MW  subsidie voor het valueren van het nieuwe dementiespecifieke waarderingsin- 
strum ent voor kwalite it van leven bij dementie, de DQI. W e gaan gewoon door!
En last but not least Ton Smets en Rae Schilling, beiden Ph.D, Psy.D en licensed psy- 
chologists (Rae zelfs Professor Emerita) in de USA. Hun ideale combinatie van w eten­
schappelijke en tweetalige deskundigheid was onmisbaar om er een goed leesbaar 
Engels boek van te  maken. En bovendien is de cirkel weer rond: via Marja zorgden 
jullie  destijds ook voor de gevalideerde Nederlandse vertaling van de Engelse SEI- 
QoL, dus jullie  hoorden er van het begin af aan bij. Heel harte lijk bedankt!
Maar het a llerm eest dank ik natuurlijk Justien, my one and only. Liefste Justien, bij 
jou kan ik mezelf zijn en nu gaan we écht (cross my heart!) meer tijd  besteden aan 
de leuke dingen die onze eigen kw alite it van leven bepalen.
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